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ABSTRACT  
 Drinking water disinfection was one of the major public health accomplishments of 20th 
century.  Water disinfection helps in reducing waterborne diseases like typhoid fever, cholera, 
and hepatitis A. However, chemical water disinfection also produces unwanted toxic chemicals, 
known as water disinfection by-products (DBPs). Most of the DBPs are cytotoxic, neurotoxic, 
genotoxic, mutagenic, carcinogenic and teratogenic but the toxicity mechanism is not completely 
understood. Therefore, the objectives of this dissertation were to i) understand the toxicity 
mechanisms and identify the molecular targets of all the regulated and non-regulated haloacetic 
acids (HAAs) water DBPs, ii) to differentiate among the toxicity mechanisms of mono-, di-, and 
triHAAs, iii) to evaluate the toxicity potential of chlorinated and chloraminated wastewater 
effluents, and iv) to evaluate the mutagenicity potential of the particle associated contaminants 
such as polyaromatic hydrocarbons (PAHs) associated with coal tar and soot, extracted from lake 
core sediments.  
Studies based on the toxicity mechanism of HAAs water DBPs demonstrated that 
monoHAAs were the strongest inhibitors of glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) where, di-, and triHAAs were weaker inhibitors. MonoHAAs greatly reduced the ATP 
contents of the cells. Unlike monoHAAs, triHAAs increased the cellular ATP levels as compared 
to the negative controls. Exogenous pyruvate supplementation rescued cells from monoHAA-
induced DNA damage and ATP depletion. These results confirmed that monoHAA-induced 
genotoxicity was due to GAPDH inhibition. HAAs not only affected the GAPDH kinetics and 
disturbed the cellular energy homeostasis but also increased pyruvate dehydrogenase complex 
(PDC) activity. Increased PDC activity by monoHAAs was due to changes in metabolite ratios 
e.g., ATP/ADP, and NADH/NAD ratio but the increase induced by di-, and triHAAs was due to 
the inhibition of pyruvate dehydrogenase kinase (PDK). Results demonstrated that HAA-induced 
toxicity is due to disruption in cellular energy homeostasis. This research demonstrated that there 
was a difference among the HAA-induced toxicity mechanisms and their molecular targets. 
MonoHAAs had an indirect effect on mitochondrial metabolism by inhibiting GAPDH, affecting 
the generation of pyruvate, inducing oxidative stress and reducing the final output of 
mitochondria in the form of ATP. Among monoHAAs, the rank order of toxicity was iodoacetic 
acid > bromoacetic acid >> chloroacetic acid (IAA > BAA >> CAA). This toxicity pattern was 
directly correlated with the inhibition of GAPDH kinetics, ATP depletion, and PDC activation. 
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Whereas, di- and triHAAs induced toxicity by directly affecting mitochondrial metabolism by 
PDK inhibition, which led to PDC activation.  
The toxicity potential of chlorinated and chloraminated wastewater effluents extracted 
with XAD-8 and XAD-4 resins was evaluated. For chlorinated water, the organic extracts eluted 
from XAD-8 were more cytotoxic than that of the chloraminated wastewater extracts. However, 
the XAD-4 extracts of the chlorinated wastewaters and chloraminated wastewaters did not show 
any significance difference. Unlike the cytotoxicity analyses, the chloraminated wastewater 
XAD-8 extracts showed a higher genotoxic effect in mammalian cells than the XAD-4 extracts. 
Thus the major cytotoxicity and genotoxicity components in wastewater effluents were 
associated with hydrophobic acid fractions as compared to the transphilic acid fractions. 
The mutagenicity evaluation of the coal tar and soot associated polyaromatic 
hydrocarbons (PAHs) from lake sediments demonstrated that the coal tar and soot extracts were 
not direct acting mutagens but needed S9 microsomal activation. It was also found that coal tar 
extracts induced a higher rate of base pair substitution mutations as compared to the induction of 
frameshift mutations. Soot extracts induced a relatively higher rate of frameshift mutations as 
compared to the coal tar extract frameshift mutation rate.     
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"Have ye observed the water that ye drink? Is it ye who shed it from the raincloud, or are do we? If 
we willed we verily could make it salt. Why, then, give ye not thanks? (Quran 56: 68-70).   
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CHAPTER 1 
INTRODUCTION AND LITERATURE REVIEW  
1.1. INTRODUCTION  
 Contaminated water is a major health risk throughout the world; contamination, whether 
natural or anthropogenic affects the quality of life and the public health (World Health 
Organization 2011; Ngwenya et al. 2013). Drinking water disinfection was the greatest public 
health achievement of the 20th century (Cutler and Miller 2005).  When water from melted snow 
and rain flows into source water such as lakes and rivers, it collects a variety of toxic chemicals 
from variety of surfaces with some from the sealcoating of roads, streets and parking lots e.g. 
polyaromatic hydrocarbons (PAHs) and pathogens e.g. bacteria and viruses that come from 
wastewaters. These different sources of pollutions may generate drinking water contamination 
and habitat degradation for aquatic life. In order to provide safe drinking water to hundreds of 
millions of Americans, source water is processed and disinfected to reduce pollutants and 
waterborne diseases. Water disinfectants are powerful oxidizing agents and they react with the 
natural organic matter and other water contaminants and inadvertently produce toxic water 
disinfection by-products (DBPs) (Richardson et al. 2007a; Richardson and Postigo 2012). Safe 
drinking water is a pivotal factor of the quality of human life and lakes and rivers provide 
habitats for aquatic life and are used as source water for drinking water. It is an important goal to 
study the toxicity of water contaminants (Plewa and Wagner 2015). In this dissertation, I discuss 
the toxicity mechanism of haloacetic acid water DBPs, DBPs generated in water after 
chlorination of wastewaters, and toxic agents associated with contaminants originating from 
sealcoats in lake sediments and wastewaters. Thus the overall theme of this dissertation is water 
and the generation of anthropogenic mediated toxic contaminants in water.  
1.2. WATER DISINFECTION BY-PRODUCTS AND ADVERSE HEALTH OUTCOMES  
 The introduction of water disinfection was associated with the recognition that drinking 
water was a significant source of infectious disease transmission. Drinking water disinfection 
safeguarded against waterborne diseases, e.g., typhoid fever, cholera, amoebiasis, shigellosis, 
salmonellosis, and hepatitis A (Akin et al. 1982). In water treatment processes, controlling 
waterborne diseases by eliminating microbiological contaminants is achieved by two basic 
approaches, removing pathogens from the water or inactivating the pathogens. Inactivating 
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pathogens as a water treatment strategy is referred to as disinfection. In 1881, Koch, 
demonstrated that chlorine can inactivate pathogenic bacteria (Koch 1881).  In the United States, 
chlorine was first used for water disinfection in New Jersey, in 1908 (American Chemistry 
Council 2015). In water works practice, the purpose of disinfection is not just the inactivation of 
microorganisms in the source water (primary disinfection) but also to avoid regrowth of these 
pathogens by maintaining a disinfectant residual in the treated-water distribution system 
(secondary disinfection) (Crittenden et al. 2012).  Disinfectants are powerful oxidants and they 
not only kill harmful microorganisms but also generate toxic water disinfection by-products 
(DBPs) (Krasner 2009). DBPs are formed when chemical disinfectants (chlorine, chlorine 
dioxide, chloramine, and ozone) react with organic precursors such as, natural organic matter 
(NOM), and inorganic precursors such as halide ions. Disinfectants oxidize organic and 
inorganic precursors and convert them into DBPs (Krasner 2009). More than 600 DBPs have 
been identified (Richardson et al. 2007b). The spectrum of DBPs in water is influenced by a 
variety of factors, which include the type of disinfectant used, the concentration of disinfectant, 
reaction time, NOM concentrations and other organic chemical as dissolved organic carbon 
(DOC), pH, and temperature. In chlorinated water, the most abundant classes of DBPs are the 
trihalomethane (THMs) and the haloacetic acids (HAAs) (Krasner et al. 2006; Krasner 2009). 
The first DBPs identified were THMs reported in chlorinated drinking water, in 1974 
(Bellar et al. 1974; Rook 1974). Rook showed for the first time that THMs were produced due to 
the reaction of chlorine with NOM in raw surface water (Rook 1974). After the discovery of 
chloroform in chlorinated drinking water, National Cancer Institute (NCI) published the results 
of a rodent cancer bioassay on chloroform, in 1976 (U. S. Environmental Protection Agency 
2001; Hrudey 2009), health concerns associated with chloroform and THMs lead to the adoption 
of drinking water guidelines and the development standards to control DBPs and reduce the level 
of consumer’s exposure to these hazardous chemicals. In 1979, under the Safe Drinking Water 
Act, the U.S. Environmental Protection Agency (U.S. EPA) issued the Total Trihalomethane 
Rule with a regulatory standard for THM4  (sum of chloroform, bromodichloromethane, 
chlorodibromomethane, and bromoform) at 100 µg/L (U. S. Environmental Protection Agency 
1979).  The U.S. EPA published the final Stage 1 Disinfectants/Disinfection By-Product 
(D/DBP) Rule in 1998 with the lowered THM4 maximum contaminant level (MCL) to be 80 
µg/L and regulated HAA5 (chloroacetic acid (CAA), dichloroacetic acid (DCA), trichloroacetic 
	   3	  
acid (TCA), bromoacetic acid (BAA), and dibromoacetic acid (DBA)) to a total maximum 
contaminant level of 60 µg/L (U. S. Environmental Protection Agency 1998). Afterwards, in 
2006, the final stage 2 DBP rule was established. The stage 2 DBP rule continued with the 
previous MCLs from stage 1 rule but added changes to monitoring design and determination of 
compliance of the rule (U. S. Environmental Protection Agency 2006).   
Concerns regarding the adverse health outcomes of DBPs initiated epidemiological 
studies to evaluate the health effects of these hazardous complex mixtures present in disinfected 
water. Epidemiological studies demonstrated a relationship between lifetime chronic exposure to 
DBPs and colorectal cancer (King et al. 2000; Bove et al. 2002; Rivera-Núñez and Wright 2013; 
Rahman et al. 2014), bladder cancer (King et al. 2000; U. S. Environmental Protection Agency 
2001; Villanueva et al. 2007), skin cancer (Karagas et al. 2008) and to a lesser extent adverse 
pregnancy outcomes (Chisholm et al. 2008; Jeong et al. 2012; Rivera-Núñez and Wright 2013). 
However, these DBPs showed a different carcinogenicity potential in animal studies and 
discrepancies in it’s carcinogenicity potential among males and females were also found (David 
and Elsebeth 1999). The discrepancies in carcinogenic potency of different DBPs might be 
because of the target organ specificity and species differences in sensitivity (Bull et al. 2011), but 
a gap in the knowledge connecting DBPs exposure and adverse health outcomes continues.  
Drinking water disinfection has undoubtedly improved the quality of life by inactivating 
pathogenic microorganisms present in source-waters and by controlling waterborne diseases in 
the developed countries. However, the unwanted generation of hazardous DBPs in drinking 
water chronically exposes a population to toxic agents and increases potential health risks 
associated with the drinking water disinfection. Different modes of toxicity for these DBPs were 
proposed including genotoxicity and oxidative stress but the mechanisms linking these toxicities 
to increased risk of cancer and other adverse health outcomes are not well understood. Further 
research on the molecular mechanism of toxicity of specific DBPs complexes and individual 
DBPs is essential to understand their cumulative effects and adverse health outcomes. 
Understanding DBP modes of action may also help in the identification of populations 
susceptible to the toxic effects of DBPs due to genetic polymorphisms for different genes e.g. 
those responsible for DNA repair, metabolic functions, and responses to oxidative stress.  
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Formation, Occurrence and Toxicity of Mono-, Di-, and Trihaloacetic acids    
 Formation and Occurrence of HAAs  
There are 10 HAAs commonly identified in drinking water; iodoacetic acid (IAA), 
chloroacetic acid (CAA), dichloroacetic acid (DCA), trichloroacetic acid (TCA), bromoacetic 
acid (BAA), dibromoacetic acid (DBA), bromochloroacetic acid (BCA), bromodichloroacetic 
acid (BDCA), chlorodibromoacetic acid (CDBA) and tribromoacetic acid (TBA) (Health Canada 
2008). HAAs belong to the family of halogenated aliphatic carboxylic acids and carry two 
carbon carboxylic acids in which one or more halogen atoms take the place of 
the hydrogen atoms attached to the α-carbon relative to the carboxylic acid (Figure 1.1). HAAs 
are present in water at neutral pH as salts or acetates (European Comission 2003) but in this 
document I refer to them as acids. HAAs are generated in treated water when chlorine or other 
disinfectants react with NOM e.g., fulvic acids and humic acids and inorganic DBP precursors 
e.g., halide ions (Br− and I−) naturally present in the raw water (WHO 2000; Stuart 2009). 
Various water treatment methods including chlorination, ozonotaion, and chloramination, lead to 
the formation of chlorinated, brominated and iodinated acetic acids. In the case of chlorination, 
hypochlorous acid (HOCl) and the hypochlorite ion (OCl) are formed, which then react with a 
bromide ion present in the water and oxidize it to hypobromous acid and hypobromite ion, 
respectively. Hypochlorous acid and hypobromous acid then react with NOM to form different 
DBPs, including HAAs. The chlorinated HAAs generally dominate; however, in high-bromide 
waters, the formation of brominated HAAs may be more frequent. Chloramination also results in 
HAA production if chloramine is produced by chlorination followed by ammonia addition 
(WHO 2000; Health Canada 2008). HAA formation may be more prevalent when drinking water 
is chlorinated under a slightly acidic pH. Whereas THM formation increases with increasing pH, 
HAA formation decreases, hydrolysis likely being a significant factor (Krasner et al. 1989; 
Pourmoghaddas and Stevens 1995). 
HAAs are the second most abundant classes of DBPs in chlorinated drinking water 
(Krasner et al. 2006). In 1989, a study on 35 U.S. utilities analyzed 19 different halogenated 
DBPs. The halogenated compounds, collectively, accounted for between 30 and 60% of the total 
organic halogen (TOX) found in those samples (Krasner et al. 1989). Hua et al conducted a study 
on the effect of 5 different oxidation treatments on the formation of DBPs using seven diverse 
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natural waters in the U.S. They found that the free chlorine formed more HAAs and TOX than 
chloramines or chlorine dioxide. The TOX produced by chlorination was 45.1% with the HAAs 
accounted for 15.4%, pre-ozonation/post-chlorination produced 43.4% and HAAs accounted for 
14.4%, chloramination produced 19.2% and HAAs accounted for 15.4%, 
preozonation/chloramination produced 16% and HAAs accounted for 11.2%, and chlorine 
dioxide produced 19.7% with HAAs accounted for 17.3%  (Hua and Reckhow 2007). Among 
halogenated DBPs, the di-, and tri-halogenated acetic acids with multiple chlorine, or mixed 
chlorine and bromine species were the most prevalent, however, the source waters with high Br- 
and I-, brominated DBPs may be the most dominant species (Krasner et al. 2006). A nationwide 
survey of DBPs occurrence at 12 water treatment plants was conducted in the U. S. It was found 
that in the plant effluents, the TOX on a median basis was 178 µg/L as Cl- with HAAs accounted 
for 12% on a median basis. The sum of the 9 HAAs in the surveyed plants ranged from 5 µg/L to 
130 µg/L with a median of 34 µg/L (Krasner et al. 2006). A survey of DBPs occurrence at 3 
different water supplies was performed in the U.K. to evaluate the levels of HAAs in the water 
and the relationship between HAAs and THMs, pH, temperature, and free and total chlorine. The 
source water for most of the samples was surface water. Some of the samples showed levels of 
total HAAs above 200 µg/L. MCAA was not measured and DCA levels were very high, above 
100 µg/L, which is above world health organization (WHO) level of 50 µg/L, while the TCA 
levels were lower than DCA. The overall mean value for the total HAAs was 35-95 µg/L with a 
maximum concentration of 244 µg/L. Total THMs were not a good indicator of HAAs levels and 
the ratios of total THMs and HAAs was significantly correlated with the temperature, pH, and 
free and total chlorine (Malliarou et al. 2005). A study was conducted to investigate the 
concentration of different DBPs including 9 HAAs in the water from 11 different Spanish 
provinces. HAAs concentration ranged from 0.9 to 86.9 µg/L with a median of 26.4. While DCA 
and TCA had the highest concentrations of 7.3 and 6.5 µg/L (median value), respectively, among 
other 9 HAAs, CAA and TBA occurred at lowest concentrations with 60% and 50% samples 
below the quantification limit, respectively. The sum of dihalo- and trihaloacetic acids showed 
similar concentrations of 12.7 and 13.3 µg/L (median value), respectively (Villanueva et al. 
2012).  
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In most studies, 9 HAAs were studied but not IAA. IAA was first discovered in the 
nationwide occurrence study in the U. S., (Plewa et al. 2004a; Krasner et al. 2006). One recent 
survey of DBP occurrence investigated 13 drinking water plants, in Shanghai China. The source 
waters were from the Yangtze or Huangpu rivers; the disinfectant was chloramine.  In these 
water systems 9 HAAs ranged from 3.31 µg/L to 48.55 µg/L; IAA was also detected in all the 
water supplies and the concentration ranged from 0.04 µg/L to 1.66 µg/L. The maximum IAA 
concentration of 1.66 µg/L was due to the higher concentration of   I-  (18 µg/L) in the source 
water (Wei et al. 2013a).    
In vivo and epidemiological and experimental studies demonstrated that DBPs are toxic. 
Epidemiological studies showed that increased risk of bladder and colorectal cancer was 
associated with DBPs (Villanueva et al. 2007). U. S. EPA estimated that 2-17% of bladder 
cancer cases in the U.S. may be induced by DBPs (U.S. Environmental Protection Agency 
1998). Furthermore, DBPs in chlorinated drinking water were associated with spontaneous 
abortion in a prospective study of 5144 pregnant women (Waller et al. 1998). In in-vivo studies, 
HAAs (DCA, TCA, and DBA) induced hepatocellular adenomas and hepatocellular carcinomas 
in B6C3F1 mice and F344 rats (Health Canada 2008) and DCA, DBA, and bromochloroacetic 
acid (BCA) altered intestinal microflora and metabolism in rats, which could also have an effect 
on bioactivation of promutagens or procarcinogen(George et al. 2000) . IAA induced malignant 
transformation in NIH/3T3 mouse embryonic fibroblast cells and when implanted in Balb/c nude 
mice, developed into highly aggressive fibrosarcomas (Wei 2013). Gestational exposure of 
mixture of HAA5 resulted in pregnancy loss and eye malformation in rats (Narotsky et al. 2011). 
Under ex-vivo conditions, monoHAAs were teratogenic and induced dysmorphogenesis in CD-1 
mouse embryos and affected neural tube development, eye development and produced anomalies 
in heart development (Hunter et al. 1996). HAAs were cytotoxic and genotoxic in Chinese 
hamster ovary (CHO) cells (Plewa et al. 2010), mutagenic in Salmonella typhimurium and CHO 
cells (Hunter et al. 1996; Kargalioglu et al. 2002; Zhang et al. 2010).  
In vitro studies showed that monoHAAs were more toxic than the diHAAs and diHAAs 
were more toxic than the triHAAs (Hunter et al. 1996; Kargalioglu et al. 2002; Plewa et al. 2002; 
Plewa et al. 2010). A variety of studies demonstrated that of the monoHAAs, IAA was the most 
toxic and CAA was the least toxic. These data indicated that the toxicity of these monoHAAs 
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was dependent on the type of halogen substituent (Hunter Iii and Tugman 1995; Plewa et al. 
2004b; Pals et al. 2011; Dad et al. 2013) 
 The focus of my project is on the toxicity mechanism of 10 HAAs (Figure 1.1). I present 
the toxicity mechanism(s) of the mono, di-, and trihaloacetic acids with variability in their 
chemical structures based on the number and type of their halogen substituent. The toxicity of 
the HAAs reported in the literature is reviewed below.   
 Toxicity of HAAs 
  HAAs are cytotoxic and genotoxic in mammalian cells (Plewa et al. 2002; Plewa et al. 
2010) mutagenic in Salmonella strain TA100 (Kargalioglu et al. 2002), induce reproductive and 
developmental toxicity (Narotsky et al. 2015; Teixido et al. 2015) , and carcinogenic (Pan et al. 
2014).   
HAAs Induced Mutagenicity   
 HAAs are mutagenic in variety of cell-based studies (Kargalioglu et al. 2002; Wang et al. 
2011).  Nelson et al studied the effect of cecal microbiota on the mutagenicity of HAAs and also 
the changes in the intestinal microflora and changes in the enzyme activities produced by the 
intestinal microflora. 1 mg/mL of CAA, BAA, DCA, DBA, TCA, TBA, and BCA in PYG 
medium was inoculated with rat cecal homogenate and was incubated at 37°C. HAAs 
mutagenicity in Salmonella TA100 was determined using microsuspension bioassay. After 15 h 
of incubation, the activities of beta-glucuronidase, beta-galactosidase, beta-glucosidase, 
azoreductase, nitroreductase, dechlorinase, and dehydrochlorinase was also determined. Results 
showed that all the HAAs except BCA were toxic to microflora. DBA, TBA, and BCA were 
mutagenic in the microsuspension assay, but the presence of the intestinal microflora did not 
significantly alter the mutagenicity. BCA increased the activities of several enzymes involved in 
the biotransformation of xenobiotics  (Nelson et al. 2001). HAAs were mutagenic in CHO-K1 
cells, when evaluated using hypoxanthine-guanine phosphoribosyltransferase (HGPRT) mutation 
assay (Zhang et al. 2010). The mutagenicity of HAAs was evaluated in Salmonella typhimurium 
strains TA98, TA100, and RSJ100 +/- S9. Among the three different strains used in the study for 
mutagenicity evaluation, TA100 - S9 was the most sensitive to the HAAs induced mutagenicity. 
The rank order for the mutagenic potency for HAAs excluding other DBPs involved in the study 
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was BAA > DBA > DCA > CAA with TBA and TCA not mutagenic. The mutagenic and 
cytotoxic potential of the different HAAs showed that brominated HAAs were more toxic than 
the chlorinated ones. Moreover, the mutagenicity potential of these HAAs had an inverse 
relationship with the number of halogen atoms present on the HAAs molecules (Kargalioglu et 
al. 2002).  
Genotoxicity and DNA Damage  
 Studies demonstrated that HAAs induce DNA damage (Plewa et al. 2002; Plewa et al. 
2010). Escobar et al studied the genotoxic and clastogenic effect of HAAs in primary human 
lymohocytes. All monoHAAs were genotoxic in the human lymphocytes with IAA being the 
most toxic followed by BAA and then CAA. The human lymphocytes showed less HAA-induced 
DNA damage repair as compared to the other mammalian cells. HAAs induced chromosomal 
aberrations in these human cells (Escobar-Hoyos et al. 2013). Using SOS/umu test with 
S. typhimurium, TA1535/pSK1002 without S9 activation, the genotoxic effect of the brominated 
HAAs and brominated THMs was investigated in a comparison study of the genotoxic effect of 
the treated and untreated water. It was found that the brominated HAAs induced genotoxic 
effect. However, the brominated THMs were more toxic than the brominated HAAs (Wang et al. 
2011). The cytotoxic and genotoxic potential of the 12 individual HAAs was investigated using 
CHO cell line AS52. It was found that most of the HAAs included in the study were cytotoxic 
with the rank order of IAA > BAA > TBAA > CDBAA > DIAA > DBAA > BDCAA > BCAA > 
CAA > BIAA > TCAA > DCAA. The rank order for genotoxicity was IAA > BAA > CAA > 
DBAA > DIAA > TBAA > BCAA > BIAA > CDBAA. DCAA, TCAA, and BDCAA were not 
genotoxic. The trend for the cytotoxicity and genotoxcity for all the HAAs was again iodinated 
HAAs > brominated HAAs > chlorinated HAAs (Plewa et al. 2010). The evaluation of the 
cytotoxicity and genotxocity of haloacetic acids using microplate-based cytotoxicity assay and 
CHO hypoxanthine-guanine phosphoribosyltransferase (HGPRT) gene mutation assay in CHO-
K1 cells showed some toxicity. The chronic cytotoxicity of the HAAs showed some variation 
among the HAAs included in the study. They were rank ordered in the following descending 
order IAA >BAA > DBA > CAA > DCA > TCA. All HAAs were mutagenic to CHO-K1 cells in 
the HGPRT mutation study. The DBPs included in the mutation assay were rank ordered as 
follows: IAA > DBA > BAA > CAA > DCA > TCA. The cytotoxicity and HGPRT mutation 
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induced by these HAAs were significantly correlated showing that these two endpoints are 
suitable for comparing their toxic potentials quantitatively (Zhang et al. 2010). The genotoxocity 
and the clastogenic and/or aneugenic effects of the monoHAAs treated TK6 cells were evaluated 
using cytokinesis-block micronucleas assay. Results showed that none of the three monoHAAs 
included in the study was able to significantly increase the frequency of micronucleus in the 
binucleated TK6 cells. The rank order for the cytotoxicity potential was IAA > BAA >> CAA 
(Liviac et al. 2010).   
Carcinogenicity  
 HAAs are carcinogenic. Ronald et al, investigated the carcinogenic potency of DBA. 
Male and female F344/N rats and B6C3F1 mice were exposed to 0, 50, 500 and 1000 mg/L of 
DBA for different time periods, ranging from 2 weeks to 2 years. In the 2 year study, neoplasms 
were induced in rats and mice at different sites, including mononuclear cell leukemia and 
abdominal cavity mesothliomas in rats, and lung and liver cancer in mice. The liver cancer 
incidence was increased in male mice even at the lowest concentration of 50 mg/L (≈4 mg/kg 
dose) (Melnick et al. 2007). Another study by the National Toxicology Program (NTP), 
evaluated DCA for its carcinogenic effect.  Results showed that 500 mg/kg of DCA exposure for 
39 weeks induced squamous cell papillomas at the site of application in male and female Tg.AC 
hemizygous mice (National Toxicology 2007), which is a transgenic mouse line created by a 
pronuclear injection of v-Ha-ras oncogene fused to a fetal zeta globulin protein at 5’ and to a SV-
40 polyadenylation/ splice site sequence at the 3’ end in the FVB/N mouse strain (Tennant et al. 
2001). A few bronchiolar/alveolar carcinomas were also appeared in both males and females 
when they were exposed to 1000 mg/L of DCA for 41 weeks. There was an increased occurrence 
of pulmonary adenomas or carcinomas compared to the control group in both dermally and 
orally exposed groups for a period of 39-41 weeks (National Toxicology Program 2007).  Heren 
et al studied the carcinogenic effect of trichloroethylene (TCE) and its major metabolite TCA 
and minor metabolite DCA.  Since TCE and its metabolites induce peroxisome proliferation so 
they were evaluated as tumor promoters in mouse liver. Male B6C3F1 mice were exposed 
intraperitoneally to 0, 2.5, or 10 µg/g body weight ethylnitrosourea (ENU) on Day 15 of age. At 
28 days of age, the mice were exposed to TCE (3 or 40 mg/liter), TCA (2 or 5 g/liter), or DCA (2 
or 5 g/liter drinking water containing either) in drinking water. After 61 weeks of exposure, the 
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animals were killed; they found that DCA and TCA were carcinogenic at a concentration of 5 
g/liter without prior initiation with ENU, resulting in hepatocellular carcinomas in 81 and 32% of 
the animals, respectively. None of the untreated animals had hepatocellular carcinomas; this 
study indicated that DCA and TCA are complete hepatocarcinogens in B6C3F1 mice (Herren-
Freund et al. 1987). Recently, IAA was reported to induce malignant transformation in NIH/3T3 
mouse embryonic fibroblast cells and malignant cells progressed to a highly aggressive 
fibrosarcoma when implanted in Balb/c nude mice (Wei et al. 2013b). These studies 
demonstrated many of the HAAs are carcinogenic excluding CAA (DeAngelo et al. 1997). It is 
interesting that the U.S. EPA regulated DBP has not been studied for carcinogenicity (e.g., BAA) 
(Richardson et al. 2007b).   
HAAs Toxicity Mechanism  
 HAAs are alkylating agents and follow SN2 reactivity. In SN2 reaction (Figure 1.2) the 
bond between the carbon and the halogen is polarized. The halogen is slightly more 
electronegative than the carbon so the halogen is partially negatively charged while the carbon 
has a partial positive charge. When a nucleophile presents itself, it attacks the partial positive 
carbon. The nucleophilic attack on the carbon and electron withdrawing from the carbon by the 
halogen group happens simultaneously. Therefore, the nucleophilic attack on the carbon happens 
from the opposite side of the halogen-leaving group. This process is known as substitution 
nucleophilic bimolecular (SN2) reaction because the rate of this reaction is dependent on the 
concentration of the two reactants (R-X and Nu). Hence, the rate law for this reaction is R= K[R-
X] [Nu]. This process is also dependent on the carbon-halogen bond length and the bond 
dissociation energy. For the three monoHAAs, the α-carbon-halide (αC-X) bond length follows 
the pattern of C-I > C-Br > C-Cl, which implies that the greater the bond length, the lower the 
dissociation energy required to react with the target molecule (Plewa et al. 2004b) (Table 1.1) 
(Loudon 1995). Cytotoxic and genotoxic potencies of monoHAAs expressed the pattern of IAA 
> BAA >> CAA. The toxic potential of monoHAAs was highly correlated with the pattern of 
SN2 reactivity, αC-X bond length and bond dissociation energy (Plewa et al. 2004b). The 
mutagenicity of the monoHAAs in S. typhimurium and CHO cells did not require any exogenous 
metabolic activation. These agents were classified as direct acting mutagens (Plewa et al. 2004b). 
HAAs are alkylating agents and the specific biological molecules alkylated by all the mono-, di-, 
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and triHAAs and the disturbance induced in cellular homeostasis are discussed in this 
dissertation. 
 IAA inhibits glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Hernández-Fonseca 
et al. 2008; Schmidt and Dringen 2009; Pals et al. 2011). GAPDH is a member of the 
dehydrogenase enzyme family and is a pivotal enzyme in glucose metabolism (Sirover 1999). It 
exists as a homologue tetramer, monomer and dimer (Carlile et al. 2000). The tetrameric form is 
comprised of four chemically identical subunits, O, P, Q, and R (Figure 1.3) and is present in the 
cytoplasm. The monomeric form is localized to the nucleus and contains two binding domains; 
an N terminal, NAD+-binding domain and a C-terminal catalytic, or glyceraldehyde-3-phosphate 
(G3P)-binding domain (Jenkins and Tanner 2006).  IAA is a thiol reagent; it is frequently used as 
an alkylating agent to modify the sulfhydryl group of a thiol molecule in the active sites of 
different enzymes containing a cysteine residue in their active sites (Albrecht et al. 1993; Gali 
and Board 1997). IAA inhibits GAPDH irreversibly by making a thioether bond with the 
cysteine residue in the active site of GAPDH or in the G3P binding domain and make the G3P 
binding domain unavailable for binding the physiological substrate glyceraldehyde-3-phosphate 
(G3P) to carry on the following reaction. Therefore, IAA renders GAPDH inactive (Schmidt and 
Dringen 2009).    
 
 
GAPDH is a pivotal metabolic enzyme; any disturbance in glycolysis due to the inactivation of 
GAPDH enzyme disturbs the cellular energy homeostasis (Kahlert and Reiser 2000; Hernández-
Fonseca et al. 2008; Dad et al. 2013), leads to cytosolic Ca2+ toxicity (Kahlert and Reiser 2000; 
Hernández-Fonseca et al. 2008), oxidative stress (Hernández-Fonseca et al. 2008), hypoglycemia 
and ischemia (Hernández-Fonseca et al. 2008) in CHO cells (Dad et al. 2013), rat hippocampus 
astrocytes (Kahlert and Reiser 2000)and cultured hippocampus neurons (Hernández-Fonseca et 
al. 2008). Since brain cells are very sensitive to hypoglycemia and very vulnerable to oxidative 
stress, IAA is commonly used to study the role of metabolism in different neurodegenerative 
diseases; especially, the role of glycolysis by IAA-induced inhibition of GAPDH and ultimately 
glycolysis (Kahlert and Reiser 2000; Rodríguez et al. 2010).  
GAPDH 
Glyceraldehyde-3-phosphate + NAD+ + Pi  D  1,3-bisphposphoglycerate + NADH 
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 Cellular Ca2+ homeostasis is crucial for different cellular functioning. In all cells 
including brain cells, the regulation of cytosolic Ca2+ concentration is a major part of the 
different signaling pathways linked to the control of metabolism, apoptosis and survival of 
neurons. At rest, the cytosolic Ca2+ is lower than the extracellular Ca2+. In order to regulate the 
Ca2+ concentration in the cytosol, different systems are available e.g., plasma membrane Ca2+  
ATPase powered  by ATP and Na+/Ca2+ - exchangers fuelled by the Na+ gradient, push the Ca2+  
outside the cytosol into the extracellular space, while sarcoendoplasmic reticulum Ca2+ ATPase 
(SERCA) pumps Ca2+  into endoplasmic reticulum (ER), which can be transported into the 
mitochondria. The distribution of Ca2+ into its proper cellular compartments requires energy, 
which is produced by metabolism (Szalai et al. 1999; Kahlert and Reiser 2000). Studies showed 
that different glycolytic products e.g., phosphoenol pyruvate and ATP produced by glycolysis 
were directly associated with the Ca2+ compartmentalization especially with the Ca2+ uptake by 
the SERCA pump into ER (Xu et al. 1995). The inhibition of glycolysis and oxidative 
phosphorylation reduced the ATP content by 85%.  It was believed that the Ca2+ excitotoxicity is 
due to the influx of Ca2+ through N-methyl-D-aspartate receptor (NMDA), which further leads to 
oxidative stress. Hernanadaz et al compared the two mechanisms and found that during the 
severe impairment of glycolysis due to the inhibition of GAPDH by IAA (100 µM), the cellular 
ATP level was drastically reduced, which increased the cytosolic Ca2+ and induced ROS. 
Moreover, they found that the BAPTA-AM, a Ca2+ chelator rescued the cells against the IAA 
(100 µM) induced ROS. However, an antagonist of the NMDA receptor MK-801 did not 
significantly reduce the IAA induced ROS. This proved that the Ca2+ excitoxicity induced 
oxidative stress in the IAA treated cultured hippocampal neurons, was due to the ATP depletion 
(Hernández-Fonseca et al. 2008). IAA also affected the GSH content of the cells (Schmidt and 
Dringen 2009). Studies showed that not only IAA but other HAAs also inhibit GAPDH and 
reduce ATP contents of the cells. The ROS induced by the HAAs lead to DNA damage and 
apoptosis. It was found that CAA down-regulated Bcl-2 and Mcl-1 (anti-apoptotic protein), 
while up-regulated Bax (pro-apoptotic protein) level, which was also associated with the 
cytochrome c release and pro-caspace cascade activation. The apoptotic effects induced by CAA 
was reversed by the N-acetyl-cysteine (NAC), which is an antioxidant; proving that HAAs 
inhibit glycolysis by inactivating GAPDH, reduced ATP levels, increased cytosolic Ca2+ 
concentration, induced ROS, leading to DNA damage, and inducing apoptosis (Chen et al. 2013).  
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Allosteric Changes in Pyruvate Dehydrogenase Kinase (PDK) Regulate Pyruvate 
Dehydrogenase Complex (PDC) Activity  
 In 1974, Whitehouse et al discovered that DCA activates pyruvate dehydrogenase 
complex by inhibiting pyruvate dehydrogenase kinase (Whitehouse et al. 1974); this finding was 
confirmed by other studies (Kline et al. 1997; Sutendra and Michelakis 2013; Ferriero et al. 
2015).  The pyruvate dehydrogenase complex (PDC) is a member of the α-ketoacid 
dehydrogenase complex family. PDC is responsible for the oxidative decarboxylation of 
pyruvate and its conversion into acetyl-CoA in the presence of different cofactors including 
thiamine pyrophosphate (TPP), CoA, and NAD+. Mammalian PDC has multiple copies of 6 
different components; they are pyruvate dehydrogenase (E1), dihydrolipoamide  
acetyltransferase (E2), dihydrolipoamide dehydrogenase (E3), E1 specific kinases, phospho-E1 
phosphotase and X protein (De Marcucci and Lindsay 1985; Jilka et al. 1986). E1, E2, and E3 
are the major catalytic components, which are responsible for the stepwise decarboxylation and 
dehydrogenation of the pyruvate into acetyl- CoA (Patel and Roche 1990).  
 The E1 component is a tetramer (α2β2). The tetrameric E1 contains two sites for TPP 
binding, which is required for the first step of pyruvate decarboxylation. In the first step, E1 
catalyzes the TPP dependent decarboxylation of pyruvate to hydroxyethyl TPP and also leaves 
an acetyl group, which is covalently linked to lipoamide group of E2. E1α component of the 
tetrameric E1 is inactivated/phosphorylated by pyruvate dehydrogenase kinase (PDK) enzyme 
and activated/dephosphorylated by a specific phosphatase enzyme. The dephosphorylation of 
these sites by phospho-E1-phosphotase leads to the activation of the enzyme (Frey et al. 1989; 
Patel and Roche 1990). (Figure. 1.4) 
 E2 is responsible for transferring the acetyl group from acetyl-lipoyl to CoA and 
generation of acetyl-CoA. Sixty percent of the NH2-terminal of the E2 component is a 
multidomain structure and comprises three 80-amino acid domains, each of these domains 
carries a lipoyl prosthetic group attached to a specific lysine residue, followed by a 50-amino 
acid subunit binding domain that precedes the remaining 40% of the structure that forms the 
oligomeric inner domain (Stephens et al. 1983). Between each of these domains are interdomain 
sequences, which are rich in alanine, proline, and charged amino acids (Texter et al. 1988; 
Perham and Packman 1989). The number of E2 domains is different in different organisms. 
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Human E2 has 2 lipoyl domains presented as L1 and L2. The E2B or subunit-binding domain is 
responsible for binding E1 and E3. The inner domain (E-I) catalyzes the transacetylation reaction 
and self-association to form the dodecahedral structure, which contain 60 subunits. The E2 
component also plays a crucial role in the activation and inactivation of the pyruvate 
dehydrogenase by providing a binding site to the PDK and phospho-E1-phosphotase enzymes 
(Patel and Roche 1990; Patel and Korotchkina 2003) (Figure.1.5)   
 E3 transfers electrons from dihydrolipoamide to NAD+. It is a homodimer and each 
polypeptide noncovalently binds to a molecule of FAD. (Patel and Roche 1990)   
 Pyruvate dehydrogenase kinase (PDK) plays an important role in regulating the PDC. 
PDK has four isoforms and exhibit tissue specific expression; PDK1 is detected in heart, 
pancreatic islets, and skeletal muscles; PDK2 is expressed in all tissues; PDK3 is present in 
testes, kidney, and pancreatic islets. Phosphorylation of E1p by PDK occurs at three different 
serine residues (S264: site 1, S271: site 2, and S203: site 3). Among the three conserved 
phosphorylation sites, site 1 is the most rapidly phosphorylated site where site 3 is the slowest 
phosphorylated site (Sale and Randle 1981; Korotchkina and Patel 1995). Structural studies of 
the PDKs showed that all the four isoforms of PDKs phosphorylate sites 1 and 2, but only PDK1 
modifies Site 3 (Korotchkina and Patel 2001).  
 Different mitochondrial protein kinases comprising PDKs and some related BCKs do not 
carry the motif, which are normally present in eukaryotic Ser/Thr/Tyr protein kinases. The rat 
PDK2 structure revealed that these proteins have two distinct domains; the C-terminal domain is 
an α/β structure with a five strand β sheet. These enzymes also have four conserved motifs (N-
G1-,G2-, and G3-boxes), which build a unique ATP-binding fold. The ATP-binding fold has a 
structure known as the “ATP lid”. The conformational changes in ATP-lid are linked with the 
ATP hydrolysis and protein-protein interaction. (Wigley et al. 1991; Ban et al. 1999) The N-
terminal domain of these kinases consists of a four-helix bundle that resembles the histidine 
phosphoryl-transfer domains of the two component systems (Davie et al. 1995).  The binding of 
the PDKs to the L2 domain of the E2p subunit of the PDC activates PDK activity, but this 
activation of different PDK isoforms occurs in a different fashion (Kato et al. 2005). Crystal 
structures of the PDK3-L2 complex with or without (apo) bound nucleotides (ATP or ADP) 
indicated that the C-terminal domain of PDK3 binds ATP or ADP through conserved motifs. The 
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ATP binding site is present on the sidewall of the C-terminal domain facing the cleft between the 
N and C terminal domains (Dutta and Inouye 2000) (Figure 1.6). The ϒ-phosphate of the bound 
ATP in the cleft is accessible to the E1p subunit for its serine residue phosphorylation and 
eventually inactivation. The PDK3-L2 structure showed that there is no direct interaction 
between the bound L2 and the active-site cleft so L2 exerts its effect on PDK3 through an 
allosteric mechanism (Kato et al. 2005). 
 The crystal structure of PDK3 with and without L2 binding showed that in the closed 
conformation, the C-terminal tails in the PDK3 dimer are disordered and keeps the ATP lid in 
the active-site cleft in a partially ordered form, which traps ADP with high affinity and renders 
PDK3 inactive. In the L2-binding-induced open conformation, both C- terminal tails are ordered 
and exist in a crossover configuration. The crossover configuration induces the opening of the 
active-site cleft with a disordered ATP lid. The disordered ATP lid has a low affinity for the 
ADP binding, which leads to the release of ADP and results in the removal of PDK3 inhibition 
caused by bound ADP, resulting in the L2-stimulated PDK3 activity (Kato et al. 2005). (Figure 
1.7).   
 These structural studies demonstrated that PDKs are regulated by the classic allosteric 
mechanism of R(relaxed) to T(tight) equilibrium between the L2-bound and free PDK3, with the 
L2 bound form facilitating the R or open conformation (Kato et al. 2005).  
 DCA Induces Allosteric Conformational Changes in PDK and Modulates PDC Activity  
 Recent mutational studies and the PDK2 structure with dichloroacetic acid (DCA) 
revealed that DCA binds to the N-terminal domain of PDK2. The E2P/E3BP scaffold-free 
activity showed that DCA reduces PDK1 and PDK3 activity in a similar fashion to 4% and 17%, 
respectively (Kato et al. 2007). L2 binding promotes the opening of the active-site cleft and 
destabilizes the ATP lid facilitating ADP dissociation in the PDK3-L2 complex, which renders 
PDK active (Kato et al. 2005). Kinetic studies showed that exposure to DCA prevents the ADP 
dissociation from the active-site cleft resulting in PDK inhibition.  ADP binding to PDK reduces 
the affinity of this enzyme for L2 binding by 3-fold; the presence of DCA and ADP 
synergistically decreases the affinity of the PDK for L2 by 130-fold as compared to ADP alone 
and eventually affects the L2-induced activation of the PDK. The inhibition of the PDK by DCA 
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induced allosteric change keeps the PDC in its active state and accelerates the tricarboxylic acid 
(TCA) cycle (Kato et al. 2007).   
 DCA is Used to Activate PDC in Different Disease States  
 Bonnet et al showed that DCA induces apoptosis in the tumor cells by reversing the 
Warburg effect (Bonnet et al. 2007). They found that DCA activates PDC by inhibiting PDK and 
shifts the glycolytic-based metabolism to mitochondria in the tumor cells. The results 
demonstrated that DCA decreased the mitochondrial membrane potential (ΔΨm) by activating 
TCA cycle, generating more protons by mitochondria, and by decreasing cytosolic Ca++ 
concentration. The decrease in ΔΨm also induced mitochondrial transition pore (MTP) opening. 
The opening of MTP activated the release of cytochrome-C, which is required for the caspase 
activation and apoptosis induction. DCA induced activation of mitochondrial metabolism and it 
activates complex-I induced ROS generation. The complex-I induced ROS generation 
upregulated the K+ channel Kv1.5 expression and decreased K+ concentration, which also helped 
in the activation of apoptosis in the tumor cells (Bonnet et al. 2007). DCA was also used to lower 
the plasma lactate, alanine, cholesterol, and glucose levels in adult, noninsulin-dependent 
diabetic patients (Stacpoole et al. 1978).  Studies showed that DCA also reduced lactic acidosis 
in patients with pyruvate dehydrogenase deficiency (Stacpoole et al. 2006).  DCA showed 
oncolysis in attenuated oncolytic measles virus Edmonston strain (MV-Edm) caused 
glioblastoma cells by inhibiting aerobic glycolysis. It was found that DCA enhanced the MV-
Edm replication (increasing bioenergetic consumption) and inhibited glycolysis (decreasing 
bioenrgetic production), which, in combination, accelerated bioenergetic exhaustion leading to 
necrotic cell death (Li et al. 2015).  
 Rationale for Research  
 Water disinfection greatly reduces exposure to water-borne pathogens but exposure to the 
inadvertently produced toxic DBPs is unavoidable (Akin et al. 1982; Krasner 2009). Different 
epidemiological and experimental studies concluded that disinfecting water increases the risk of 
bladder cancer (Villanueva et al. 2007), colorectal cancer (King et al. 2000; Bove et al. 2002) 
and adverse pregnancy outcomes (Chisholm et al. 2008; Jeong et al. 2012; Rivera-Núñez and 
Wright 2013). Some of the HAAs e.g., IAA the mode of action for toxicity induction is based on 
oxidative DNA damage and GAPDH inhibition. However, the difference among the toxicity 
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mechanisms of the different classes of HAAs present in the disinfected water and their link to the 
adverse health outcomes is unknown. In order to fill this gap additional research is required.  
 The monoHAAs inhibit GAPDH and induce toxicity; it is important to find out if there is 
a link between the GAPDH inhibition HAA-induced genotoxicity. The difference among the 
mono-, di-, and triHAA toxicity mechanisms are also unknown. In this dissertation a link 
between the HAA-induced GAPDH inhibition and genotoxicity is discussed. Furthermore, the 
difference between the toxicity mechanisms of the mono-, di-, and triHAAs are explored. 
 My working hypothesis is that the monoHAAs inhibit GAPDH depleting glycolytic ATP 
and reducing the generation of pyruvate used as a mitochondrial substrate during tricarboxylic 
acid (TCA) cycle for the further production of ATP. The unavailability of pyruvate for the TCA 
cycle disturbs the normal generation of reducing power (NADH and FADH2). Reducing power 
produced by the TCA cycle is required for oxidative phosphorylation for the complete reduction 
of O2 to water. During O2 reduction through oxidative phosphorylation, electromotive force is 
generated, which is utilized by ATP synthase to produce ATP. Glycolytic and mitochondrial 
ATP is required to maintain cellular Ca2+ homeostasis. Since the monoHAAs inhibit GAPDH 
and reduce the generation of pyruvate they disturb the normal production of reducing power 
through the TCA cycle. Due to the unavailability of reducing power O2 is not completely 
reduced to H2O and incomplete O2 reduction generates superoxide radicles (O2-) or hydroxyl 
radicles (̇●ȮH), also known as reactive oxygen species (ROS). The unavailability of reducing 
power not only produces ROS but also disrupts the mitochondrial membrane potential and 
electromotive force generated during oxidative phosphorylation and ultimately affects ATP 
synthesis and disturbs cellular Ca2+ homeostasis. Increased ROS and ATP depletion due to 
monoHAA-induced GAPDH inhibition leads to genomic DNA damage (Figure 1.8. A). If this 
hypothesis is correct, then supplementing monoHAA-treated cells with exogenous pyruvate 
should restore cellular ATP levels and prevent or reduce genomic DNA damage. (Figure 1.8. B) 
  Unlike the monoHAAs the di-, and triHAAs are not the good inhibitors of the GAPDH. 
Considering the toxicity mechanism of di-, and triHAAs, I postulate that increased activation of 
PDH activity by diHAAs and triHAAs due to PDK inhibition accelerates pyruvate transport in 
mitochondria, which is coupled with Ca2+ influx and enhance the oxidative decarboxylation of 
pyruvate into acetyl CoA, which in turn will produce more reducing power in the form of 
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NADH. The NADH will be further utilized by oxidative phosphorylation to produce more ATP. 
The accelerated TCA cycle due to PDH activation and enhanced NADH formation will 
consumes more O2 as a final electron acceptor, which might lead to hypoxia and eventually ROS 
production. In order to keep providing the pyruvate supply required by di-, and triHAAs induced 
activated PDH, the cells will consume more glucose and will accelerate the release of pyruvate, 
lactate and alanine from cells (Evans and Stacpoole 1982), which in turn will disturb the glucose 
homeostasis and may lead to toxicity. The chronic exposure to diHAAs and triHAAs through 
drinking water may be involved with hypolactatemia, disturbed glucose homeostasis and 
hepatotoxicity in humans especially sensitive populations (featuses). (Figure 1.9) 
To test the mentioned hypothesis illustrated in (figure 1.8, 1.9) I propose the following 
objectives.  
 Objectives  
1. To study the effect of HAAs on GAPDH inhibition kinetics. (Chapter 3) 
2. To investigate the effect of HAAs on cellular energy homeostasis by measuring the ATP 
content in HAA-treated cells. (Chapter 3) 
3. To study the relationship of HAA-induced GAPDH inhibition and genomic DNA damage 
in HAA-treated cells by supplementing cells with exogenous pyruvate. (Chapter 2)  
4. To study the relationship of HAA-induced GAPDH inhibition with the ATP content of 
the cells by supplementing cells with the exogenous pyruvate. (Chapter 2) 
5. To investigate the difference among mono-, di- and triHAA toxicity mechanisms by 
measuring PDH activity in HAA-treated cells. (Chapter 3)  
6. To study the oxidative stress in HAA-treated cells.  (Chapter 2) 
 
1.3. TOXICITY OF DBPS GENERATED AFTER CHLORINATION OF WASTE 
WATER EFFLUENTS  
 
Domestic wastewaters have several health safety concerns. Pathogenic microorganisms present 
in wastewater include enteric bacteria, viruses, and protozoan cysts. In order to provide 
protection against these pathogens, wastewater is treated with different chemical disinfectants. 
The target disinfectant is usually chlorine and is the most commonly used chemical disinfectant 
in both Kingdom of Saudi Arabia (KSA) and USA. In this study, the target waters are 
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wastewater effluents containing ammonia and nitrogenous organic matter. Ammonia and organic 
nitrogen presence in excess with respect to the chlorine dose result in a very fast conversion of 
the free chlorine into monochloramine and organic chloramines. Chloramines then react with 
both inorganic and organic constituents in water forming a large number of disinfection 
byproducts (DBPs). Relevant reactions to this study involving inorganic species are the oxidation 
of iodide ion (Iˉ) by monochloramine (NH2Cl) to form hypoiodous acid (HOI) (Bichsel and von 
Gunten 1999). In this study, the cytotoxicity and genotoxicity potentials of the chlorinated and 
chloraminated wastewater effluents extracts, extracted through XAD-8 and XAD-4 were 
analyzed.   
 Objectives  
 
The objectives of this part of my research include the following;  
 
1. To determine the cytotoxicity and genotoxicity potential of the chlorinated wastewater 
effluents extracted through XAD-8 and XAD-4 resin. (Chapter 4) 
 
2. To analyze the cytotoxicity and genotoxicity potential of the chloraminated wastewater 
effluents extracted through XAD-8 and XAD-4 resin.  (Chapter 4) 
    
 
1.4. TOXICITY OF POLYCYCLIC AROMATIC HYDROCARBONS ASSOCIATED 
WITH COAL TAR PARTICLES IN URBAN LAKES  
 
Particle-associated contaminants (PACs) are hazardous to flora and fauna in the aquatic 
systems and also to humans because most of the PACs are highly stable, bioaccumulative and 
toxic. Studies demonstrated that most of the PACs are persistent in nature and continue to occur 
in the environment years after their use was abandoned (Mahler and Van Metre 2003). Results 
from water quality surveys (Van Metre and Mahler 2005; Chalmers et al. 2007) showed that 
metal, polychlorinated biphenyls and DDT concentrations decreased in water since the 1970’s 
after their regulation. However, total concentrations of polycyclic aromatic hydrocarbons (PAHs) 
have increased (Van Metre and Mahler 2005) with increasing urbanization.  
PAHs are atmospheric pollutants found in soil, air and water, which have two or more 
single or fused aromatic rings sharing a carbon atoms pair between the rings in their molecules, 
e.g. benzo(α)pyrene. PAHs containing six fused aromatic rings are known as small PAHs while 
those with more than 6 are known as large aromatic hydrocarbons (Buha 2011). The major 
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sources of PAHs include the incomplete combustion of organic material such as cigarette smoke, 
vehicle exhausts, wildfires, agricultural burning and residential wood burning; other sources are 
asphalt roads, coal, coal tar, municipal and industrial waste incineration and hazardous waste 
sites (Mumtaz and Julia 1995). Sources of particle associated PAHs in urban lake sediments are 
automobile and industry emission-based combustion sources, coal-tar and asphalt based 
sealcoats on parking lots, driveway pavements, roofs and vulcanized rubber products such as 
automobile tires (Hoffman et al. 1984; Mahler et al. 2005). Particles worn from coal-tar 
pavements are transported into urban lakes and streams via runoff and can be a primary source of 
PAHs in these urban water bodies (Mahler et al. 2005; Yang et al. 2010).  
Total PAH concentrations in coal-tar sealcoat particles are higher than other particles 
including particles from unsealed concrete, asphalt parking lots, road dust and residential soils. 
Moreover, coal tar seal coat contributes 84% of the total PAH in urban lakes (Yang et al. 2010). 
A study using contaminant mass-balance receptor modeling showed that coal tar sealcoat is the 
main source of PAHs over the past 20 years in 40 lakes located throughout the United States 
(Van Metre and Mahler 2010). PAHs are lipophilic in nature and are generally found adsorbed 
on particles surface in water and bioaccumulate in edible marine organisms. Background levels 
of PAHs in drinking water ranged from 4 to 24 ng per liter. The U.S. EPA selected 17 PAHs and 
profiled them in a single group based on their highest concentrations at national Priority List 
(NPL) sites, their level of harmful effects, exposure and the available information for these PAHs 
(Mumtaz and Julia 1995). These PAHs were genotoxic and carcinogenic (Farmer 2003) and 
induced lung cancer in workers exposed to coal tar pitch volatiles measured as benzene-soluble 
matter (Armstrong 1994). Several fractions of creosote P1 were found as mutagenic in 
Salmonella typhimurium strain TA98. The mutagenicity of creosote fractions was due to the 
presence of 0.18 and 1.1% of benzo(α)pyrene and benz(α)anthracene, respectively (Bos et al. 
1984). The fate of PAHs from coal tar sealcoat in aquatic systems is not well understood. It is not 
clear if PAHs redistribute in water and lose their toxic potential or if they are lost to the water 
column with ageing. A mechanistic and quantitative approach is needed to understand the 
distribution of PAHs in water and the changes in the toxic potential of PAHs associated with its 
distribution in aquatic systems.   
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 Hypothesis 
In order to determine the best management practices to alleviate the impact of coal tar seal 
coating and associated PAHs in sediments, it is important to study the fate and toxicity of PAHs 
in water. I shall determine the mutagenicity of the PAHs associated with coal tar and other 
carbonaceous material particles in urban lake sediments. We hypothesize that the toxicity of pore 
water in sediments decreases with time as PAHs and other organic pollutants redistribute from 
less strongly sorbing carbonatious materials like coal tar to more strongly sorbing black carbon, 
and as less recalcitrant pollutants are biologically degraded over time. Urban lakes are sources of 
recreation and/or drinking water for large populations, and understanding contribution of coal tar  
toxicity is an important step in protecting the environment and public health.  
 Objectives  
The objectives of this project are listed below.  
1. To compare the toxicity of PAHs associated with the less strongly sorbing carbonatious 
material like coal tar and more strongly sorbing carbonatious material like soot. (Chapter 5) 
2. To analyze these PACs linked PAHs for mutagenicity using the plate incorporation assay 
with S. typhimurium cells strains TA100 and TA98 and determine the induction of base-pair 
substitution mutation versus frameshift mutations.  (Chapter 5)  
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1.5. FIGURES AND TABLES  
	  
	  
	  Figure 1.1. Different regulated and nonregulated mono-, di-, and triHAAs 
	  
	  
	  
	  
	  
	  
Figure 1.2. SN2 reaction between cysteine and iodoacetic acid. SH group of cysteine acts as a 
nucleophile and attacks “C “ of the halogen-leaving group. 
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a 
Abbreviations: HAA, haloacetic acids. IAA, iodoacetic acid; BAA, bromoacetic acid; CAA,  
chloroacetic  acid. b α-Carbon-halogen bond. c C−X  bond length summarized from  (Loudon 1995).d 
C−X  bond dissociation energy summarized from (Loudon 1995).    	  	  	  	  	  	  	  	  
Table 1.1. Monohaloacetic acid characteristics, sources and purities. 
HAA 
a 
CASN MW 
(g/mol) 
 
C−X b Bond 
Length 
(Å) c 
Dissociation 
Energy 
(kcal/mol) d 
Source Purity 
IAA 64-69-7 185.95 C−I 2.14 57.4 Sigma-Aldrich >99% 
BAA 79-08-3 138.95 C−Br 1.93 65.9 Fluka >99% 
CAA 79-11-8 94.50 C−Cl 1.77 78.5 Fluka >99% 
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Figure 1.3. Ribbon view of the human placental GAPDH, subunits O, P, Q, and R. GAPDH 
active-sites clefts are indicated by arrows on each of the asymmetric subunits, P, Q, and R 
(Jenkins and Tanner 2006)  
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Figure 1.4. Different components of the pyruvate dehydrogenase complex activity 	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  Figure 1.5. The structural domains of E2 and binding protein of pyruvate dehydrogenase 
complex (Patel and Korotchkina 2003) 	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Figure 1.6. The position of ATP binding site between the N and C-terminal domain of PDK3 
(Kato et al. 2005)   
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Figure 1.7. Closed and open confirmation of ATP lid of PDK3 in response to L2 and ADP 
binding (Kato et al. 2005) 	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Figure 1.8. (A) Effect of IAA on the ATP contents and genome integrity of the cell in response 
to GAPDH inhibition. 
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Figure 1.8 (B). The effect of exogenous pyruvate on the oxidative DNA damage and reduction in 
the ATP contents of the cells induced by IAA mediated GAPDH inhibition.  
	  	  	  	  	  IAA	  
Pyruvate	  
Glucose	  	  
4ADP	  +	  Pi	  	  	  4ATP	  
Glyceraldehyde-­‐3-­‐phosphate	  
GAPDH	  
2ATP	  	  	  2ADP	  Aldolase	  
2NAD+	  +	  2Pi	  2NADH+	  +	  2H	  
Acetyl	  CoA	  	  	  	  PDH	  
Krebs	  Cycle	  
Electron	  Transport	  chain	  
Exogenous	  pyruvate	  
Exogenous	  pyruvate	  
ATP	  	  NADH	  +	  FADH2	  	  CO2	  	  Ca2+	  	  
	  31	  
	  
	  	   	  	   	   	  
	   
	  
	  
	  	   	  	   	   	  
4ADP	  +	  Pi	   	   	  	  4ATP 
Glucose	   
Aldolase Glyceraldehyde	   3-­‐phosphate 
2ATP	   	   	  	  2ADP 
Pyruvate 
2NAD+	  +	  2Pi 2NADH+	  +	  2H GAPDH Acetyl	  CoA 	  	  	  PDH 
Krebs	  Cycle 
Electron	  Transport	  chain 
	   	  
PDK 
PDH 
Acetyl-­‐
CoA 	  	  	  	  	  	  	  	   
ATP 
NADH	  +	  
FADH2	   	   
Hypoxia Glucose	  homeostasis	  imbalance	  
Figure 1.9. Effect of a triHAA on pyruvate dehydrogenase kinase (PDK) controlled pyruvate 
dehydrogenase complex (PDC) activity and its ultimate effect on mitochondrial metabolism. 	  	  
	  32	  
1.6. REFERENCES 
Akin EW, Hoff JC, Lippy EC. 1982. Waterborne outbreak control: which disinfectant? 
Environmental Health Perspectives Vol. 46:7-12. 
Albrecht J, Talbot M, Kimelberg HK, Aschner M. 1993. The role of sulfhydryl groups and 
calcium in the mercuric chloride-induced inhibition of glutamate uptake in rat primary 
astrocyte cultures. Brain Research 607(1–2):249-254. 
American Chemistry Council. 2015. Chlorine Chemistry: Essential to Safer Water for 100 Years, 
and Running. http://chlorine.americanchemistry.com/Safer-Water. 
Armstrong B. 1994. Lung cancer mortality and polynuclear aromatic hydrocarbons: A case- 
cohort study of aluminum production workers in Arvida, Quebec, Canada. Am J 
Epidemiol 139(3):250-262. 
Ban C, Junop M, Yang W. 1999. Transformation of MutL by ATP binding and hydrolysis: a 
switch in DNA mismatch repair. Cell 97(1):85-97. 
Bellar TA, Lichtenberg JJ, Kroner RC. 1974. Occurence of organohalides in chlorinated drinking 
waters Journal American Water Works Association 66(12):703-706. 
Bichsel Y, von Gunten U. 1999. Oxidation of iodide and hypoiodous acid in the disinfection of 
natural waters. Environmental Science & Technology 33(22):4040. 
Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R, Lee CT, 
Lopaschuk GD, Puttagunta L, Bonnet S, Harry G, Hashimoto K, Porter CJ, Andrade MA, 
Thebaud B, Michelakis ED. 2007. A mitochondria-K+ channel axis is suppressed in 
cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 
11(1):37-51. 
Bos RP, Theuws JLG, Leijdekkers CM, Henderson PT. 1984. The presence of the mutagenic 
polycyclic aromatic hydrocarbons benzo(a)pyrene and benz(a)anthracine in creosote-P1 
Mutat Res 130(3):153-158. 
Bove F, Shim Y, Zeitz P. 2002. Drinking Water Contaminants and Adverse Pregnancy 
Outcomes: A Review. Environ Health Perspect 110 Suppl 1:61. 
Buha A. 2011. Polycyclic Aromatic Hydrocarbons. 
Bull RJ, Reckhow DA, Li X, Humpage AR, Joll C, Hrudey SE. 2011. Potential carcinogenic 
hazards of non-regulated disinfection by-products: Haloquinones, halo-cyclopentene and 
cyclohexene derivatives, N-halamines, halonitriles, and heterocyclic amines. Toxicology 
286(1–3):1-19. 
Carlile GW, Chalmers-Redman RM, Tatton NA, Pong A, Borden KE, Tatton WG. 2000. 
Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of 
tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer. Mol Pharmacol 
57(1):2-12. 
Chalmers AT, Van Metre PC, Callender E. 2007. The chemical response of particle-associated 
contaminants in aquatic sediments to urbanization in New England, U.S.A. J Contam 
Hydrol 91(1-2):4-25. 
Chen CH, Chen SJ, Su CC, Yen CC, Tseng TJ, Jinn TR, Tang FC, Chen KL, Su YC, Lee k I, 
Hung DZ, Huang CF. 2013. Chloroacetic acid induced neuronal cells death through 
oxidative stress-mediated p38-MAPK activation pathway regulated mitochondria-
dependent apoptotic signals. Toxicology 303:72-82. 
	  33	  
Chisholm K, Cook A, Bower C, Weinstein P. 2008. Risk of birth defects in Australian 
communities with high levels of brominated disinfection by-products. Environ Health 
Perspect 116(9):1267-1273. 
Crittenden JC, Trussell RR, Hand DW, Howe KJ, Tchobanoglous G. 2012. Disinfection. MWH's 
Water Treatment: Principles and Design, Third Edition: John Wiley & Sons, Inc. p 903-
1032. 
Cutler D, Miller G. 2005. The role of public health improvements in health advances: The 
twentieth-century United States. Demography 42(1):1-22. 
Dad A, Jeong CH, Pals JA, Wagner ED, Plewa MJ. 2013. Pyruvate Remediation of Cell Stress 
and Genotoxicity Induced by Haloacetic Acid Drinking Water Disinfection By-Products. 
Environmental and Molecular Mutagenesis 54(8):629-637. 
David DM, Elsebeth L. 1999. Chloroform 
http://monographs.iarc.fr/ENG/Publications/techrep42/TR42-16.pdf. 
Davie JR, Wynn RM, Meng M, Huang YS, Aalund G, Chuang DT, Lau KS. 1995. Expression 
and characterization of branched-chain alpha-ketoacid dehydrogenase kinase from the rat. 
Is it a histidine-protein kinase? J Biol Chem 270(34):19861-19867. 
De Marcucci O, Lindsay JG. 1985. Component X. An immunologically distinct polypeptide 
associated with mammalian pyruvate dehydrogenase multi-enzyme complex. European 
Journal of Biochemistry 149(3):641-648. 
DeAngelo AB, Daniel FB, Most BM, Olson GR. 1997. Failure of monochloroacetic acid and 
trichloroacetic acid administered in the drinking water to produce liver cancer in male 
F344/N rats. J Toxicol Environ Health 52(5):425-445. 
Dutta R, Inouye M. 2000. GHKL, an emergent ATPase/kinase superfamily. Trends Biochem Sci 
25(1):24-28. 
Escobar-Hoyos LF, Hoyos-Giraldo LS, Londono-Velasco E, Reyes-Carvajal I, Saavedra-Trujillo 
D, Carvajal-Varona S, Sanchez-Gomez A, Wagner ED, Plewa MJ. 2013. Genotoxic and 
clastogenic effects of monohaloacetic acid drinking water disinfection by-products in 
primary human lymphocytes. Water Res 47(10):3282-3290. 
European Comission 2003. European Comission Report: Scientific Committee on Toxicity, 
Ecotoxicity and the Environment (CSTEE); Opinion on the Results of the Risk 
Assessment of Monochloroacetic acid (MCCA) Environmental Part (Cas NO. 79-11-8 ) 
Evans OB, Stacpoole PW. 1982. Prolonged hypolactatemia and increased total pyruvate 
dehydrogenase activity by dichloroacetate. Biochem Pharmacol 31(7):1295-1300. 
Farmer PB. 2003. Molecular epidemiology studies of carcinogenic environmental pollutants - 
Effects of polycyclic aromatic hydrocarbons (PAHs) in environmental pollution on 
exogenous and oxidative DNA damage. Mutat Res 544(2-3):397-402. 
Ferriero R, Iannuzzi C, Manco G, Brunetti-Pierri N. 2015. Differential inhibition of PDKs by 
phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by 
combination with dichloroacetate. J Inherit Metab Dis. 
Frey PA, Flournoy DS, Gruys K, Yang YS. 1989. Intermediates in reductive transacetylation 
catalyzed by pyruvate dehydrogenase complex. Annals of the New York Academy of 
Sciences 573:21-35. 
Gali RR, Board PG. 1997. Identification of an essential cysteine residue in human glutathione 
synthase. Biochem J 321 ( Pt 1):207-210. 
George SE, Nelson GM, Swank AE, Brooks LR, Bailey K, George M, DeAngelo A. 2000. The 
disinfection by-products dichloro-, dibromo-, and bromochloroacetic acid impact 
	  34	  
intestinal microflora and metabolism in Fischer 344 rats upon exposure in drinking water. 
Toxicol Sci 56(2):282-289. 
Health Canada. 2008. Guidelines for Canadian Drinking Water Quality: Guideline Technical 
Document — Haloacetic Acids. 
Hernández-Fonseca K, Cárdenas-Rodríguez N, Pedraza-Chaverri J, Massieu L. 2008. Calcium-
dependent production of reactive oxygen species is involved in neuronal damage induced 
during glycolysis inhibition in cultured hippocampal neurons. J Neurosci Res 86(8):1768-
1780. 
Herren-Freund SL, Pereira MA, Khoury MD, Olson G. 1987. The carcinogenicity of 
trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in 
mouse liver. Toxicol Appl Pharmacol 90(2):183-189. 
Hoffman EJ, Mills GL, Latimer JS, Quinn JG. 1984. Urban runoff as a source of polycyclic 
aromatic-hydrocarbons to coastal waters Environ Sci Technol 18(8):580-587. 
Hrudey SE. 2009. Chlorination disinfection by-products, public health risk tradeoffs and me. 
Water Research 43(8):2057-2092. 
Hua G, Reckhow DA. 2007. Comparison of disinfection byproduct formation from chlorine and 
alternative disinfectants. Water Research 41(8):1667-1678. 
Hunter ES, 3rd, Rogers EH, Schmid JE, Richard A. 1996. Comparative effects of haloacetic 
acids in whole embryo culture. Teratology 54(2):57-64. 
Hunter Iii ES, Tugman JA. 1995. Inhibitors of glycolytic metabolism affect neurulation-staged 
mouse conceptuses in vitro. Teratology 52(6):317-323. 
Jenkins JL, Tanner JJ. 2006. High-resolution structure of human D-glyceraldehyde-3-phosphate 
dehydrogenase. Acta Crystallogr D Biol Crystallogr 62(3):290-301. 
Jeong CH, Wagner ED, Siebert VR, Anduri S, Richardson SD, Daiber EJ, McKague AB, 
Kogevinas M, Villanueva CM, Goslan EH, Wentai L, Isabelle LM, Pankow JF, 
Grazuleviciene R, Cordier S, Edwards SC, Righi E, Nieuwenhuijsen MJ, Plewa MJ. 
2012. Occurrence and toxicity of disinfection byproducts in european drinking waters in 
relation with the HIWATE epidemiology study. Environ Sci Technol 46(21):12120-
12128. 
Jilka JM, Rahmatullah M, Kazemi M, Roche TE. 1986. Properties of a newly characterized 
protein of the bovine kidney pyruvate dehydrogenase complex. J Biol Chem 
261(4):1858-1867. 
Kahlert S, Reiser G. 2000. Requirement of glycolytic and mitochondrial energy supply for 
loading of Ca2+ stores and InsP(3)-mediated Ca2+ signaling in rat hippocampus 
astrocytes. J Neurosci Res 61(4):409-420. 
Karagas MR, Villanueva CM, Nieuwenhuijsen M, Weisel CP, Cantor KP, Kogevinas M. 2008. 
Disinfection byproducts in drinking water and skin cancer? A hypothesis. Cancer Cause 
Control 19(5):547-548. 
Kargalioglu Y, McMillan BJ, Minear RA, Plewa MJ. 2002. Analysis of the cytotoxicity and 
mutagenicity of drinking water disinfection by-products in Salmonella typhimurium. 
Teratogenesis Carcinogenesis and Mutagenesis 22(2):113-128. 
Kato M, Chuang JL, Tso SC, Wynn RM, Chuang DT. 2005. Crystal structure of pyruvate 
dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase 
complex. Embo j 24(10):1763-1774. 
	  35	  
Kato M, Li J, Chuang JL, Chuang DT. 2007. Distinct structural mechanisms for inhibition of 
pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol. 
Structure 15(8):992-1004. 
King WD, Marrett LD, Woolcott CG. 2000. Case-control study of colon and rectal cancers and 
chlorination by-products in treated water. Cancer Epidemiol Biomarkers Prev 9(8):813-
818. 
Kline JA, Maiorano PC, Schroeder JD, Grattan RM, Vary TC, Watts JA. 1997. Activation of 
pyruvate dehydrogenase improves heart function and metabolism after hemorrhagic 
shock. J Mol Cell Cardiol 29(9):2465-2474. 
Koch R. 1881. Über Desinfektion. Mitt kaiserl Gesundheitsamte 1:234–282. 
Korotchkina LG, Patel MS. 1995. Mutagenesis studies of the phosphorylation sites of 
recombinant human pyruvate dehydrogenase. Site-specific regulation. J Biol Chem 
270(24):14297-14304. 
Korotchkina LG, Patel MS. 2001. Site specificity of four pyruvate dehydrogenase kinase 
isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase. J 
Biol Chem 276(40):37223-37229. 
Krasner SW. 2009. The formation and control of emerging disinfection by-products of health 
concern. Philos Trans A Math Phys Eng Sci 367(1904):4077-4095. 
Krasner SW, McGuire MJ, Jacangelo JG, Patania NL, Reagan KM, Marco Aieta E. 1989. 
Occurrence of disinfection by-products in US drinking water. Journal / American Water 
Works Association 81(8):41-53. 
Krasner SW, Weinberg HS, Richardson SD, Pastor SJ, Chinn R, Sclimenti MJ, Onstad GD, 
Thruston Jr AD. 2006. Occurrence of a new generation of disinfection byproducts. 
Environ Sci Technol 40(23):7175-7185. 
Li C, Meng G, Su L, Chen A, Xia M, Xu C, Yu D, Jiang A, Wei J. 2015. Dichloroacetate blocks 
aerobic glycolytic adaptation to attenuated measles virus and promotes viral replication 
leading to enhanced oncolysis in glioblastoma. Oncotarget 6(3):1544-1555. 
Liviac D, Creus A, Marcos R. 2010. Genotoxicity testing of three monohaloacetic acids in TK6 
cells using the cytokinesis-block micronucleus assay. Mutagenesis 25(5):505-509. 
Loudon GM. 1995. Organic Chemistry 3rd ed. Redwood, CA: Benjamin/Cummings Publ. Co. 
Mahler BJ, Van Metre PC. 2003. A simplified approach for monitoring hydrophobic organic 
contaminants associated with suspended sediment: Methodology and applications. Arch 
Environ Contam Toxicol 44(3):288-297. 
Mahler BJ, van Metre PC, Bashara TJ, Wilson JT, Johns DA. 2005. Parking Lot Sealcoat: An 
Unrecognized Source of Urban Polycyclic Aromatic Hydrocarbons. Environ Sci Technol 
39(15):5560-5566. 
Malliarou E, Collins C, Graham N, Nieuwenhuijsen MJ. 2005. Haloacetic acids in drinking 
water in the United Kingdom. Water Research 39(12):2722-2730. 
Melnick RL, Nyska A, Foster PM, Roycroft JH, Kissling GE. 2007. Toxicity and carcinogenicity 
of the water disinfection byproduct, dibromoacetic acid, in rats and mice. Toxicology 
230(2/3):126-136. 
Mumtaz M, Julia G. 1995. Toxicologial profile for polycyclic aromatic hydrocarbons Toxic 
substances portal-polycyclic aromatic hydrocarbons (PAHs). 
Narotsky MG, Best DS, McDonald A, Godin EA, Hunter ES, 3rd, Simmons JE. 2011. Pregnancy 
loss and eye malformations in offspring of F344 rats following gestational exposure to 
mixtures of regulated trihalomethanes and haloacetic acids. Reprod Toxicol 31(1):59-65. 
	  36	  
Narotsky MG, Klinefelter GR, Goldman JM, DeAngelo AB, Best DS, McDonald A, Strader LF, 
Murr AS, Suarez JD, George MH, Hunter ES, 3rd, Simmons JE. 2015. Reproductive 
Toxicity of a Mixture of Regulated Drinking-Water Disinfection By-Products in a 
Multigenerational Rat Bioassay. Environ Health Perspect. 
National Toxicology P. 2007. NTP report on the toxicology studies of dichloroacetic acid (CAS 
No. 79-43-6) in genetically modified (FVB Tg.AC hemizygous) mice (dermal and 
drinking water studies) and carcinogenicity studies of dichloroacetic acid in genetically 
modified [B6.129-Trp53(tm1Brd) (N5) haploinsufficient] mice (drinking water studies). 
Natl Toxicol Program Genet Modif Model Rep(11):1-168. 
National Toxicology Program. 2007. NTP report on the toxicology studies of dichloroacetic acid 
(CAS No. 79-43-6) in genetically modified (FVB Tg.AC hemizygous) mice (dermal and 
drinking water studies) and carcinogenicity studies of dichloroacetic acid in genetically 
modified [B6.129-Trp53(tm1Brd) (N5) haploinsufficient] mice (drinking water studies). 
Natl Toxicol Program Genet Modif Model Rep(11):1-168. 
Nelson GM, Swank AE, Brooks LR, Bailey KC, George SE. 2001. Metabolism, microflora 
effects, and genotoxicity in haloacetic acid-treated cultures of rat cecal microbiota. 
Toxicol Sci 60(2):232-241. 
Ngwenya N, Ncube EJ, Parsons J. 2013. Recent advances in drinking water disinfection: 
successes and challenges. Rev Environ Contam Toxicol 222:111-170. 
Pals JA, Ang JK, Wagner ED, Plewa MJ. 2011. Biological mechanism for the toxicity of 
haloacetic acid drinking water disinfection byproducts. Environ SciTechnol 45(13):5791-
5797. 
Pan S, An W, Li H, Su M, Zhang J, Yang M. 2014. Cancer risk assessment on trihalomethanes 
and haloacetic acids in drinking water of China using disability-adjusted life years. J 
Hazard Mater 280:288-294. 
Patel MS, Korotchkina LG. 2003. The biochemistry of the pyruvate dehydrogenase complex*. 
Biochemistry and Molecular Biology Education 31(1):5-15. 
Patel MS, Roche TE. 1990. Molecular biology and biochemistry of pyruvate dehydrogenase 
complexes. FASEB J 4(14):3224-3233. 
Perham RN, Packman LC. 1989. 2-Oxo acid dehydrogenase multienzyme complexes: domains, 
dynamics, and design. Ann N Y Acad Sci 573:1-20. 
Plewa MJ, Cemeli E, Anderson D, Wagner ED. 2004a. The genotoxicity of the drinking water 
disinfection by-product iodoacetic acid is reduced by modulators of oxidative stress. 
Environmental and Molecular Mutagenesis 44(3):220-220. 
Plewa MJ, Kargalioglu Y, Vankerk D, Minear RA, Wagner ED. 2002. Mammalian cell 
cytotoxicity and genotoxicity analysis of drinking water disinfection by-products. 
Environmental and Molecular Mutagenesis 40(2):134-142. 
Plewa MJ, Simmons JE, Richardson SD, Wagner ED. 2010. Mammalian Cell Cytotoxicity and 
Genotoxicity of the Haloacetic Acids, A Major Class of Drinking Water Disinfection By-
Products. Environmental and Molecular Mutagenesis 51(8-9):871-878. 
Plewa MJ, Wagner ED. 2015. Charting a New Path to Resolve the Adverse Health Effects of 
DBPs. In Occuarance , Formation, Health Effects and Control of Disinfection By-
Products Am Chem Soc In Press. 
Plewa MJ, Wagner ED, Richardson SD, Thruston Jr AD, Woo YT, McKague AB. 2004b. 
Chemical and biological characterization of newly discovered iodoacid drinking water 
disinfection byproducts. Environ Sci Technol 38(18):4713-4722. 
	  37	  
Pourmoghaddas H, Stevens AA. 1995. Relationship between trihalomethanes and haloacetic 
acids with total organic halogen during chlorination. Water Research 29(9):2059-2062. 
Rahman MB, Cowie C, Driscoll T, Summerhayes RJ, Armstrong BK, Clements MS. 2014. 
Colon and rectal cancer incidence and water trihalomethane concentrations in New South 
Wales, Australia. BMC Cancer 14(1). 
Richardson SD, Crumley FG, Plewa MJ, Wagner ED, Mize T, Ange P, Orlando R, Williamson 
L, Bartlett MG. 2007a. Chlorinated vs. chloraminated drinking water: Toxicity-based 
identification of disinfection by-products using ESI-MS and ESI-MS/MS. Abstracts of 
Papers of the American Chemical Society 233:572-572. 
Richardson SD, Plewa MJ, Wagner ED, Schoeny R, DeMarini DM. 2007b. Occurrence, 
genotoxicity, and carcinogenicity of regulated and emerging disinfection by-products in 
drinking water: A review and roadmap for research. Mutation Research-Reviews in 
Mutation Research 636(1-3):178-242. 
Richardson SD, Postigo C. 2012. Drinking water disinfection by-products. . Berlin, Germany: 
Springer. 
Rivera-Núñez Z, Wright JM. 2013. Association of Brominated Trihalomethane and Haloacetic 
Acid Exposure with Fetal Growth and Preterm Delivery in Massachusetts. Journal of 
Occupational and Environmental Medicine 55(10):1125-1134. 
Rodríguez E, Rivera I, Astorga S, Mendoza E, García F, Hernández-Echeagaray E. 2010. 
Uncoupling oxidative/energy metabolism with low sub chronic doses of 3-nitropropionic 
acid or iodoacetate in vivo produces striatal cell damage. International Journal of 
Biological Sciences 6(3):199-212. 
Rook JJ. 1974. Formation of haloforms during chlorination of natural waters. Water Treat 
Examination 23:234-243. 
Sale GJ, Randle PJ. 1981. Analysis of site occupancies in [32P]phosphorylated pyruvate 
dehydrogenase complexes by aspartyl-prolyl cleavage of tryptic phosphopeptides. Eur J 
Biochem 120(3):535-540. 
Schmidt MM, Dringen R. 2009. Differential effects of iodoacetamide and iodoacetate on 
glycolysis and glutathione metabolism of cultured astrocytes. Frontiers in neuroenergetics 
1:1-1. 
Sirover MA. 1999. New insights into an old protein: the functional diversity of mammalian 
glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta 13(2):159-184. 
Stacpoole PW, Kerr DS, Barnes C, Bunch ST, Carney PR, Fennell EM, Felitsyn NM, Gilmore 
RL, Greer M, Henderson GN, Hutson AD, Neiberger RE, O'Brien RG, Perkins LA, 
Quisling RG, Shroads AL, Shuster JJ, Silverstein JH, Theriaque DW, Valenstein E. 2006. 
Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in 
children. Pediatrics 117(5):1519-1531. 
Stacpoole PW, Moore GW, Kornhauser DM. 1978. Metabolic effects of dichloroacetate in 
patients with diabetes mellitus and hyperlipoproteinemia. N Engl J Med 298(10):526-
530. 
Stephens PE, Darlison MG, Lewis HM, Guest JR. 1983. The pyruvate dehydrogenase complex 
of Escherichia coli K12. Nucleotide sequence encoding the dihydrolipoamide 
acetyltransferase component. Eur J Biochem 133(3):481-489. 
Stuart WK. 2009. The formation and control of emerging disinfection by-products of health 
concern. Philosophical Transactions of the Royal Society a-Mathematical Physical and 
Engineering Sciences 367(1904):4077-4095. 
	  38	  
Sutendra G, Michelakis ED. 2013. Pyruvate dehydrogenase kinase as a novel therapeutic target 
in oncology. Front Oncol 3:38. 
Szalai G, Rajeshwari, Krishnamurthy, Hajnoczky G. 1999. Apoptosis driven by IP3-linked 
mitochondrial calcium signals. EMBO Journal 18(22):6349-6361. 
Teixido E, Pique E, Gonzalez-Linares J, Llobet JM, Gomez-Catalan J. 2015. Developmental 
effects and genotoxicity of 10 water disinfection by-products in zebrafish. J Water Health 
13(1):54-66. 
Tennant RW, Stasiewicz S, Eastin WC, Mennear JH, Spalding JW. 2001. The Tg.AC (v-Ha-ras) 
transgenic mouse: nature of the model. Toxicol Pathol 29 Suppl:51-59. 
Texter FL, Radford SE, Laue ED, Perham RN, Miles JS, Guest JR. 1988. Site-directed 
mutagenesis and 1H NMR spectroscopy of an interdomain segment in the pyruvate 
dehydrogenase multienzyme complex of Escherichia coli. Biochemistry 27(1):289-296. 
U. S. Environmental Protection Agency. 1979. National interim primary drinking water 
regulations:Total trihalomethanes. Fed Regist 44(228):68624. 
U. S. Environmental Protection Agency. 1998. National Primary Drinking Water Regulations: 
Disinfectants and Disinfection Byproducts. 69390-69476 p. 
U. S. Environmental Protection Agency. 2001. Environmental Protection Agency report on the 
toxicological review of chloroform; (CAS No. 67-66-3)  
U. S. Environmental Protection Agency. 2006. National primary drinking water regulations: 
Stage 2 disinfectants and disinfection byproducts rule. Fed Regist 71(2):387-493. 
U.S. Environmental Protection Agency. 1998. Quantification of Cancer Risk from Exposure of 
Chlorinated Drinking Water Washington,DC: Office of Water, Office of Science and 
Technology, Health and Ecological Criteria Division. 
Van Metre PC, Mahler BJ. 2005. Trends in hydrophobic organic contaminants in urban and 
reference lake sediments across the United States, 1970-2001. Environ Sci Technol 
39(15):5567-5574. 
Van Metre PC, Mahler BJ. 2010. Contribution of PAHs from coal-tar pavement sealcoat and 
other sources to 40 U.S. lakes. Sci Total Environ 409(2):334-344. 
Villanueva CM, Cantor KP, Grimalt JO, Malats N, Silverman D, Tardon A, Garcia-Closas R, 
Serra C, Carrato A, Castaño-Vinyals G, Marcos R, Rothman N, Real FX, Dosemeci M, 
Kogevinas M. 2007. Bladder cancer and exposure to water disinfection by-products 
through ingestion, bathing, showering, and swimming in pools. Am J Epidemiol 
165(2):148-156. 
Villanueva CM, Castano-Vinyals G, Moreno V, Carrasco-Turigas G, Aragones N, Boldo E, 
Ardanaz E, Toledo E, Altzibar JM, Zaldua I, Azpiroz L, Goni F, Tardon A, Molina AJ, 
Martin V, Lopez-Rojo C, Jimenez-Moleon JJ, Capelo R, Gomez-Acebo I, Peiro R, Ripoll 
M, Gracia-Lavedan E, Nieuwenhujsen MJ, Rantakokko P, Goslan EH, Pollan M, 
Kogevinas M. 2012. Concentrations and correlations of disinfection by-products in 
municipal drinking water from an exposure assessment perspective. Environ Res 114:1-
11. 
Waller K, Swan SH, DeLorenze G, Hopkins B. 1998. Trihalomethanes in drinking water and 
spontaneous abortion. Epidemiology 9(2):134-140. 
Wang D, Xu Z, Zhao Y, Yan X, Shi J. 2011. Change of genotoxicity for raw and finished water: 
Role of purification processes. Chemosphere 83(1):14-20. 
	  39	  
Wei X, Chen X, Wang X, Zheng W, Zhang D, Tian D, Jiang S, Ong CN, He G, Qu W. 2013a. 
Occurrence of Regulated and Emerging Iodinated DBPs in the Shanghai Drinking Water. 
PLoS ONE 8(3). 
Wei X, Wang S, Zheng W, Wang X, Liu X, Jiang S, Pi J, Zheng Y, He G, Qu W. 2013b. 
Drinking water disinfection byproduct iodoacetic acid induces tumorigenic 
transformation of NIH3T3 cells. Environmental Science & Technology 47(11):5913-
5920. 
Wei XW, S.; Zheng, W.; Wang, X.; Liu, X.; Jiang, S.; He, G.; Zheng, Y.; Qu, W., . 2013. 
Tumorigenicity of drinking water disinfection byproduct iodoacetic acid  in NIH3T3 
cells. Envion Sci Technol Submitted. 
Whitehouse S, Cooper RH, Randle PJ. 1974. Mechanism of activation of pyruvate 
dehydrogenase by dichloroacetate and other halogenated carboxylic acids. Biochemical 
Journal 141(3):761-774. 
WHO. 2000. Environmental Health Criteria. Disinfectants and disinfectant by-products. 
Environmental Health Criteria Disinfectants and disinfectant by-products 216:i-xxvii, 1-
499. 
Wigley DB, Davies GJ, Dodson EJ, Maxwell A, Dodson G. 1991. Crystal structure of an N-
terminal fragment of the DNA gyrase B protein. Nature 351(6328):624-629. 
World Health Organization. 2011. Guidlines for Drinking Water Quality United Nations: 
Geneva, Switzerland. 541 p. 
Xu KY, Zweier JL, Becker LC. 1995. Functional coupling between glycolysis and sarcoplasmic 
reticulum Ca2+ transport. Circ Res 77(1):88-97. 
Yang Y, Van Metre PC, Mahler BJ, Wilson JT, Ligouis B, Razzaque MD, Schaeffer DJ, Werth 
CJ. 2010. Influence of coal-tar sealcoat and other carbonaceous materials on polycyclic 
aromatic hydrocarbon loading in an urban watershed. Environ Sci Technol 44(4):1217-
1223. 
Zhang SH, Miao DY, Liu AL, Zhang L, Wei W, Xie H, Lu WQ. 2010. Assessment of the 
cytotoxicity and genotoxicity of haloacetic acids using microplate-based cytotoxicity test 
and CHO/HGPRT gene mutation assay. Mutat Res 703(2):174-179. 
 
 
 
 
 
 
	  
	  
	  
 
	  40	  
CHAPTER 2  
INVESTIGATE THE MOLECULAR TARGET OF THE MONOHALOACETIC ACID 
WATER DISINFECTION BY-PRODCUTS AND ITS TOXICITY MECHANISM  
 
Preface  
This research was published in the journal of Environmental and Molecular Mutagenesis: Dad, 
A.; Jeong, C. H.; Pals, J. A.; Wagner, E. D.; Plewa, M. J., Pyruvate remediation of cell stress and 
genotoxicity induced by haloacetic acid drinking water disinfection by-products. Environ. Mol. 
Mutagen. 2013, 54, (8), 629-637. With permission from Wiley and Sons. A. Dad is the first 
author of the paper. 
2.1. INTRODUCTION  
 A preeminent public health accomplishment achieved during the last century was the 
disinfection of drinking water. Water treatment and distribution of disinfected water was an 
effective strategy in controlling waterborne diseases such as cholera, typhoid and dysentery 
(Cutler and Miller 2005). However, disinfection byproducts (DBPs) are inadvertently generated 
when chlorine or other disinfectants react with organic matter present in source water (Cutler and 
Miller 2005; Richardson 2011). Many DBPs are cytotoxic, genotoxic, mutagenic, carcinogenic 
and teratogenic (Richardson et al. 2007). Epidemiological studies demonstrated an association 
between lifetime exposures to DBPs and increased risk of bladder cancer (Villanueva et al. 2004; 
Villanueva et al. 2007; Costet et al. 2011; Kogevinas 2011), colorectal cancer (King et al. 2000; 
Rahman et al. 2010) and skin cancer (Karagas et al. 2008). The U.S. Environmental Protection 
Agency (U.S. EPA) estimated that between 2 and 17% of bladder cancer cases in the United 
States may be induced by DBPs (U. S. Environmental Protection Agency 1998). 
Epidemiological studies also demonstrated an association between disinfected drinking water 
and adverse pregnancy outcomes (Costet et al. 2012; Jeong et al. 2012; Righi et al. 2012). 
 Currently, over 600 DBPs have been identified and the spectrum of DBP chemical 
classes are influenced by the source water, water contaminants and the disinfectant used (Zhang 
et al. 2000; Hua and Reckhow 2007; Richardson 2011). In chlorinated water the second largest 
occurring DBP chemical class is the haloacetic acids (HAAs) (Krasner et al. 2006). The HAAs 
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are the most highly regulated DBPs. The U.S. EPA regulates chloroacetic acid (CAA), 
dichloroacetic acid, trichloroacetic acid, bromoacetic acid (BAA), and dibromoacetic acid to a 
total maximum contaminant level of 60 µg/L (U. S. Environmental Protection Agency 2006). At 
all water sites measured, the U.S. EPA Information Collection Rule recorded the mean and 90th 
percentile concentration for the 5 regulated HAAs (HAA5) as 23 µg/L and 47.5 µg/L, 
respectively (McGuire et al. 2002). 
 HAAs are alkylating agents and follow SN2 reactivity, which is primarily dependent on 
the carbon-halogen bond length and the bond dissociation energy. The α-carbon-halide (αC-X) 
bond length follows the pattern of C-I > C-Br > C-Cl, which implies that the greater the bond 
length, the lower the dissociation energy required to react with the target molecule (Plewa et al. 
2004). Cytotoxic and genotoxic potencies induced by the monohaloacetic acids (monoHAAs) 
expressed the pattern of iodoacetic acid (IAA) > BAA >> CAA, which highly correlated to the 
SN2 reactivity, αC-X bond length and αC-X dissociation energy (Plewa et al. 2004). 
 HAAs are mutagenic in Salmonella typhimurium and Chinese hamster ovary (CHO) cells 
(Kargalioglu et al. 2002; Plewa et al. 2004; Zhang et al. 2010).  They are cytotoxic and genotoxic 
in CHO cells (Plewa et al. 2010), non-transformed human cells (Attene-Ramos et al. 2010) and 
toxic in a variety of other bioassays (Richardson et al. 2007). The monoHAAs modulated the 
gene expression pathways of ATM, MAPK, p53, BRCA1, BRCA2, and ATR, in non-
transformed human FHs 74-Int cells; these pathways are involved in stress response to DNA 
damage and regulate different stages in cell cycle progression or apoptosis (Attene-Ramos et al. 
2010; Muellner et al. 2010). FHs 74-Int cells originated from a female fetus 3-4 months into 
gestation (Smith 1979). Recently, IAA induced malignant transformation in NIH/3T3 mouse 
embryonic fibroblast cells that progressed to highly aggressive fibrosarcomas when implanted in 
Balb/c nude mice (Wei et al. 2013). Under ex-vivo conditions, monoHAAs were teratogenic and 
induced dysmorphogenesis in 3-6 somite staged CD-1 mouse embryos and affected neural tube 
development, eye development and produced hypoplastic pharyngeal arches and anomalies in 
heart development (Hunter et al. 1996). F344 rats gavaged with a mixture of HAA5 during 
gestation resulted in pregnancy loss and eye malformation in surviving litters (Narotsky et al. 
2011).  
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  IAA induced toxicity in hippocampal neuronal cells by inhibiting the glycolytic enzyme 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which led to hypoglycemia and the 
generation of reactive oxygen species (ROS) (Hernandez-Fonseca et al. 2008). IAA induced 
similar effects in hippocampal astrocytes (Kahlert and Reiser 2000). The direct role of 
monoHAA-mediated inhibition kinetics of GAPDH and their high correlation with many toxicity 
measurements was recently published by our laboratory (Pals et al. 2011).  
 Our working hypothesis is that GAPDH is inhibited by monoHAAs, which reduces the 
generation of pyruvate and ATP that is required for the tricarboxylic acid (TCA) cycle for the 
further production of ATP. We postulate that the unavailability of pyruvate causes mitochondrial 
stress leading to the generation of ROS and a reduction in cellular ATP levels, which may lead to 
cytotoxicity. The increased levels of ROS induce genomic DNA damage in HAA-treated cells.  
If this hypothesis is correct, then supplementing monoHAA-treated cells with exogenous 
pyruvate should restore cellular ATP levels and prevent or reduce genomic DNA damage. The 
objective of this research was to test this hypothesis. We measured the impact of the monoHAAs 
on ATP levels and the induction of genomic DNA damage with and without pyruvate 
supplementation.   
2.2. MATERIALS AND METHODS  
Reagents  
 General reagents were purchased from Fisher Scientific Co. (Itasca, IL) and Sigma 
Chemical Co. (St. Louis, MO). The sources and purities of the monoHAAs used in this research 
are listed in Table 2.1. Cell culture F12 medium and fetal bovine serum (FBS) were purchased 
from Fisher Scientific Co. Pyruvic acid was purchased from Acros Organics (NJ). Cell Titer-Glo 
reagent was purchased from Promega (Madison, WI). The monoHAAs were dissolved in 
dimethylsulfoxide (DMSO) and stored at −20°C in sealed sterile glass vials (Sulpelco, Bellefonte 
PA).  Pyruvate was dissolved directly either in F12 or Hank’s balanced salt solution (HBSS) 
according to the experimental design, while individual IAA, BAA and CAA stock solutions in 
DMSO (1M) were diluted in F12 medium or HBSS depending upon the experimental design.    
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Chinese Hamster Ovary Cells  
 CHO cell clone 11-4-8 was used  (Wagner et al. 1998). Cells were grown in 100 mm 
glass petri plates with F12 medium containing 5% FBS, 1% glutamine and 1% antibiotic-
antimycotic solution at 37°C in a humidified atmosphere of 5% CO2. 
ATP Analysis  
 Cellular ATP levels were determined after exposure to monoHAAs alone, pyruvic acid 
alone or monoHAAs plus pyruvic acid with a TUNE-SpectraMax Paradigm® Multi-Mode 
Microplate Detection Platform using Promega Cell Titer–Glo ATP reagents. The day before 
ATP analysis, 3×104 CHO cells/well were cultured in a 96 well opaque microplate in 200 µL of 
F12 plus 5% FBS. The next day, the cells were washed with 100 µL of HBSS and treated with 
concentrations of the monoHAAs with and without pyruvic acid in 50 µL HBSS (with 1.3 mM 
CaCl2 and 1.1 mM MgSO4). The microplate was covered with AlumnaSeal and incubated for 4 h 
at 37°C, 5% CO2. Each experiment contained a concurrent negative control, a bioluminescence 
background control, pyruvic acid (10 mM), the monoHAAs, monoHAAs plus pyruvic acid and 
an ATP standard curve. After a 4 h incubation, the cells were washed with 100 µL of HBSS and 
supplemented with 10 mM pyruvate (for the pyruvate containing treatment groups), covered with 
AlumnaSeal and incubated for 30 min at 37°C, 5% CO2 and then equilibrated to room 
temperature for 30 min. The ATP contents of the cells were measured according to the 
manufacturer’s protocol using 50 µL of Cell Titer-Glo ATP reagents. Data were collected in an 
Excel spreadsheet and used in calculating pmols of ATP.  
Protein Determination  
 Parallel ATP and protein analyses were performed. The day before the experiment, 3×104 
CHO cells/well were cultured in a 96 well flat bottom clear microplate in 200 µL of F12 plus 5% 
FBS. The next day, cells were treated with the HAAs with and without pyruvate as discussed 
above for the ATP analysis. After treatment, the cells were lysed by adding 25 µL of Solulyse® 
cell homogenizing solution (Genlantis, San Diego, CA). The microplate was covered with sterile 
AlumnaSeal and put on a rocker platform (at 37°C) shaken for 5 min after which the plate was 
rotated and shaken for an additional 5 min. After cell lyses, 10 µL of the lysate from each well 
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was transferred into a new microplate; into each well was added 10 µL of an anti-foaming agent 
(Sigma 240, 0.01% v/v), 40 µL of Bradford solution (BioRad), and 140 µL of dH2O for a final 
volume of 200 µL. A BioRad protein (BSA) standard was prepared on the same microplate, 
using 0.68 µg/µL of a BSA standard solution. The contents of each well were carefully mixed 
and incubated at room temperature for 20 min. The absorbance was read at 595 nm using a 
SpectraMax Molecular Device plate reader. The data were collected in an Excel spreadsheet and 
the mg of protein was calculated for each well.  
Single Cell Gel Electrophoresis Assay  
 The alkaline single cell gel electrophoresis (SCGE) or Comet assay is a sensitive, 
quantitative method for the detection of genomic DNA damage in individual cells (Tice et al. 
2000; Rundell et al. 2003). CHO cells were treated with a series of concentrations of IAA, BAA 
or CAA with and without pyruvic acid and the level of genomic DNA damage was measured. 
The SCGE microplate assay was performed as described by (Wagner and Plewa 2009). The day 
before treatment, 4×104 cells were cultured into each well of a 96 well microplate in 200 µl of 
F12 plus 5% FBS and incubated overnight. The following day, cells were washed twice with 100 
µL of HBSS and treated with a series of concentrations of a monoHAA alone, pyruvic acid alone, 
and the monoHAA plus pyruvic acid in a total volume of 25 µL. The cells were covered with 
sterile AlumnaSeal and incubated for 4 h at 37°C in a humidified atmosphere of 5% CO2. Each 
experiment had a concurrent negative control (F12 medium only) and a positive control (3.8 mM 
ethylmethanesulfonate). After treatment, the cells were washed with HBSS, harvested with a 
0.05% trypsin +53 µM EDTA solution and incorporated into agarose microgels. For each 
concentration group, acute cytotoxicity was measured using the vital dye trypan blue (Phillips 
1973). The microgels were electrophoresed and analyzed if the viability of the cell suspensions 
was >70%. The microgels were placed in lysing solution overnight at 4°C to remove cell 
membranes (2.5 M NaCl, 100 mM Na2 EDTA, 10 mM Trisma base, 26 g of NaOH and 1% 
sodium lauryl sarcosinate, pH 10) with10% DMSO and 1% Triton X-100 added just prior to use. 
The microgels were rinsed twice with cold deionized water and the DNA was denatured for 20 
min in electrophoresis buffer (1 mM Na2EDTA and 300 mM NaOH, pH 13.5). The microgels 
were electrophoresed for 40 min at 25 V, 300 mA (0.72 V/cm) at 4°C. After electrophoreses, the 
microgels were neutralized with 400 mM Tris buffer (pH 7.5), dehydrated in methanol (4°C) and 
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dried for 5 min at 50°C. The microgels were stored in the dark at room temperature. To analyze 
the microgels they were first hydrated in deionized water for 30 min at 4°C, stained with 65 µL 
of 20 µg/mL ethidium bromide and rinsed in cold deionized water.  After staining, a cover slip 
was applied onto the microgel and 25 randomly selected nuclei per microgel were analyzed 
under a Zeiss fluorescence microscope with the Comet IV imaging system (Perspective 
Instruments, Suffolk, UK). The data were automatically transferred to an Excel spreadsheet. For 
DNA damage the unit of measure for each microgel was the average % tail DNA, which is the 
amount of DNA that migrated into the gel from the nucleus. The mean % tail DNA values were 
calculated for the microgels in a treatment group and were analyzed with an ANOVA statistical 
test. If a significant F value of P < 0.05 was obtained, a Holm-Sidak pairwise comparison versus 
the control group analysis was conducted (power ≥ 0.8 at α = 0.05).   
Reactive Oxygen Species (ROS) Analysis in HAA-treated CHO Cells  
 A titer of 4×104 CHO cells were seeded into a 6 well plate in phenol free F12 plus 5% 
FBS medium with the final volume of 1 mL and incubated overnight at 37°C, 5%  CO2. The 
next day, cells were washed with HBSS twice and treated with each monoHAA (50 µM IAA, 
100 µM BAA, and 6 mM CAA) for 2 h with and without pyruvate in phenol free F12 medium. 
Every experiment included cells treated with 1 mL of phenol free F12 medium as a negative 
control and cells treated with 500 µM of H2O2 as a positive control. The wells with the treated 
cells were covered with AlumnaSeal and incubated for 2 h at 37 °C, 5% CO2. After incubation, 
cells were washed with HBSS and treated with 15 µM of 2’,7’dichlorofluorescein (H2DCF) for 
20 min. After incubation, cells were washed with cold phosphate buffer solution (PBS). The 
ROS produced by monoHAAs oxidized the non-fluorescent substrate to a green florescent 
product. Cell membranes were permeable to esterified forms of H2DCF. Therefore, H2DCF 
entered into cells freely. Intracellular esterases deacetylate the H2DCF. Therefore, it was trapped 
intracellularly (Owusu-Ansah et al. 2008). The green florescence produced by the ROS induced 
oxidation of H2DCF into DCF was measured by florescence microscopy with FITC filter and the 
images were saved. These data tested the hypothesis that monoHAA mediated GAPDH 
inhibition generated ROS via pyruvate starvation.   
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2.3. RESULTS AND DISCUSSION 
 Five HAAs are regulated by the U.S.EPA; two of the five are BAA and CAA (U. S. 
Environmental Protection Agency 2006). MonoHAAs are cytotoxic, genotoxic, mutagenic and 
teratogenic (Richardson et al. 2007). This study extends our research on the molecular 
mechanism(s) of toxicity of these important DBPs by investigating the impact of monoHAAs on 
cellular ATP levels, their induction of genomic DNA damage and the attenuation of this DNA 
damage by pyruvate supplementation.  
 Previous studies demonstrated that IAA blocked glycolysis by inhibiting GAPDH that led 
to neurotoxicity (Matthews et al. 1997; Kahlert and Reiser 2000; Hernandez-Fonseca et al. 
2008), ROS generation (Matthews et al. 1997; Hernandez-Fonseca et al. 2008), ATP depletion  
(Kahlert and Reiser 2000; Hernandez-Fonseca et al. 2008) and disruption of intracellular Ca2+ 
homeostasis (Kahlert and Reiser 2000; Chinopoulos and Adam-Vizi 2006). We recently 
demonstrated that the relative rates of monoHAA-induced GAPDH inhibition kinetics were 
highly correlated with many toxicity metrics (Pals et al. 2011). Central to its glycolytic function 
is a conserved cysteine residue in the active site of GAPDH. This cysteine serves as a 
nucleophile in the first catalytic step in the conversion of glyceraldehyde-3-phosphate to 1,3-bis-
phosphoglycerate (Nakajima et al. 2007).  The α-carbon of each monoHAA is a primary alkyl 
halide and an electrophile due to electron withdrawal from the carbon by the halogen substituent. 
IAA, BAA and CAA inhibit GAPDH when the α-carbon undergoes an SN2 reaction with the 
nucleophilic thiol group on the catalytic cysteine residue. This results in a carboxymethylated 
cysteine which irreversibly inhibits the catalytic function of the enzyme. Our overall working 
hypothesis is that the monoHAAs inhibit GAPDH by alkylating the thiol group at the GAPDH 
active site. This leads to glycolytic ATP depletion and blocks the production of pyruvate that is a 
mitochondrial substrate for the TCA cycle (Tristan et al. 2011). Pyruvate starvation enhances 
mitochondrial stress, disrupts the TCA cycle and affects the generation of reducing power 
(NADH and FADH2) within mitochondria during the TCA cycle. This deficiency in reducing 
power disturbs normal oxidative phosphorylation, which eventually generates ROS, depletes 
mitochondrial ATP and increases cytosolic Ca2+ concentration (Nakajima et al. 2007; 
Hernandez-Fonseca et al. 2008; Csordas and Hajnoczky 2009; Peng and Jou 2010). This 
proposed mechanism is supported in that IAA-induced mutagenicity in Salmonella typhimurium 
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and genotoxicity in CHO cells was repressed by the antioxidants catalase and butylated 
hydroxyanisole (Cemeli et al. 2006). We believe that ATP depletion and ROS generation are the 
principal forcing mechanisms for monoHAA-mediated toxicity (Schlisser et al. 2010; Pals et al. 
2011).     
Depletion of ATP by MonoHAAs 
 MonoHAAs inhibited GAPDH kinetics with a rank order of IAA > BAA >> CAA (Pals 
et al. 2011). We proposed that cells exposed to monoHAAs would express ATP depletion. To 
test this, CHO cells were treated with 25 and 40 µM IAA, 60 µM BAA and 6 mM CAA for 4 h 
in HBSS. The concentrations of each monoHAA were previously determined to be genotoxic in 
CHO cells without acute cytotoxicity (Komaki et al. 2009). The cellular ATP levels (as the 
average bioluminescence unit) for monoHAA-treated cells were significantly reduced as 
compared to the negative control. The ATP levels with CAA-treated cells were approximately 
the same as the blank (Figure 2.1). These data demonstrate that IAA, BAA and CAA 
significantly reduced cellular ATP levels; however, this experimental design could generate an 
artifact. Although, by observation, we did not detect CHO cell cytotoxicity after 4 h, we did not 
have a direct quantitative measurement of cell viability of the cell suspensions from which these 
ATP measurements were generated.  
Pyruvate Supplementation and ATP Levels in monoHAA-Treated Cells 
 To avoid the artifacts that may be associated with the direct ATP measurements alone the 
experimental designs were refined and expanded to include protein analyses. We determined the 
minimum concentration of each monoHAA in HBSS (with 1.3 mM CaCl2 and 1.1 mM MgSO4) 
that induced a significant reduction in cellular ATP levels. The lowest non-cytotoxic 
concentrations of IAA, BAA and CAA that induced a significant reduction in ATP levels as 
compared to each concurrent negative control was 3 µM, 6 µM, and 1 mM, respectively (Figure 
2.2).  Using these concentrations of IAA, BAA and CAA, we conducted parallel experiments to 
determine the absolute amount of ATP and the total protein content of each cell suspension 
within each treatment group. Each monoHAA treatment had a negative control, a blank control, 
a pyruvate control, a monoHAA treatment and a monoHAA plus 10 mM pyruvate treatment. The 
number of replicate clones for the IAA treatment group was 40 while for BAA and CAA the 
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number of replicate clones were 37 and 32, respectively. This experimental design allowed us to 
determine concentrations of ATP and protein for each CHO cell suspension for a precise 
measurement of ATP depletion and restoration. The concentration of ATP as pmol/mg protein 
for each monoHAA treatment group is presented in Table 2.2. Figure 2.3 illustrates cellular ATP 
levels (pmol ATP/mg protein) normalized as 100% for each concurrent negative control for each 
monoHAA treatment group. A reduction in ATP levels was observed with exposures to 3 µM 
IAA, 6 µM BAA and 1 mM CAA with levels of 18.7 %, 48.2 % and 50.8 %, respectively, of the 
concurrent negative controls. When monoHAA- treated cells were simultaneously treated with10 
mM pyruvate a significant recovery of cellular ATP levels was measured. For IAA, ATP 
concentrations increased from 18.7 % to 45.0 % of the concurrent negative control. Similar 
responses were observed for BAA (48.2 % to 122.1 %) and CAA (50.8 % to 80.2 %) (Figure 
2.3). These data support our hypothesis that a major pathway in the toxic mode of action by the 
monoHAAs is the irreversible inhibition of GAPDH and the subsequent reduction of cellular 
ATP levels and a blockage in the generation of pyruvate from glucose.  
 From these ATP measurements an interesting and familiar pattern of response emerged. 
Comparing the monoHAAs, the CHO cells treated with IAA expressed the greatest reduction in 
cellular ATP levels (0.54 %) per pmol IAA as compared to the negative control. For the BAA 
and CAA treatment groups, the reduction in cellular ATP levels per pmol monoHAA was 0.15% 
for BAA and approximately 0.001% for CAA (Table 2.2). The monoHAA-mediated ATP 
depletion followed a rank order of IAA > BAA >> CAA. This pattern and magnitude of ATP 
depletion directly correlated with the αC-X bond length and relative alkylation potential of each 
monoHAA and was inversely correlated with the αC-X bond dissociation energy (Table 2.3). 
ATP depletion was highly correlated with the inhibition kinetics of GAPDH (Pals et al. 2011) 
(Table 2.4). Of importance is that ATP depletion by the monoHAAs (Table 2.5) are highly 
correlated with diverse measurements of toxicity including cytotoxicity, genotoxicity, 
mutagenicity and teratogenicity published in the literature over the past 17 years (Table 2.4).    
Pyruvate Attenuation of MonoHAA-Induced Genotoxicity 
 The monoHAAs are direct-acting mutagens in S. typhimurium (Kargalioglu et al. 2002; 
Plewa et al. 2004) and in CHO cells (Zhang et al. 2010) and do not require monooxygenase-
mediated metabolic activation for genotoxicity in CHO cells (Plewa et al. 2010). The 
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monoHAAs do not induce genomic damage via direct alkylation of DNA (Pals et al. 2011). We 
suggest that monoHAAs induce DNA damage by alkylating the thiol group of the cysteine 
residue in the active site of GAPDH (Jenkins and Tanner 2006). The resulting reduction in ATP 
and pyruvate levels leads to ROS generation (Matthews et al. 1997) and subsequent DNA 
damage (Kumagai et al. 2008). We postulated that if genomic DNA damage is linked to GAPDH 
inhibition then supplementing cells with exogenous pyruvate should lead to a reduction in 
genomic DNA damage. To test this hypothesis, CHO cells were treated with monoHAA 
concentrations that did not induce acute cytotoxicity but were strongly genotoxic in the SCGE 
assay (Table 2.5). We treated CHO cells with 25 µM IAA, 60 µM BAA or 6 mM CAA for 4 h 
with and without 10 mM pyruvate. Genomic DNA damage was measured by the SCGE assay. 
The mean % tail DNA values for the negative control and 10 mM pyruvate control were 2.80 and 
2.79, respectively and were not statistically different (Table 2.5). All of the monoHAAs induced 
a significant level of DNA damage in CHO cells as compared to the negative controls. However, 
when 25 µM IAA was supplemented with pyruvate a significant reduction in the mean SCGE % 
tail DNA values was observed (IAA alone, 21.5 compared to IAA + pyruvate, 10.6). Similar 
reductions in genomic DNA damage with pyruvate supplementation were recorded for 60 µM 
BAA (BAA alone and BAA + pyruvate, 49.8 and 8.1 % tail DNA, respectively), and 6 mM CAA 
(CAA alone and CAA + pyruvate, 47.2 and 24.9 % tail DNA, respectively) (Table 2.5). When 
these data were normalized such that the concurrent monoHAA positive control equaled 100% of 
the observed DNA damage, pyruvate supplementation significantly repressed the induction of 
genomic DNA damage (Figure 2.4).  
 This proposed model for the toxicity of the monoHAAs has a unifying pattern of 
response (IAA > BAA >> CAA) that we identified a decade ago (Plewa et al. 2004). Although 
many iodinated DBPs are more toxic than their brominated and chlorinated analogues (Plewa et 
al. 2008; Plewa and Wagner 2009) the monoHAAs provide a class of substrates with a single 
variable (the single halogen atom bound to the α-carbon). Originally we believed that the 
monoHAAs induced genomic damage via direct alkylation of DNA; there was a high correlation 
among the alkylating potential, αC-X bond dissociation energy, cytotoxicity and genotoxicity in 
S. typhimurium and CHO cells (Table 2.4) (Plewa et al. 2004). These DBPs are direct-acting 
mutagens in that they do not require S9 microsomal activation in S. typhimurium (Plewa et al. 
2004) or CHO cells (Zhang et al. 2010). However, we discovered that while the monoHAAs 
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induce DNA damage using the cellular SCGE assay (treatment of intact cells), the capacity to 
damage DNA was lost when analyzed with the acellular SCGE assay (treatment of nuclei) (Pals 
et al. 2011). We concluded that DNA was not the direct target of the monoHAAs. Previously 
CAA and IAA were demonstrated to inhibit GAPDH without affecting other glycolytic enzymes 
(Sakai et al. 2005; Hernandez-Fonseca et al. 2008). The linkage between GAPDH inhibition and 
the quantitative toxicity of the monoHAAs was established by the inhibition kinetics of GAPDH, 
which also expressed the pattern of IAA > BAA >> CAA. GAPDH inhibition kinetics were 
highly correlated with a host of toxicity metrics (Table 2.4) (Pals et al. 2011). From the present 
study we further define the role of GAPDH inhibition and the induction of toxicity. Cellular ATP 
depletion in monoHAA-treated cells followed the pattern of IAA > BAA >> CAA and was 
highly correlated with their SN2 alkylating potential and with the induction of toxicity (Table 
2.3). Pyruvate is a product of glycolysis; pyruvate supplementation restored ATP levels and 
reduced the genomic DNA damage in monoHAA-treated cells. These results strongly support 
our hypothesis that GAPDH inhibition and subsequent generation of ROS is linked with 
cytotoxicity, genotoxicity, teratogenicity, and neurotoxicity and may play a substantive role in 
neurodegenerative diseases such as Alzheimer's disease (Butterfield et al. 2010). The data 
presented here establish a comprehensive and testable model for the toxic mechanisms of the 
haloacetic acids, a major class of drinking water DBPs.  
HAA Induced ROS Generation in CHO Cells  
4×104 CHO cells were exposed to 500 µM H2O2 , 50 µM, and 100 µM IAA  and a 
negative control in a 6 well plate. The CHO cells treated with IAA and H2O2 generated ROS. 
The H2DCFDA dye crossed the cell membrane and was hydrolyzed by cellular esterases into 
non-florescent DCFH. The ROS generated inside the cells oxidized the non-florescent DCFH 
into highly florescent molecules of DCF (Hafer et al. 2008). Therefore, cells treated with IAA 
and H2O2 were more florescent as compared to negative control (Figure 2.5). In order to 
investigate the antioxidant potential of pyruvate and its role in the monoHAA mediated genetic 
toxicity, these experiments will be repeated with the co-treatment of each monoHAA and 
pyruvate.   
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2.4. CONCLUSION  
This study enhanced our understanding of the toxicity mechanisms of monoHAAs. The cellular 
rescue against the monoHAA-induced genomic DNA damage and increase in the cellular ATP 
level by exogenous pyruvate supplementation to the HAA-treated cells proved that the 
genotoxicity induced by these HAAs is due to disturbance in the cellular metabolism, generation 
of ROS, and cellular energy homeostasis. 
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2.5. TABLES AND FIGURES  
	  
	  a	  Abbreviations:	  HAA,	  haloacetic	  acids.	  IAA,	  iodoacetic	  acid;	  BAA,	  bromoacetic	  acid;	  CAA,	  chloroacetic	  acid.	  b	  α-­‐Carbon-­‐halogen	  bond.	  c	  C−X	  	  bond	  length	  summarized	  from	  (Loudon	  1995).d	  C−X	  	  bond	  dissociation	  energy	  summarized	  from	  (Loudon	  1995).	  	  	  	  
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Table	  2.1.	  Monohaloacetic	  acid	  characteristics,	  sources	  and	  purities.	  HAA	  a	   CASN	   MW	  (g/mol)	  	   C−X	  b	   Bond	  Length	  (Å)	  c	   Dissociation	  Energy	  (kcal/mol)	  d	   Source	   Purity	  IAA	   64-­‐69-­‐7	   185.95	   C−I	   2.14	   57.4	   Sigma-­‐Aldrich	   >99%	  BAA	   79-­‐08-­‐3	   138.95	   C−Br	   1.93	   65.9	   Fluka	   >99%	  CAA	   79-­‐11-­‐8	   94.50	   C−Cl	   1.77	   78.5	   Fluka	   >99%	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   NA,	  not	  applicable.	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 	  
 	  	  
Table	  2.2.	  Effect	  of	  the	  HAAs	  on	  ATP	  levels	  in	  CHO	  cells	  with	  and	  without	  pyruvate	  supplementation.	  HAA	  Group	   Treatment	  Conditions	   pmol	  ATP/mg	  Protein	  Mean	  Value	  ±	  SE	   %	  Reduction	  per	  pmol	  HAA	  
IAA	   Negative	  Control	  	  (IAA)	   29788	  ±	  3197	   NA	  10	  mM	  Pyruvate	   29476	  ±	  3575	   NA	  3	  µM	  IAA	   5557	  ±	  274	   0.54229	  3	  µM	  IAA	  +	  Pyruvate	   13411	  ±	  1105	   NA	  
BAA	   Negative	  Control	  (BAA)	   18225	  ±	  1503	   NA	  10	  mM	  Pyruvate	   29297	  ±	  2782	   NA	  6	  µM	  BAA	   8786	  ±	  897	   0.15136	  6	  µM	  BAA	  +	  Pyruvate	   24338	  ±	  2487	   NA	  
CAA	   Negative	  Control	  (CAA)	   6814	  ±	  755	   NA	  10	  mM	  Pyruvate	   23464	  ±	  2278	   NA	  1	  mM	  CAA	   3463	  ±	  419	   0.00098	  1	  mM	  CAA	  +	  Pyruvate	   5465	  ±	  589	   NA	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  a	  Calculated	  ELUMO	  (energy	  of	  the	  lowest	  unoccupied	  molecular	  orbital)	  summarized	  from	  	  (Richard	  and	  Hunter	  1996).	  b	  Summarized	  from	  (Loudon	  1995).	  c	  Calculated	  from	  data	  presented	  in	  this	  paper.	  	  
 
 
 
 
 	  	  	  	   	  
Table	  2.3.	  Pearson	  Product	  Moment	  Correlation	  analyses	  of	  HAA	  physiochemical	  parameters	  and	  the	  percent	  reduction	  of	  cellular	  ATP	  per	  pmol	  HAA	  in	  CHO	  cells.	  	   Physicochemical	  Parameters	   ELUMO	  (r)	  a	   αC─X	  Bond	  Length	  (r)	  b	  
αC─X	  Dissociation	  Energy	  (r)	  b	   Relative	  Alkylation	  Potential	  (SN2)	  (r)	  b	  ATP	  %	  Reduction	  per	  pmol	  HAA	  c	   −0.986	   0.985	   −0.935	   0.999	  ELUMO	   	   −1.000	   0.981	   −0.980	  C─X	  Bond	  Length	   	   	   −0.982	   0.979	  C─X	  Dissociation	  Energy	   	   	   	   −0.922	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Table	  2.4.	  Pearson	  Product	  Moment	  Correlation	  analyses	  of	  HAA	  toxicological	  parameters	  and	  the	  percent	  reduction	  of	  cellular	  ATP	  per	  pmol	  HAA	  in	  CHO	  cells.	  	  HAA	  Toxico-­‐logical	  	  Parameters	  	  
CHO	  cell	  cyto-­‐toxic	  index	  (r)	  
CHO	  cell	  geno-­‐toxic	  index	  (r)	  
FHs	  cell	  geno-­‐toxic	  index	  (r)	  
Salmonell
a	  cytotoxic	  index	  (r)	  
Salmonell
a	  mutagenic	  potency	  (r)	  
CHO	  cell	  mutagen-­‐icity	  index	  (r)	  
Mouse	  terato-­‐genicity	  (r)	  
GAPDH	  inhibi-­‐tion	  (r)	  
ATP	  %	  reduction	  per	  pmol	  HAA	  a	   1.00	   0.968	   0.992	   0.991	   0.993	   0.965	   0.999	   −0.986	  CHO	  cell	  cytotoxic	  index	  b	   	   0.976	   0.996	   0.995	   0.996	   0.956	   0.998	   −0.990	  CHO	  cell	  genotoxic	  index	  c	   	   	   0.992	   0.993	   0.991	   0.868	   0.959	   −0.997	  FHs	  cell	  genotoxic	  index	  c	   	   	   	   1.00	   1.00	   0.925	   0.987	   −0.999	  
Salmonella	  cytotoxic	  index	  d	   	   	   	   	   1.00	   0.921	   0.986	   −0.999	  
Salmonella	  mutagenic	  potency	  d	   	   	   	   	   	   0.926	   0.988	   −0.999	  CHO	  cell	  mutagenicity	  index	  e	   	   	   	   	   	   	   0.974	   −0.906	  Mouse	  terato-­‐genicity	  f	   	   	   	   	   	   	   	   −0.979	  GAPDH	  inhibition	  kinetics	  g	   	   	   	   	   	   	   	   1.00	  	  a	  Calculated	  from	  data	  presented	  in	  this	  paper.	  b	  Derived	  as	  the	  reciprocal	  of	  the	  LC50	  concentration	  (×	  constant	  to	  generate	  whole	  numbers),	  data	  from	  (Plewa	  et	  al.	  2010).	  	  c	  Derived	  as	  the	  reciprocal	  of	  the	  SCGE	  genotoxic	  potency	  value	  (×	  constant	  to	  generate	  whole	  numbers),	  data	  from	  (Plewa	  et	  al.	  2010;	  Pals	  et	  al.	  2011).	  	  d	  Data	  from	  (Kargalioglu	  et	  al.	  2002;	  Plewa	  et	  al.	  2004).	  e	  Data	  from	  (Zhang	  et	  al.	  2010).	  f	  Data	  from	  (Hunter	  et	  al.	  1996).	  g	  The	  average	  rate	  of	  GAPDH	  inhibition	  per	  μM	  monoHAA	  concentration	  derived	  from	  the	  slope	  of	  the	  inhibition	  curves	  for	  each	  monoHAA	  (Pals	  et	  al.	  2011).	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Table	  2.5.	  Induction	  of	  genomic	  SCGE	  DNA	  damage	  in	  CHO	  cells	  by	  HAAs	  with	  and	  without	  pyruvate	  supplementation.	  Treatment	  Groups	   Number	  of	  Microgels	   Mean	  SCGE	  %	  Tail	  DNA	  Value	  (±SE)	   ANOVA	  Test	  Statistic	  F7,	  81	  =	  74.4;	  P	  ≤	  0.001	  Negative	  Control	  	  (a)	  	   18	   2.80	  ±	  1.33	   a	  	  10	  mM	  Pyruvate	  Control	  (b)	   10	   2.79	  ±	  1.03	   a	  vs.	  b	  (P	  =	  0.998)	  25	  µM	  IAA	  (c)	   12	   21.5	  ±	  2.07	   c	  vs.	  a	  (P	  ≤	  0.001)	  25	  µM	  IAA	  +10	  mM	  Pyruvate	  (d)	   10	   10.6	  ±	  3.50	   d	  vs.	  c	  (P	  ≤	  0.001)	  60	  µM	  BAA	  (e)	   10	   49.8	  ±	  3.17	   e	  vs.	  a	  (P	  ≤	  0.001)	  60	  µM	  BAA	  +10	  mM	  Pyruvate	  (f)	   10	   8.09	  ±	  1.13	   f	  vs.	  e	  (P	  ≤	  0.001)	  6	  mM	  CAA	  (g)	   8	   47.2	  ±	  3.79	   g	  vs.	  a	  	  (P	  ≤	  0.001)	  6	  mM	  CAA	  +10	  mM	  Pyruvate	  (h)	   11	   24.9	  ±	  1.98	   h	  vs.	  g	  	  (P	  ≤	  0.001)	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Figure 2.1. Impact	  of	  monoHAA	  exposure	  on	  the	  cellular	  ATP	  levels	  as	  measured	  using	  relative	  bioluminescence	  units.	  The	  *	  indicates	  a	  significant	  difference	  from	  the	  negative	  control.	  The	  insert	  is	  a	  ATP	  standard	  curve.	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Figure 2.2. Reduction of ATP levels measured as bioluminescence units in CHO cells after 
exposure to monoHAAs. All monoHAA treatments induced a significant reduction in ATP levels 
as compared to the concurrent negative controls.  
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Figure 2.3. Effect of pyruvate supplementation on ATP content of the monoHAAs treated cells. 	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Figure 2.4. Reduction of monoHAA-induced genomic DNA damage by pyruvate 
supplementation. (A) The SCGE % tail DNA values for the negative control and for 10mM 
pyruvate. (B) MonoHAA-induced DNA damage normalized as 100% for the positive controls 
and the reduction in DNA damage with pyruvate supplementation.  
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Figure 2.5. IAA and H2O2 generated more ROS as compared to the negative control that oxidized 
the H2DCFDA dye and produced florescence in the cells.  
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CHAPTER 3 
HALOACETIC ACIDS WATER DISINFECTION BY-PRODUCTS DISTURB 
CELLULAR GLYCOLYTIC AND MITOCHONDRIAL METABOLISM 
 
3.1. INTRODUCTION  
 Disinfection of drinking water was a preeminent public health achievement of the 20th 
century, which significantly reduced the outbreak of water-borne diseases like cholera, typhoid 
and dysentery (Cutler and Miller 2005). Disinfectants are powerful oxidants; disinfectants not 
only kill pathogenic microorganisms but also inadvertently generate disinfection by-products 
(DBPs) (Richardson et al. 2002). DBPs are formed when chemical disinfectants (chlorine, 
chlorine dioxide, chloramine, or ozone) react with organic precursors, natural organic matter 
(NOM), and inorganic precursors such as Br− and I−. Disinfectants oxidize organic and inorganic 
precursors, which are then reactive with additional chlorine or chloramine and act as halogen 
substituents to produce DBPs (Stuart 2009). Currently over 600 DBPs have been chemically 
identified (Richardson et al. 2007) and the spectrum of DBPs in water is influenced by the type 
of disinfectants used, the concentration of disinfectants, reaction time, NOM concentration as 
dissolved organic carbon (DOC), pH, and temperature (Krasner 2009). In chlorinated water, the 
second largest DBP chemical class is the haloacetic acids (HAAs) (Krasner et al. 2006; Stuart 
2009). HAAs are the most highly regulated DBPs. The U.S. Environmental Protection Agency 
(U.S.EPA) regulates five HAAs (chloroacetic acid (CAA), dichloroacetic acid (DCA), 
trichloroacetic acid (TCA), bromoacetic acid (BAA), and dibromoacetic acid (DBA)) to a total 
maximum contaminant level of 60 µg/L (U. S. Environmental Protection Agency 2006).   
 DBPs are cytotoxic, mutagenic, genotoxic, carcinogenic and teratogenic (Plewa et al. 
2002; Villanueva et al. 2007; Narotsky et al. 2011). DBP exposure was associated with increased 
risk of bladder, and colorectal cancer (Villanueva et al. 2007). U. S. EPA estimated that 2-17% 
of bladder cancer cases in the U.S. might be induced by DBPs (U. S. Environmental Protection 
Agency 1998). Furthermore, DBPs in chlorinated drinking water were associated with 
spontaneous abortion in 5144 pregnant women (Waller et al. 1998) and other pregnancy 
outcomes. In in vivo studies, HAAs (DCA, TCA, and DBA) induced hepatocellular adenomas 
and hepatocellular carcinomas in B6C3F1 mice and F344 rats (U. S. Environmental Protection 
Agency 2008) and DCA, DBA, and bromochloroacetic acid (BCA) altered intestinal microflora 
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and metabolism in rats, which could also have an effect on bioactivation of promutagens or 
procarcinogen (George et al. 2000). Moreover, iodoacetic acid (IAA) induced malignant 
transformation in NIH/3T3 mouse embryonic fibroblast cells and when implanted in Balb/c nude 
mice, developed into highly aggressive fibrosarcomas (Wei 2013). Gestational exposure of 
mixture of HAA5 resulted in pregnancy loss and eye malformation in rats (Narotsky et al. 2011). 
Under ex vivo conditions, monoHAAs were teratogenic and induced dysmorphogenesis in CD-1 
mouse embryos and affected neural tube development, eye development and produced anomalies 
in heart development (Hunter et al. 1996). Under in vitro conditions, HAAs were cytotoxic and 
genotoxic in Chinese hamster ovary (CHO) cells (Plewa et al. 2010), mutagenic in Salmonella 
typhimurium and CHO cells (Kargalioglu et al. 2002; Plewa et al. 2004; Zhang et al. 2010), 
cytotoxic and genotoxic in nontransformed human cells (Attene-Ramos et al. 2010), and 
teratogenic in mice (Andrews et al. 2004). The above-mentioned studies show that HAAs are 
cytotoxic, genotoxic, mutagenic, teratogenic and carcinogenic yet the molecular mode of toxicity 
mechanism of these HAAs is not well understood (Pals et al. 2011; Dad et al. 2013).  
 HAAs are SN2 alkylating agents (Plewa et al. 2004). The SN2 reactivity of monoHAAs is 
dependent on the α-carbon-halide (αC-X) bond length and bond dissociation energy. The αC-X 
bond length follows the pattern of C-I > C-Br >> C-Cl, which has an inverse relation with the 
bond dissociation energy (Plewa et al. 2004). The genotoxic, cytotoxic and mutagenic potencies 
expressed a high correlation with the SN2 reactivity and also followed a pattern of IAA > BAA 
>> CAA (Plewa et al. 2004). We demonstrated that monoHAAs do not directly damage DNA 
(Pals et al. 2010) but inhibit the glyceroldehyde 3-phosphate dehydrogenase (GAPDH) probably 
by alkylating the sulfhydryl group of the cysteine residue in the active site of GAPDH and 
renders it inactive (Pals et al. 2011). For the monoHAAs GAPDH is a molecular target. GAPDH 
is a pivotal enzyme in glycolysis and produce mitochondrial substrate in the form of pyruvate 
from glucose. The unavailability or scarcity of pyruvate induces mitochondrial stress by 
affecting its ability to produce reducing power (NADH) through the tricarboxylic acid   (TCA) 
cycle and causes a reduction of cellular ATP levels. Due to mitochondrial stress and the scarcity 
of reducing power reactive oxygen species (ROS) are produced. ROS can damage biological 
macromolecules such as DNA (Jena 2012).  Treating cells with exogenous pyruvate overcame 
the monoHAA –mediated reduction in cellular ATP and reduced the genomic DNA damage 
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(Dad et al. 2013). We hypothesized that di-, and triHAAs may follow the same toxicity pathway 
by inhibiting GAPDH and reducing the ATP contents of the cells.   
 DCA was used as a treatment in patients with lactic acidosis especially, in patients with 
pyruvate dehydrogenase (PDH) deficiency (Fouque et al. 2003), DCA is also used as a 
chemotherapeutic agent because it reverses the Warburg effect (Dhar and Lippard 2009) by 
activating PDH through inhibiting PDH kinase (Whitehouse et al. 1974; Kerbey et al. 1976; 
Fouque et al. 2003; Itoh et al. 2003). In oncology, in mitochondria, the phenomenon of the 
cellular energy production predominantly by a high rate of glycolysis followed by lactic acid 
fermentation by the cytosol rather than by a low rate of glycolysis followed by oxidative 
phosphorylation is known as the Warburg effect (Wikipedia). 
 The pyruvate dehydrogenase complex (PDC) is a multi-enzyme complex, a member of 
the α-ketoacid dehydrogenase complex family (De Marcucci and Lindsay 1985) and catalyzes 
the conversion of pyruvate, NAD+, and coenzyme-A into acetyl-CoA, NADH and CO2 in the 
presence of thiamine pyrophosphate and Mg+2 (Tymoczko et al. 2013). Mammalian PDC has 
multiple copies of 6 different components; they are (i) pyruvate dehydrogenase (E1), (ii)  
dihydrolipoamide  acetyltransferase (E2), (iii) dihydrolipoamide dehydrogenase (E3), (iv) E1 
specific kinases, (v) phospho-E1 phosphotase and (vi) X protein (De Marcucci and Lindsay 
1985; Jilka et al. 1986). E1, E2, and E3 are the major catalytic components, which are 
responsible for the stepwise decarboxylation and dehydrogenation of pyruvate into acetyl- CoA 
(Patel and Roche 1990).  
 The E1 component of PDC is a tetramer (α2β2), which has two thiamine pyrophosphate 
(TPP) binding sites. TPP is required for the first step of pyruvate decarboxylation, which 
involves TPP-dependent decarboxylation of pyruvate to hydroxyl TPP. This reaction leaves an 
acetyl group, which links to the lipomide group of E2. The E1α component of the tetrameric E1 
component of the PDC is inactivated/phosphorylated by pyruvate dehydrogenase kinase (PDK) 
enzyme and activated/dephosphorylated by a specific phosphatase enzyme. The 
dephosphorylation of these sites by phospho-E1-phosphotase leads to the activation of the 
enzyme (Frey et al. 1989; Patel and Roche 1990). E2 is responsible for the generation of acetyl-
CoA by transferring the acetyl group from acetyl-lipoyl to CoA. E2 has different structural 
domains, which are different in different organisms. Human E2 has 2 lipoyl domians presented 
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as L1 and L2. The E2B or subunit-binding domain is responsible for binding E1 and E3. The 
inner domain (E-I), catalyzes the transacetylation reaction and self association to form the 
dodecahedral structure, which contain 60 subunits. The E2 component also plays a crucial role in 
the activation and inactivation of the pyruvate dehydrogenase by providing a binding site to the 
PDK and phospho-E1-phosphotase enzymes (Patel and Roche 1990; Patel and Korotchkina 
2003). The third main component of the PDC is E3, which transfers electrons from 
dihydrolipoamide to NAD+. It is a homodimer and each polypeptide noncovalently binds to a 
molecule of FAD (Patel and Roche 1990).   
 Pyruvate dehydrogenase kinase (PDK) plays an important role in regulating the PDC. 
PDK has four isoforms and exhibit tissue specific expression; PDK1 is detected in heart, 
pancreatic islets, and skeletal muscles; PDK2 is expressed in all tissues; PDK3 is present in 
testes, kidney, and pancreatic islets. Phosphorylation of E1p by PDK occurs at three different 
serine residues (S264: site 1, S271: site 2, and S203: site 3). Among the three conserved 
phosphorylation sites, site 1 is the most rapidly phosphorylated site where site 3 is the slowest 
phosphorylated site (Sale and Randle 1981; Korotchkina and Patel 1995). Structural studies of 
the PDKs showed that all the four isoforms of PDKs phosphorylate sites 1 and 2, but only PDK1 
modifies site 3 (Korotchkina and Patel 2001).  
 The rat PDK2 structure revealed that these proteins have two distinct domains; the N-
terminal domain and the C-terminal domain; the C-terminal domain is an α/β structure with a 5 
stranded β sheet. These enzymes also have four conserved motifs (N-G1-,G2-, and G3-boxes), 
which build a unique ATP-binding fold. The ATP-binding fold has a structure known as the 
“ATP lid”. The conformational changes in ATP-lid are linked with the ATP hydrolysis and 
protein-protein interaction (Wigley et al. 1991; Ban et al. 1999). The binding of the PDKs to the 
L2 domain of the E2p subunit of the PDC activates PDK activity, but this activation of different 
PDK isoforms occurs in a different fashion (Kato et al. 2005).  The L2 domain of the E2 
component of the PDC plays an important role in regulation of the PDC by inducing allosteric 
changes in the PDK enzyme. The crystal structure of PDK3 with and without L2 binding showed 
that L2 binding affects the ATP lid confirmation and regulates the activation of PDK. PDK3 
without L2 binding had the ATP lid in the ordered form, which had high affinity for ADP 
binding and rendered PDK3 inactive. Where PDK3 with L2 binding had the ATP lid in a 
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disordered form, the low affinity for ADP of the disordered ATP lid led to the release of ADP, 
which resulted in the removal of PDK inhibition caused by bound ADP and resulted in L2-
induced PDK3 activity (Kato et al. 2005).  
 PDK2 structure with dichloroacetic acid (DCA) revealed that DCA binds to the N-
terminal domain of PDK2. The E2P/E3BP scaffold-free activity showed that DCA reduced 
PDK1 and PDK3 activity in a similar fashion to 4% and 17%, respectively (Kato et al. 2007). L2 
binding promotes the opening of the active-site cleft and destabilizes the ATP lid facilitating 
ADP dissociation in the PDK3-L2 complex, rendered PDK active(Kato et al. 2005). Kinetic 
studies demonstrated that the exposure to DCA prevented the ADP dissociation from the active-
site cleft resulting in PDK inhibition.  ADP binding to PDK reduces the affinity of this enzyme 
for L2 binding by 3-fold; the presence of DCA and ADP synergistically decreases the affinity of 
the PDK for L2 by 130-fold as compared to ADP alone and eventually affects the L2-induced 
activation of the PDK. The inhibition of the PDK by DCA-induced allosteric change keeps the 
PDC in its active state and accelerates the tricarboxylic acid (TCA) cycle (Kato et al. 2007).   
 DCA induced apoptosis in the tumor cells by reversing the Warburg effect (Bonnet et al. 
2007). DCA activated PDC by inhibiting PDK and shifting the glycolytic-based metabolism to 
mitochondria in tumor cells. Bonnet et al showed that DCA decreased the mitochondrial 
membrane potential (ΔΨm) by activating TCA cycle, generating more protons by mitochondria, 
and by decreasing cytosolic Ca++ concentration. The decrease in ΔΨm also induced 
mitochondrial transition pore (MTP) opening. The opening of MTP activated the release of 
cytochrome-C, which is required for the caspase activation and apoptosis induction. DCA 
induced activation of mitochondrial metabolism and it activated complex-I induced ROS 
generation. The complex-I induced ROS generation upregulated the K+ channel Kv1.5 
expression and decreased K+ concentration, which augmented the activation of apoptosis in 
tumor cells. DCA lowered the plasma lactate, alanine, cholesterol, and glucose levels in adult, 
noninsulin-dependent diabetic patients (Stacpoole et al. 1978). DCA also reduced lactic acidosis 
in patients with pyruvate dehydrogenase deficiency (Stacpoole et al. 2006).  DCA generated 
oncolysis in attenuated oncolytic measles virus Edmonston strain (MV-Edm) caused 
glioblastoma cells by inhibiting aerobic glycolysis. DCA enhanced the MV-Edm replication 
(increasing bioenergetic consumption) and inhibited glycolysis (decreasing bioenergetics 
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production), which, in combination, accelerated bioenergetics exhaustion caused necrotic cell 
death (Li et al. 2015).  
  Cellular Ca+2  concentration plays a major role in regulating mitochondrial metabolism. 
Browning et al reported that DCA inhibited the phosphorylation of intra-mitochondrial PDH ά-
subunit in a concentration-dependent manner, which was accompanied by PDH activation and 
pyruvate supported calcium accumulation. PDH activity and pyruvate-supported calcium 
accumulation showed similar dependence on pyruvate concentration of 40 µM and 30 µM, 
respectively (Browning et al. 1981). In concert with above information, ruthenium red inhibited 
the uniporter and stopped the calcium uptake by mitochondria and in turn inhibited the PDH 
activity (McCormack and England 1983). These studies indicated that pyruvate supported 
calcium transportation in mitochondria and pyruvate dehydrogenase activation are coupled 
activities and play a major role in cellular calcium homeostasis and ATP production. Moreover, 
the cellular ATP/ADP ratio also plays a significant role in regulating PDK, PDC and overall 
mitochondrial metabolism (J.M. et al. 2002).  
  My central hypothesis is that increased activation of PDH activity by the HAAs 
accelerates pyruvate transport in mitochondria, which is coupled with Ca+2 influx and enhanced 
oxidative decarboxylation of pyruvate into acetyl CoA, this will produce more reducing power in 
the form of NADH. The NADH will be further utilized by oxidative phosphorylation to produce 
more ATP. The accelerated TCA cycle due to PDC activation and enhanced NADH formation 
will utilize more O2 as a final electron acceptor, which may lead to hypoxia and eventually ROS 
production. In order to generate more pyruvate, required by mitochondria due to HAA- induced 
activation, the cells will consume more glucose and will accelerate the release of pyruvate, 
lactate and alanine from cells (Evans and Stacpoole 1982), this process will disturb the glucose 
homeostasis and may lead to toxicity. The chronic exposure to diHAAs and triHAAs through 
drinking water may be involved with hypolactatemia, disturbed glucose homeostasis and 
hepatotoxicity in humans especially sensitive populations e.g. featuses.  
 The objectives of this research are (i) measure GAPDH inhibition in HAA-treated cells (ii) 
determine the effect of HAA-treatment in CHO cells on PDC activity, and (iii) measure the 
impact of HAA exposure on cellular ATP levels.    
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3.2. MATERIALS AND METHODS 
Reagents  
 General reagents were purchased from Fisher Scientific Co. (Itasca, IL) and Sigma 
Chemical Co. (St. Louis, MO). DBA, DCA, TBA, TCA, and, CAA were purchased from Fluka, 
IAA and BAA were purchased from Sigma Chemical Co.  (St. Louis, MO), DBCA was from 
Radian international, DBCA from Cerilliant, and BCA from U. S. EPA. Cell culture F12 
medium and fetal bovine serum (FBS) were purchased from Fisher Scientific Co. Cell Titer-Glo 
reagent was purchased from Promega (Madison, WI). The Pyruvate Dehydrogenase (PDH) 
Activity Colorimetric Assay Kit was purchased from BioVision (San Fransisco, CA). 
Glyceraldehyde-3-phosphate was purchased from Sigma-Aldrich (St. Louis, MO). 
 HAAs were dissolved in dimethylsulfoxide (DMSO) and stored at −20°C in sealed sterile 
glass vials (Sulpelco, Bellefonte PA). HAAs were diluted in Hank’s balanced salt solution 
(HBSS).    
Chinese Hamster Ovary (CHO) Cells  
 CHO cell strain AS52 (derived from K1) clone 11-4-8 was used in all experiments 
(Wagner et al. 1998). Cells were grown in 100 mm glass petri plates with F12 medium 
containing 5% FBS, 1% glutamine and 1% antibiotic-antimycotic solution at 37°C in a 
humidified atmosphere of 5% CO2.   
Glycerladehyde-3-Phosphate Dehydrogenase (GAPDH) Enzyme kinetics Analysis  
 CHO cells were grown in F12, 5% FBS medium on 60 mm plastic cell culture plates. The 
medium was removed and the cells were washed 3× with 2 mL of cold phosphate-buffered saline 
(PBS) and once with 2 mL of cold buffer K (1 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, pH 
7.6).  Then the cells were tumefied with buffer K for 2 min at room temperature. After treatment 
with buffer K, cells were homogenized with a sterilized cell scraper. The cell homogenate was 
collected in microfuge tubes and centrifuged at 16,100 ×g for 3 min at room temperature to 
remove cellular debris.  A reaction mixture (0.1 M Tris-HCl (pH 8.5) containing 5 mM KH2PO4, 
20 mM NaF, 1.7 mM NaAsO2, and 1 mM NAD) was prepared. The supernatant fluid (CHO cell 
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homogenate) was analyzed for GAPDH activity. The reaction mixture was dispensed in tubes 
with 854 µL per tube.  To the reaction mixture, added 220 µL of the 5× solution of the test agent 
and then added 22 µL of the cell homogenate, vortexed, and incubated for 2 min. This reaction 
mixture of 996.3 µL was transferred to a cuvette and served as a blank. After the blanked 
reading, 3.7 µL of 1 mM glyceraldyde-3-phospate (G3P) was added to the mixture to initiate the 
reaction. The increase in absorption at 340 nm every 10 s for a total of 60 s was recorded using a 
Beckman DU7400 UV-vis spectrophotometer. The absorbance signal for NADH formation at 
340 nm was used to determine GAPDH activity. Each experiment included a negative control 
and different concentrations of the HAAs included in the experiment with three replicates for 
each concentration. Absorbance values were plotted against time for each individual experiment 
and linear regression was conducted. Rates were calculated using the slope of the regression. 
GAPDH activity rates were calculated as µMol NADH/min/µg protein. Data were normalized to 
the concurrent negative control for each experiment. The data from multiple experiments were 
combined and statistical significance was calculated using an ANOVA test.  
ATP Analysis and Protein Determination  
 Cellular ATP levels of control and HAA-treated cells were measured as pmol ATP/mg 
protein using the Promega Cell Titer-Glo reagent in a 96-well microplate assay with a TUNE-
SpectraMax Paradigm® Multi-Mode Microplate Detection Platform. The day before ATP 
analysis, 3×104 CHO cells/well were cultured in a 96 well opaque microplate in 200 µL of F12 
plus 5% FBS. The next day, the cells were washed with 100 µL of HBSS and treated with 
concentrations of the HAAs in 50 µL HBSS (with 1.3 mM CaCl2 and 1.1 mM MgSO4). The 
microplate was covered with AlumnaSeal and incubated for 4 h at 37°C, 5% CO2. Each 
experiment contained a concurrent negative control, a bioluminescence background control, 
HAAs, and an ATP standard curve. After 4 h incubation, the cells were washed with 100 µL of 
HBSS and equilibrated to room temperature for 30 min. The ATP contents of the cells were 
measured according to the manufacturer’s protocol using 50 µL of Cell Titer-Glo ATP reagents. 
Data were collected in an Excel spreadsheet and used in calculating pmols of ATP.  
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Protein Determination  
 Parallel ATP and protein analyses were performed. The day before the experiment, 3×104 
CHO cells/well were cultured in a 96 well flat bottom clear microplate in 200 µL of F12 plus 5% 
FBS. The next day, cells were treated with the HAAs as discussed above for the ATP analysis. 
After treatment, the cells were lysed by adding 25 µL of Solulyse® cell homogenizing solution 
(Genlantis, San Diego, CA). The microplate was covered with sterile AlumnaSeal and put on a 
rocker platform (at 37°C) shaken for 5 min after which the plate was rotated and shaken for an 
additional 5 min. After cell lyses, 10 µL of the lysate from each well was transferred into a new 
microplate; into each well was added 10 µL of an anti-foaming agent (Sigma 240, 0.01% v/v), 40 
µL of Bradford solution (BioRad), and 140 µL of dH2O for a final volume of 200 µL. A BioRad 
protein (BSA) standard was prepared on the same microplate, using 0.68 µg/µL of a BSA 
standard solution. The contents of each well were carefully mixed and incubated at room 
temperature for 20 min. The absorbance was read at 595 nm using a SpectraMax Molecular 
Device plate reader. The data were collected in an Excel spreadsheet and the mg of protein was 
calculated for each well.  
Pyruvate Dehydrogenase (PDH) Enzyme Kinetics Analysis    
 PDH enzyme activity was measured in HAA-treated CHO cells using BioVison PDH 
colorimetric assay kit with a TUNE-SpectraMax Paradigm® Multi-Mode Microplate Detection 
Platform. CHO cells at 3×106 cells/ mL with 2 mL/well in a 6-well plate were cultured in F12 
5% FBS medium and incubated overnight at 37°C, 5% CO2 in a tissue culture incubator. The 
following day, medium was aspirated and the cells were washed with 2 mL HBSS twice. After 
washing, the cells were treated with monoHAAs (3 µM IAA, 15 µM BAA, 300 µM CAA), 
diHAAs (900 µM DBA, 900 µM BCA, 50 µM DCA), and triHAAs (300 µM TCA, 300 µM 
CDBA, 500 µM TBA, 900 µM BDCA) in HBSS plus 1.3 mM CaCl2 and 0.5 mM MgCl2 and 
incubated at 37°C, 5% CO2 for 4 h. After incubation, the cells were washed with HBSS once and 
harvested with 500 µL trypsin / well. The harvested cells from different wells with the same test 
agent and same concentrations were collected in a single tube and centrifuged at 16,100 ×g for 1 
min. After centrifugation, cell pellets were washed with 500 µL HBSS and homogenized in 200 
µL PDH buffer/tube using a Fisherbrand Motorized Tissue Grinder. Homogenates were 
incubated on ice for 10 min. Meanwhile, reaction mixture was prepared according to the 
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manufacturer’s protocol. Each experiment had a series of control that included a negative 
control, NADH standard curve, positive control, and a background control. After incubation on 
ice, the homogenates were centrifuged at 10,000 × g for 5 min at 4°C. 50 µL of the supernatant 
for each treatment group were transferred to a 96-well microplate.  50 µL of the reaction mixture 
was added to each well and absorbance was measured immediately at 450 nm in kinetic mode for 
60 min at 10 min interval at 37 °C.  Each treatment group had three replicates in every 
experiment and every experiment was repeated at least three times. The data were collected in 
excel sheet and blank corrected. NADH standard curve was calculated and used to determine the 
PDH activity as nmol NADH/min/mL using formula given below.   
Sample Pyruvate Dehydrogenase Activity = B/(ΔT × V) × D = nmol/min/mL 
Where: B = NADH amount from standard curve (nmol) 
ΔT = reaction time (min) 
V = Sample volume added into the reaction well (ml) 
D = Dilution factor 
 
 The amount of protein was measured in each sample using the Bradford assay and nmol 
NADH/min/mg protein was calculated. To determine significance differences among the 
different HAAs an ANOVA test statistics was employed.  
3.3. RESULTS AND DISCUSSION 
 Pyruvate dehydrogenase plays a pivotal role in mitochondrial metabolism. Pyruvate 
dehydrogenase is present in the form of a multienzyme complex and converts pyruvate, NAD+ 
and coenzyme-A into acetyl-CoA, NADH, and CO2 in the presence of thiamine pyrophosphate 
(TPP) and Mg+2 and links glycolysis to the TCA cycle (Tymoczko et al. 2013). Mammalian 
pyruvate dehydrogenase complex (PDC) has multiple copies of 6 different components but the 
three major components are (i) pyruvate dehydrogenase (E1), (ii) dihydrolipoamide  
acetyltransferase (E2), (iii) dihydrolipoamide dehydrogenase (E3) (De Marcucci and Lindsay 
1985; Jilka et al. 1986). E1, E2, and E3 are the major catalytic components, which are 
responsible for the stepwise decarboxylation and dehydrogenation of pyruvate into acetyl- CoA 
(Patel and Roche 1990). The activity of PDC is regulated by different metabolic precursors such 
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as ATP/ADP, NADH/NAD, and Acetyl-CoA/CoA ratios (Kerbey et al. 1976) . Other than the 
different precursor’s ratios, pyruvate dehydrogenase kinase (PDK) and phospho-E1-phosphatase 
are also involved in the regulation of PDC (Whitehouse et al. 1974; Kato et al. 2005). The E1α 
component of the tetrameric E1 component of the PDC is inactivated/phosphorylated by 
pyruvate dehydrogenase kinase (PDK) enzyme and activated/dephosphorylated by a specific 
phosphatase enzyme. The dephosphorylation of these sites by phospho-E1-phosphotase leads to 
the activation of the enzyme (Frey et al. 1989; Patel and Roche 1990). 
 In humans, PDH deficiency disease is X-linked (Lissens et al. 2000); it reduces 
mitochondrial function and is associated with different abnormalities. It results in 2 forms of 
abnormality: a metabolic form (lactic acidosis) and a neurological form (neurodevelopment 
delay and hypotonia) (Patel et al. 2012). Studies showed that PDH is also involved in the 
oncogene-induced senescence (Bonnet et al. 2007; Kaplon et al. 2013); activation of PDH 
enhances pyruvate utilization and increases respiration and redox stress (Bonnet et al. 2007).  
 Studies showed that DCA inhibited pyruvate dehydrogenase kinase by inducing allosteric 
changes in it and activated PDC activity (Kato et al. 2005). DCA was used to activate the PDC 
activity in different diseased states based on PDH deficiency (Stacpoole et al. 1978; Li et al. 
2015). However, monoHAAs were involved in the blockage of glycolysis due to monoHAA-
induced GAPDH inhibition (Pals et al. 2011). Previous studies revealed that monoHAAs induced 
their cytotoxicity and genotoxicity by generating oxidative stress (Pals et al. 2013). The HAA-
generated ROS induced toxicity was based on the inhibition of GAPDH (Kahlert and Reiser 
2000; Pals et al. 2011), ATP depletion, pyruvate remediation of cell stress and genotoxicity, and 
rescue against genotoxicity by antioxidants (Cemeli et al. 2006; Dad et al. 2013).  However, the 
differences among the toxicity mechanisms of mono-, di-, and triHAAs are still unknown. We 
postulate that di-, and triHAAs are inhibiting PDK and activate PDC leading to increased cellular 
ATP levels. Where monoHAAs are the strongest inhibitors of GAPDH and greatly reduce ATP 
levels leading to ATP/ADP ratio disruption and require cells to accelerate TCA cycle by 
increasing PDC activity. To test this hypothesis we analyzed the effect of all HAAs on GAPDH 
kinetics, cellular energy level and PDC activity.  
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Effect of HAAs on GAPDH Kinetics  
 CHO cells were grown to confluence in a 60 mm plastic petri-plate in F12 5% FBS and 
then homogenized. GAPDH kinetic study was performed on homogenates treated with HAAs for 
2 min. Results showed that monoHAAs were the strongest inhibitors of GAPDH, which agrees 
with the previous study (Pals et al. 2011). Figure 3.1 presents the percent reduction in GAPDH 
activity by 1 µM HAA. These data demonstrated that monoHAAs are the strongest inhibitors of 
GAPDH as comparaed to di-, and triHAAs. Among monoHAAs, IAA was the strongest inhibitor 
of GAPDH followed by BAA and then CAA. However, di-, and triHAAs were weaker inhibitors 
of GAPDH. Figure 3.2 illustrates the percent reduction by 1 µmol BAA, DBA, and TBA as 
representative of the mono-, di-, and triHAAs.  Data for the GAPDH kinetic study from BAA, 
DBA, and TCA treated cells showed that monoHAAs were the strongest inhibitors of GAPDH as 
1 µmol of BAA reduced GAPDH activity by 478.3% , where DBA reduced the activity by 
37.5% and TBA reduced the activity by 21%. These data suggest that monoHAAs are the 
strongest inhibitors of GAPDH, where di-, and triHAAs are the weaker inhibitors of GAPDH. 
GAPDH is a pivotal enzyme in glycolysis and plays a crucial role in cellular energy homeostasis. 
Our data showed that HAAs are the inhibitors of GAPDH; to study the association between 
GAPDH inhibition and ATP depletion; we also studied the effect of HAAs on the cellular ATP 
levels.  
The Effect of HAAs on ATP Levels in Chinese Hamster Ovary Cells   
 CHO cells were treated with HAAs for 4 h in HBSS  (with 1.3 mM CaCl2 and 1.1 mM 
MgSO4) using different concentrations. The concentrations used in this experiment were based 
on the genotoxicity and cytotoxicity data of HAAs determined previously (Plewa et al. 2010) 
(Figure 3.3).  To test for a significant difference between the effect of an HAA on the cellular 
ATP levels and its concurrent negative control a t-test analysis was performed, which is 
presented in Table 3.1. Results showed that monoHAAs greatly reduced the ATP levels as 
compared to the “concurrent negative control” and as compared to di-, and triHAAs. Figure 3.3 
illustrates the effect of HAAs on ATP levels as pmol ATP/mg protein normalized against 100% 
for each concurrent negative control for each HAA treatment group. All HAAs except TCA 
induced significant alterations of cellular ATP levels. The reduction in ATP levels by di-, and 
triHAAs was also expected, as they were also the weak inhibitors of GAPDH. However, some of 
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the triHAAs (TBA, CDBA, DCBA) induced a significant increase on cellular ATP levels. An 
interesting trend was found in the ATP levels and the number of halogens attached (Table 3.1 
and Figure 3.3-3.4). MonoHAAs induced the greatest reduction in ATP levels, where diHAAs 
induced a moderate reduction with higher concentration ranges. TriHAAs induced a significant 
increase in ATP levels except for TCA. MonoHAAs and diHAAs decreased the ATP levels by 
59.1% and 27.1% as compared to the negative control, respectively. Where the average ATP 
levels as the percent of the negative control for triHAAs was 120%, meaning that triHAAs 
increased the cellular ATP (Figure 3.4). The unexpected increase in ATP levels by triHAAs 
suggested that these HAAs may have other targets involved in ATP regulation pathways. 
Previous studies demonstrated that DCA and TCA inhibited PDK (Whitehouse et al. 1974; Kato 
et al. 2005) and elevated the active/phosphorylated proportion of PDC (Whitehouse et al. 1974). 
The decorboxylation of pyruvate into acetyl-CoA by PDC links glycolysis to the TCA cycle and 
is a rate-limiting step as the pyruvate decarboxylation by PDC provides substrate (acetyl-CoA) 
for the TCA cycle (Tymoczko et al. 2013). Kerby et al showed that 1 mM DCA increased the 
active proportion of PDC in rat heart by inhibiting PDK and also showed that there was an 
inverse relation between NADH/NAD+, ATP/ADP, and acetyl-CoA/CoA and active proportion 
of PDC with a few exceptions (Kerbey et al. 1976). The GAPDH inhibition kinetics data showed 
that Di-, and triHAAs were relatively weaker inhibitors of GAPDH and triHAAs increased ATP 
levels where diHAAs induced a moderate reduction in ATP levels. MonoHAAs were the 
strongest inhibitors of GAPDH and greatly reduced ATP contents. From previous studies, we 
also know that TCA cycle and oxidative phosphorylation are the pivotal steps in the cellular 
energy homeostasis. Since TCA is dependent on PDC for its substrate, PDC regulation plays an 
important role in overall energy homeostasis. PDC is either regulated by different metabolite 
ratios such as the NADH/NAD+, ATP/ADP, and acetyl-CoA/CoA, and also by PDK (Kerbey et 
al. 1976; Kato et al. 2005). It would be interesting to see the effect of these HAAs on the overall 
PDC activity and the difference among the mode of actions of these HAAs on PDC activity 
modulation.  
Effect of HAAs on Pyruvate Dehydrogenase Complex Activity  
 Data in Figure 3.1-3.3 demonstrated that monoHAAs were the strongest inhibitors of 
GAPDH and greatly reduced the ATP contents of the cells. However, di-, and triHAAs were 
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relatively weaker inhibitors of GAPDH and triHAAs unexpectedly increased the ATP contents 
of cells as compared to the negative control. PDC activity is regulated by different cellular 
metabolite ratios e.g. NADH/NAD+, ATP/ADP, and acetyl-CoA/CoA, and also by PDH 
phosphorylation state, which is controlled by PDK; based on these data and the PDC activity 
regulation mechanisms, we hypothesize that monoHAAs activate PDC activity by reducing ATP 
contents of the cells due to the strong GAPDH inhibition leading to ATP/ADP ratio disruption, 
which requires cells to activate PDC activity and eventually TCA cycle to produce more energy 
and maintain the ATP/ADP. However, di-, and triHAAs are the weaker inhibitors of GAPDH 
and increase the ATP contents of the cells; we hypothesize that di-, and triHAAs increase the 
ATP contents of the cells due to PDK inhibition, which leads to increased PDC activity and 
elevated levels of ATP contents. To test this hypothesis, PDC activity was measured in CHO 
cells cultured in F12 5% FBS medium using different concentrations of HAAs. Concentrations, 
which gave best response, were used for further experiments. PDC kinetics activity was 
measured for 60 min at 10 min interval and the final data were recorded as nmol NADH/min/mg 
protein.  We found that most of the HAAs except BCA and BDCA increased the PDC activity. 
The Data demonstrated that monoHAAs greatly increased the PDC activity as compared to di-, 
and triHAAs. Among monoHAAs , IAA had the highest increase in PDC activity, which was 
369.5% of the negative control followed by BAA (308.1%) and then by CAA (193.8%) 
(Table.3.2). Previous studies and our current GAPDH kinetics study and ATP data showed that 
IAA is the strongest inhibitor of GAPDH and greatly reduces ATP levels followed by BAA and 
then CAA (Pals et al. 2011; Dad et al. 2013). Previous studies also demonstrated that there was 
an inverse relation between NADH/NAD+, ATP/ADP, and acetyl-CoA/CoA and active 
proportion of PDC (Kerbey et al. 1976). Therefore, an increase in the PDC activity by 
monoHAAs corroborated with findings from previous studies and showed an inverse relation 
with ATP/ADP ratio.  The pattern (IAA > BAA >> CAA) found in PDC activity increase was 
also correlated with the pattern found in other HAA toxicity potentials (Pals et al. 2011; Dad et 
al. 2013) Among diHAAs , DCA increased PDC activity to 135.4% of the negative control and 
DBA increased the activity to 184.30% of the negative control (Table 3.2). However, BCA did 
not increase PDC activity and had no significant effect on PDC activity. Similarly, triHAAs also 
increased the PDC activity except CDBA and BDCA. Among triHAAs, TBA increased PDC 
activity to 255.2% of the negative control where, TCA increased the PDC activity to 148.3% of 
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the negative control. However, BDCA significantly decreased the PDC activity to 35.4% as 
compared to the negative control while CDBA had no significant effect on PDC activity. The 
significant increase or decrease by HAAs in PDC activity as compared to negative control is 
presented in the Figure 3.5.  These data demonstrated that increased PDH activity by monoHAAs 
was due to disturbances in the metabolite ratios (ATP/ADP, NADH/NAD+) induced by GAPDH 
inhibition while di-, and triHAAs were the weaker inhibitors of GAPDH and had no drastic 
reduction in the ATP levels (Figure 3.3) , which suggests that increased PDC activity by di-, and 
triHAAs was due to the inhibition of PDK . We also saw a significant increase in PDC activity 
by DCA 50 µM and TCA 300µM (Figure 3.5), which conforms to previous studies (Whitehouse 
et al. 1974; Kato et al. 2005). Concentrations based on genotoxicity potential were used for the 
initial ATP study but those concentrations were different than what we used for PDC activity to 
achieve better resolution of the assays. We repeated the ATP study with the same concentrations 
that were explored in the PDC activity study to determine if this relationship between the PDC 
activity under HAA’s effect and its role in cellular energy homeostasis could be replicated. We 
observed exactly the same pattern for the HAA effect on ATP alterations as it was found in PDC 
activity study in HAA-treated cells. ATP data (Table 3.3) showed that all the monoHAAs 
significantly reduced the ATP contents of the cells and we found an inverse relation between the 
ATP content and PDC activity under the monoHAA effect. Among the diHAAs, DCA 
significantly increased cellualr ATP content to 207.4% as compared to negative control (Table 
3.3). 50 µM DCA significantly increased the PDC activity as well (Figure 3.5). Therefore, 
increase in PDC activity and changes in energy homeostasis by DCA is not due to changes in the 
metabolite ratios induced by GAPDH inhibition but due to allosteric changes induced in PDK by 
DCA, leading to inhibition of PDK and activation of PDC, which also agrees with previous 
studies (Kerbey et al. 1976; Kato et al. 2005). Other di-, and triHAAs such as DBA, TBA, and 
TCA increased ATP contents to 128.5%, 114.4%, and 128.1% respectively.  However, BCA and 
CDBA had no significant effect on cellular ATP contents like its effect on PDC activity, where 
DCBA significantly decreased the ATP contents to 37.7% as compared to negative control 
(Table 3.3). The significant increase or decrease in the ATP contents of HAA-treated cells is 
shown in Figure 3.6.   
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3.4. CONCLUSION 
 The GAPDH kinetics study, cellular ATP contents analysis, and PDC activity under the 
effect of HAAs demonstrated that mono-, di-, and triHAAs are affecting the cellular metabolism 
by disrupting the cellular energy homeostasis. However, there are some differences among their 
modes of action. MonoHAAs induce toxicity by inhibiting GAPDH and reducing the ATP 
contents of the cells. Disturbances in different cellular metabolite ratios such as ATP/ADP, and 
NADH/NAD, under the monoHAA-effect, require cells to activate the TCA cycle and rescue 
cells against the monoHAA-induced metabolites scarcity by activating the PDC activity, which 
also signifies an inverse relationship between the different metabolite ratios and PDC activity. 
Where di-, and triHAAs are the weak inhibitors of GAPDH and disrupt cellular energy 
homeostasis by inhibiting PDK, which leads to PDC activation, TCA cycle acceleration, and 
eventually cellular ATP levels elevation. Our results supported our hypothesis and demonstrated 
that monoHAAs induce their toxicity by indirectly affecting mitochondrial metabolism due to 
GAPDH inhibition where, di-, and triHAAs have a direct effect on mitochondrial metabolism by 
inhibiting PDK enzyme and activating PDC.   
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3.5. TABLES AND FIGURES  
 
Table 3.1. Effects of the HAAs on ATP levels compared to its concurrent negative control in 
CHO cells and t-test statistical analysis calculated with the LUM as the % of negative control. 
HAA Group 
Average LUM  
(RLU ± SE) 
Average LUM 
as the % of 
control (± SE) 
t P 
CAA control 4142.4 ± 185.6  100.00 ± 4.48 
10.820 <0.001 
CAA 700 µM  1386.9 ± 174.4  33.48 ± 4.21  
BAA control 5195.4 ± 222.9 100.00 ± 4.29 
10.943 <0.001 
BAA 15 µM 2585.0 ± 94.5 49.76 ± 1.82 
IAA control 4856.3 ± 309.2 100.00 ± 6.37 
8.529 <0.001 
IAA 4 µM 1917.0 ± 152.2  39.47 ± 3.13 
DCAA control 4708.8 ± 90.4 100.00 ± 1.92 
3.133 0.003 
DCAA 2000 µM 4296.0 ± 96.0 103.71 ± 2.04 
DBAA control 5270.1 ± 93.7 100.00 ± 1.78 
14.270 <0.001 
DBAA 700 µM 3707.1 ± 56.6 70.34 ± 1.07 
BCAA control 6309.8 ± 177.4 100.00 ± 2.81 
9.545 <0.001 
BCAA 700 µM 4147.8 ± 136.2 66.16 ± 2.16 
TCAA control 4760.9 ± 226.3 100.00 ± 4.75 
-0.749 0.456 
TCAA 2000 µM 4969.6 ± 164.5 104.38 ± 3.46 
TBAA control 4220.3 ± 208.5 100.00 ± 4.94 
-3.830 <0.001 
TBAA 1000 µM 5168.1 ± 133.3 122.46 ± 3.16 
BDCAA control 4852.3 ± 82.8 100.00 ± 1.71 
-5.453 <0.001 
BDCAA 2000 µM 5883.6 ± 165.8 121.25 ± 3.42 
DBCAA control 4771.7 ± 191.4 100.00 ± 4.01 
-4.473 <0.001 
DBCAA 1000 µM 6044.0 ± 210.4 126.66 ± 4.41 
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Table 3.1. (Continued) 
Abbreviations: HAA, haloacetic acid; CAA, chloroacetic acid; BAA, bromoacetic acid; IAA, iodoacetic 
acid; DCAA, dichloroacetic acid; DBAA, dibromoacetic acid; BCAA, bromochloroacetic acid; TCAA, 
trichloroacetic acid; TBAA, tribromoacetic acid; BDCAA, bromodichloroacetic acid; DBCAA, 
dibormochloroacetic acid; LUM, luminescence; RLU, relative light unit; SE, standard error.  
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Table: 3.2. Effect of HAAs on percent alteration of pyruvate dehydrogenase 
complex activity as nmol NADH/min/mg protein  
Treatment Group 
Treatment 
Concentration (µM) 
nmol 
NADH/min/mg 
protein as % of 
negative control ±SE 
Negative Control - 100.01 4.34 
IAA 3 369.50 20.34 
BAA 15 308.12 41.65 
CAA 300 193.79 11.71 
DCA 50 135.40 8.46 
BCA 900 74.23 16.52 
DBA 900 184.30 7.90 
TBA 500 255.21 43.64 
TCA 300 148.31 4.76 
CDBA 300 107.18 5.67 
BDCA 900 35.44 8.91 
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Table:3.3. Effect of HAAs on percent alteration of ATP as pmol ATP/mg protein 
as compared to negative control.   
Treatment Group 
Treatment 
Concentration (µM) 
pmolATP/mg 
protein as % of 
negative control ±SE 
Negative Control - 100 6.20 
IAA 3 28.08  3.76 
BAA 15 14.29 5.00 
CAA 300 52.18 5.31 
DCA 50 207.38 15.72 
BCA 900 73.30 4.81 
DBA 900 128.55 10.27 
TBA 500 114.35 11.26 
TCA 300 128.05 6.90 
CDBA 300 108.37 6.57 
BDCA 900 37.71 2.41 
!
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Figure 3.1. Percent reduction in GAPDH activity by 1µM of each HAA. MonoHAAs were the 
strongest inhibitors of GAPDH activity, where di-, and triHAAs were the weaker inhibitors of 
GAPDH.  
 
 
 
 
 
 
 
 
 
 
 	  	  	  	   
 
Haloacetic Acids
M
ea
n 
P
er
ce
nt
 R
ed
uc
tio
n 
in
 G
A
P
D
H
 A
ct
iv
ity
 p
er
 
µM
 H
A
A
 (±
S
E
) (
µm
ol
 N
A
D
H
/m
in
/µ
g 
P
ro
te
in
)
0.01
0.1
1
IAA BA
A
CA
A
BC
A
DB
A
DC
A
TB
A
TC
A
CD
BA
BD
CA
	  87	  
HAA Treatment Group
BAA DBA TBA
P
er
ce
nt
 R
ed
uc
tio
n 
in
 G
A
P
D
H
 a
ct
iv
ity
 a
s 
nm
ol
 N
A
D
H
/m
in
/µ
g 
P
ro
te
in
 b
y 
1µ
m
ol
 H
A
A
0
100
200
300
400
500
600
	  
 
 
 
 
 
Figure 3.2. BAA, DBA, and TBA as representatives of mono-, di-, and triHAAs with its effect 
on GAPDH activity as percent reduction in GAPDH activty/nmol NADH/min/µg protein by 1 
µmol of the given HAAs.  
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Figure 3.3. Effect of HAA-exposure on the ATP contents of the cells. ATP levels for each 
treatment group are normalized against the negative control/100%. The * indicates a statistically 
significant difference from their concurrent negative control.  
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Figure 3.4. Average ATP data catagorized in three groups based on number of halogens present 
in each HAA treatment group. ATP levels were normalized against each concurrent negative 
control.  
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Figure 3.5. Effect of HAAs on CHO PDC activity (nmolNADH/min/mg protein). PDC activity 
for each HAA treatment group was normalized against each concurrent negative control/100% 
and the negative control shown here is the average of all the negative control groups. The * 
indicates a statistically significant difference from their concurrent negative control.  	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Figure 3.6.	  Effect of HAAs on cellular ATP levels (pmol ATP/mg protein). ATP levels for each 
HAA treatment group was normalized against each concurrent negative control and the negative 
control shown here is the average of all the negative control groups. The * indicates a 
statistically significant difference from the negative control.  	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CHAPTER 4 
 
TOXICITY OF DBPs GENERATED AFTER CHLORINATION OF WASTE WATER 
EFFLUENTS 
 
4.1. INTRODUCTION 
Domestic wastewaters have different pathogenic microorganisms such as viruses, enteric 
bacteria and protozoa. The wastewater use is associated with potential health risks through direct 
(drinking and every day domestic use) and indirect (irrigation) use, if the wastewater treatment 
process was not managed properly. Therefore, wastewaters are treated with different chemical 
disinfectants to control the potential health risks associated with wastewater contaminants (Food 
and Agriculture Organization of the United Nations). Different chemical disinfectants such as 
chlorine, chlorine dioxide, ozone, and chloramine are used to inactivate the pathogenic 
microorganisms (Krasner 2009). The most prevalent chemical disinfectant is chlorine in both 
Kingdom of Saudi Arabia (KSA) and USA. Chlorine can be supplied in different forms such as 
chlorine gas, hypochlorite solution and other chlorine compounds in solid or liquid form. 
Chlorine disinfection of the wastewaters not only destroys the pathogens at the time of treatment 
but chlorine residue in the wastewater effluents prolong this oxidation and destruction of the 
pathogenic cells even after the treatment time. However, chlorine residue in water is very toxic 
to aquatic life even if it is present at a very low concentration; it also produces some unwanted 
toxic water disinfection by-products due to oxidation of some organic material present in the 
wastewaters (U. S. Environmental Protection Agency 1999). In this study, the target waters are 
wastewater effluents containing ammonia and nitrogenous organic matter. Ammonia and organic 
nitrogen presence in excess with respect to the chlorine dose result in a very fast conversion of 
the free chlorine into monochloramine and organic chloramines. Chloramines then react with 
both inorganic and organic constituents in water forming a large number of disinfection 
byproducts (DBPs). Relevant reactions to this study involving inorganic species are the oxidation 
of iodide ion (Iˉ) by monochloramine (NH2Cl) to form hypoiodous acid (HOI) (Bichsel and von 
Gunten 1999).  
In this study, the cytotoxicity and genotoxicity potentials of the chlorinated and chloraminated 
wastewater effluents extracts, extracted through XAD-8 and XAD-4 were analyzed using in vitro 
CHO cells assays.   
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4.2. MATERIALS AND METHODS  
XAD Resins 
XAD-8 with acrylic ester composition, 250 angstrom pore diameter, 140 m2/g of the 
specific surface area was used. Similarly XAD-4 with styrene divinylbenzene composition, 50 
angstroms pore diameter, 750 m2/g of specific surface area was used.  
Wastewater Samples  
Dr. Julien Le Roux shipped 10 mL of each of the concentrated organic extracts of the 
wastewater (WW) samples from King Abdullah University of Science and Technology to Dr. 
Plewa’s laboratory at the University of Illinois in May 2014. The samples were derived from two 
experiments. The XAD-8/XAD-4 experimental design for the extraction of the organic fractions 
for each wastewater sample is illustrated in Figure 4.1. 
Extraction; Experiment Series 1  
76 L of chloraminated wastewater was extracted over XAD-8 and XAD-4 resins (Figure 
4.1). The organics were eluted from the XAD columns using spectroscopy-grade ethyl acetate. 
The ethyl acetate volume was reduced over vacuum evaporation on a rotary evaporator. The 
samples were concentrated to 10 mL in ethyl acetate and shipped to Dr. Plewa’s laboratory.  
Experiment Series 2   
In this experiment the toxicity of the organics concentrated from chlorinated wastewater (HOCl) 
or chloraminated  (NH2Cl) wastewater were compared. In addition, the spent wastewater (the 
wastewater that passed through each column) was further analyzed by liquid-liquid extraction 
using methyl tertiary butyl ether (MTBE) and concentrated using a rota-vaporator. This provided 
a measure of the residual toxicity that was retained in the wastewater after XAD extraction and 
provided a measure of the efficiency of XAD to isolate toxic agents in wastewater.   
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CHO Cell Chronic Cytotoxicity Analyses  
Preparation and Storage of KAUST Wastewater Samples  
 The organic materials in the wastewater effluent samples that were concentrated over 
XAD-8 or XAD-4 were eluted in ethyl acetate and received from Drs. Jean-Philippe Croue and 
Julien Le Roux, logged into a spreadsheet file and stored at −20°C. The samples were solvent 
exchanged into dimethylsulfoxide (DMSO) at a concentration in that the organic material from 1 
L of effluent was concentrated into 10 µL of DMSO (105× concentration) and stored in Teflon-
sealed sample vials at −20°C.  
CHO Cell Cytotoxicity Assay Protocol  
The CHO cell microplate chronic cytotoxicity assay measures the reduction in cell 
density as a function of the concentration of the test agent over a 72 h period (Plewa et al. 2002; 
Plewa and Wagner 2009). A 96-well flat-bottomed microplate was used to evaluate a series of 
concentrations of wastewater effluent organic extracts. One column of eight microplate wells 
served as the blank control consisting of 200 µL of F12 + 5% fetal bovine serum (FBS) medium 
only. The concurrent negative control column consisted of eight wells with 3×103 CHO cells 
plus F12 +FBS medium. The remaining wells within the experiment contained 3×103 CHO cells, 
F12 +FBS and a known volume of water concentrate in a total of 200 µL. The wells were 
covered with a sheet of sterile Alumna Seal™. The microplate was placed on a rocking platform 
at 37°C for two 5 min-periods (turning the plate 90° after the first 5 min). This ensures an even 
distribution of cells across the bottom of the microplate wells. The cells were incubated for 72 h 
at 37°C at 5% CO2. After the treatment time, the medium from each well was aspirated, the cells 
fixed in methanol for 10 min and stained for 10 min with a 1% crystal violet solution in 50% 
methanol. The microplate was washed, and 50 µL of DMSO/methanol (3:1 v/v) was added to 
each well, and the plate incubated at room temperature for 10 min. The microplate was analyzed 
at 595 nm with a Spectramax microplate reader; the absorbency of each well was recorded and 
stored on a spreadsheet file. This assay was calibrated and there is a direct relationship between 
the absorbency of the crystal violet dye associated with the cell and the number of viable 
cells.(Plewa et al. 2002) 
 The averaged absorbency of the blank wells was subtracted from the absorbency data 
from each microplate well. The mean blank-corrected absorbency value of the negative control 
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was set at 100%. The absorbency for each treatment group well was converted into a percentage 
of the negative control. This procedure normalizes the data, maintains the variance and allows 
for the combination of data from multiple microplates. The data were used to generate a 
concentration-response curve for each test agent. Regression analysis was applied to each test 
agent concentration-response curve, which was used to calculate the LC50. The LC50 is the 
calculated concentration of test agent that induced a cell density that was 50% of the negative 
control. The original absorbency data, the blank-corrected data and the conversion to the percent 
of the negative control values were saved on the spreadsheet for each test agent analyzed. In 
general we analyzed 16-24 replicate clones for the negative controls and 4-6 replicate clones per 
concentration of the test agent with 10 concentrations of the test material. This provided the data 
with a high statistical power (1-β) > 0.8 (α = 0.05) when an analysis of variance statistical test 
was conducted. Prior to conducting the complete chronic cytotoxicity assay, we conducted a 
screening assay. In the screening assay a serial dilution of the concentrated organic extract was 
prepared in F12 +FBS medium and one clone was analyzed per concentration. A screening assay 
provided a range of concentrations in which a more complete experimental design can be 
generated with replicate experiments.  
CHO Cell Acute Genotoxicity Analyses 
 The single cell gel electrophoresis (SCGE) assay quantitatively measures the level of 
genomic DNA damage that was induced by the KAUST wastewater samples. The SCGE, or 
Comet, assay is a sensitive, quantitative method for the detection of genomic DNA damage in 
individual cells. (Tice et al. 2000; Rundell et al. 2003) The SCGE microplate assay was 
performed as previously published. (Wagner and Plewa 2009) 
CHO Cell SCGE Assay Protocol 
The day before treatment, 4×104 cells were cultured into each well of a 96-well 
microplate in 200 µL of F12 medium plus 5% FBS and incubated overnight. The following day, 
cells were washed twice with 100 µL of Hank’s Balanced Salt Solution (HBSS) and treated with 
a series of concentrations of each water sample in a total volume of 25 µL. The cells were 
covered with sterile AlumnaSeal and incubated for 4 h at 37°C in a humidified atmosphere of 
5% CO2. Each experiment had a concurrent negative control (F12 medium only) and a positive 
control (3.8 mM ethylmethanesulfonate). After treatment, the cells were washed with HBSS 
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buffer, harvested with a 0.05% trypsin, 153 µM EDTA solution and incorporated into agarose 
microgels. For each concentration group, acute cytotoxicity was measured using the vital dye 
trypan blue. (Phillips 1973) The microgels were electrophoresed and analyzed if the viability of 
the cell suspensions was >70%. The microgels were placed in lysing solution overnight at 4°C to 
remove cell membranes (2.5 M NaCl, 100 mM Na2EDTA, 10 mM Trizma base, 26 g of NaOH 
and 1% sodium lauryl sarcosinate, pH 10) with 10% DMSO and 1% Triton X-100 added just 
prior to use. The microgels were rinsed twice with cold deionized water and the DNA was 
denatured for 20 min in electrophoresis buffer (1 mM Na2EDTA and 300 mM NaOH, pH 13.5). 
The microgels were electrophoresed for 40 min at 25 V, 300 mA (0.72 V/cm) at 4°C. After 
electrophoresis, the microgels were neutralized with 400 mM Tris buffer (pH 7.5), dehydrated in 
methanol (4°C) and dried for 5 min at 50°C. The microgels were stored in the dark at room 
temperature. To analyze the microgels, they were first hydrated in deionized water for 30 min at 
4°C, stained with 65 µL of 20 µg/mL ethidium bromide and rinsed in cold deionized water. After 
staining, a cover slip was applied onto the microgel and 25 randomly selected nuclei per 
microgel were analyzed under a Zeiss fluorescence microscope with the Comet IV imaging 
system (Perceptive Instruments, Suffolk, UK). The data were automatically transferred to an 
Excel spreadsheet. For DNA damage the unit of measure for each microgel was the average % 
tail DNA, which is the amount of DNA that migrated into the gel from the nucleus. The mean % 
tail DNA values were calculated for the microgels in a treatment group and were analyzed with 
an ANOVA statistical test. If a significant F value of P ≤ 0.05 was obtained, a Holm-Sidak 
pairwise comparison versus the control group analysis was conducted (power (1-β) ≥ 0.8 at 
α=0.05).  
4.3. RESULTS AND DISCUSSION 
CHO Cell Cytotoxicity Concentration-Response Data  
  For each experiment we prepared a dilution series of each sample stock solution in F12 
+5% FBS cell culture medium and from this solution we prepared a concentration series in 
which CHO cells were exposed to the samples in microplate wells (200 µL). After 72 h the 
microplates were developed and the results are presented in the following concentration response 
curves (Figures 4.2-4.9).  
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Determination of LC50 Values and Statistical Analyses of Chronic Cytotoxicity Data 
 Employing quantitative in vitro assays allows for high precision and high statistical 
power when analyzing a series of water samples. In order to compensate for “real world” lifetime 
exposures of large populations, the standard procedure for in vitro toxicity assays is to increase 
the concentration of agents during short treatment times (hours to days). Range-finding 
experiments define the concentration range in which a response signal is observed, followed by 
focused experiments to generate concentration-response curves. Each concentration-response 
curve is generated from repeated experiments and a descriptive metric, including a LC50 value, is 
calculated using non-linear regression analyses. Bootstrap statistic tables were generated and 
averaged LC50 or cytotoxic index values were generated in order to run an ANOVA test for 
significance (Efron 1987; Singh and Xie 2008). These short-term assays with their high 
resolution can be used in optimizing engineering processing to reduce toxic agents in treated 
waters. From the data generated by the cytotoxicity concentration-response curves, for each 
KAUST EfOM sample we calculated the LC50 value, the lowest significant concentration factor 
as compared to the concurrent negative control, and the cytotoxicity index value. These metrics 
are presented in Table 4.1. The LC50 value was calculated from the regression analyses for each 
curve and it represents the concentration factor that would induce a cell density of 50% as 
compared to the concurrent control. The lowest cytotoxic concentration factor was the lowest 
concentration factor that induced a statistically significant cytotoxic response and was 
determined by the ANOVA test statistic (Table 4.1). The CHO cell chronic cytotoxicity index 
(CTI) value was calculated as the reciprocal of the LC50 value ×103 to generate unit-less whole 
numbers. A larger number indicates a greater cytotoxic potency of the KAUST EfOM sample 
(Figure 4.10). 
Statistical analyses of the data generated in the cytotoxicity concentration-response 
experiments (Figures 4.2-4.9) are presented in Table 4.1.  
CHO Cell Genotoxicity Concentration-Response Data  
 For each experiment we prepared a dilution series of each sample stock solution in F12 
(without FBS) cell culture medium and from this solution we prepared a concentration series in 
which CHO cells were exposed to the samples in microplate wells (25 µL). After treatment and 
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analyses with fluorescent microscopy the data were stored in an Excel file. The SCGE results are 
presented in the following concentration response curves (Figures 4.11-4.18).  
Determination of 50%Tail DNA Values and Statistical Analyses of Genotoxicity Data 
The SCGE %Tail DNA value for each nucleus within each microgel was measured using 
the Comet IV software. These data were stored on a spreadsheet and the Mean %Tail DNA value 
for that microgel was calculated and transferred to a data spreadsheet. In addition the acute 
cytotoxicity of the treated cells was entered into the same data spreadsheet. Within the water 
sample concentrate concentration range that allowed for 70% or greater viable cells, a 
concentration-response curve was generated. The data were plotted and a regression analysis was 
used to fit the curve and the 50%Tail DNA value was calculated. This information is presented 
in Table 4.2. The data were transferred to the SigmaPlot 11 program spreadsheet for an ANOVA 
statistical test. The %Tail DNA values in the SCGE assay are not normally distributed and 
violate the requirements for analysis by parametric statistics. The mean %Tail DNA value for 
each microgel was determined as described above and the data were averaged amongst all of the 
microgels for each water sample concentrate concentration. Averaged median or mean values 
express a normal distribution according to the central limit theorem (Box et al. 1978). The 
averaged mean %Tail DNA values obtained from repeated experiments were analyzed with a 
one-way ANOVA test (Lovell and Omori 2008). If a significant F value of P ≤0.05 was 
obtained, a Holm-Sidak multiple comparison versus the control group analysis was conducted. 
The power of the test statistic (1−β) was maintained as ≥0.8 at α=0.05. The lowest genotoxic 
concentration factor that induced a statistically significant genotoxic response is presented in 
Table 4.2.  
The SCGE genotoxic index (GTI) value was determined as the reciprocal of the 50%Tail 
DNA value ×103 to generate unit-less whole numbers. A larger GTI number indicates a greater 
genotoxic potency of the KAUST wastewater sample (Figure 4.19). 
An ANOVA test was used to analyze the GTI values derived from the bootstrap statistics. 
If there was not a significant difference between the negative control and a specific wastewater 
sample, then a GTI value was entered as zero. To prepare the comparison table and statistical 
analyses of the GTI values, a series of six zero values were used as placeholders for those 
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KAUST wastewater samples that did not express a significant response within their 
concentration-response as compared to the concurrent negative control. This allowed these non-
significant responders to be included in the comparison amongst all of the wastewater samples.  
4.4. CONCLUSIONS 
Conclusion from the CHO Cell Chronic Cytotoxicity Analyses 
From the data derived from the cytotoxicity concentration-response curves (Figures 4.2-
4.9), their statistical analyses and the ANOVA tests of the cytotoxicity index values (Figure 
4.10) we conclude the following. 
1. The wastewater XAD-8-isolated EfOM was more cytotoxic than the XAD-4 extracts of 
the same wastewaters. This suggests that halogenated hydrophobic acid fractions, 
aliphatic carboxylic acids, aromatic carboxylic acids, phenols and humic substances were 
more cytotoxic than those organic materials eluted from the XAD-4 resins. 
2. The amount of cytotoxic material retained in the XAD-8 and XAD-4 extracted (spent) 
wastewater was very low. For NH2Cl disinfection, the residual cytotoxicity of the organic 
material present in the spent wastewater was 1.4% of the summed cytotoxicity of the 
XAD-8 and XAD-4 isolated organics. With HOCl disinfection, the cytotoxicity of the 
residual organic material present in the spent wastewater was also 1.4% of the summed 
cytotoxicity of the XAD-8 and XAD-4 isolated organics. 
3. There was no significant difference between the cytotoxic indices for the spent NH2Cl 
and HOCl wastewaters. Thus the XAD-8 and XAD-4 extraction protocol was efficient in 
extracting the cytotoxic organic materials from the wastewaters. 
4. The disinfectant used with the wastewaters had an effect on the resulting cytotoxicity of 
the XAD-8 extracted organic material. Within experiment 2, the HOCl XAD-8 extract 
was significantly more cytotoxic than the NH2Cl XAD-8 extract. There was no 
significant difference between the XAD-4 extracts of HOCl and NH2Cl treated 
wastewaters.  
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Conclusions from the CHO Cell Genotoxicity Analyses 
 From the data derived from the genotoxicity concentration-response curves (Figures 
4.11- 4.18), their statistical analyses and the ANOVA tests of the genotoxicity index values 
(Figure 4.19) we conclude the following. 
1. The wastewater XAD-8-isolated EfOM was more genotoxic than the XAD-4 extracts of 
the same wastewaters. This suggests that halogenated hydrophobic acid fractions, 
aliphatic carboxylic acids, aromatic carboxylic acids, phenols and humic substances were 
more potent inducers of genomic DNA damage than those organic materials eluted from 
the XAD-4 resins. 
2. The organic material retained in the XAD-8 and XAD-4 extracted (spent) wastewater 
expressed no significant genotoxic response throughout the concentration factor range 
from 200× to 1,000×. There was no significant difference between the genotoxic indices 
for the spent NH2Cl and HOCl wastewaters. Thus the XAD-8 and XAD-4 extraction 
protocol was efficient in extracting the genotoxic organic materials from the wastewaters. 
3. The disinfectant used with the wastewaters had an effect on the resulting genotoxicity of 
the XAD-8 extracted organic material. Within experiment 2, and in contrast to the 
cytotoxicity data, the NH2Cl XAD-8 extract was significantly more genotoxic than the 
HOCl XAD-8 extract.  
 
4. XAD-4 extracted organics from the NH2Cl treated wastewaters were significantly more 
genotoxic than those of the HOCl treated wastewaters. 
These data indicate that the NH2Cl EfOM extracted over XAD-8 or XAD-4 were more genotoxic 
than EfOM from HOCl treated wastewaters. 
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4.5. FIGURES AND TABLES  
	  
	  
Figure 4.1. Experimental design for the extraction of the wastewater effluent organic fractions.  
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Figure 4.2. Experiment 1. CHO cell cytotoxicity concentration response curve for the 
chloraminated wastewater EfOM extracted over XAD-8 resin. 
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Figure 4.3. Experiment 1. CHO cell cytotoxicity concentration response curve for the 
chloraminated wastewater EfOM extracted over XAD-4 resin.  
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Figure 4.4. Experiment 2. CHO cell cytotoxicity concentration response curve for the chlorinated 
wastewater EfOM extracted over XAD-8 resin.   
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Figure 4.5. Experiment 2. CHO cell cytotoxicity concentration response curve for the chlorinated 
wastewater EfOM extracted over XAD-4 resin.  
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Figure 4.6. Experiment 2. CHO cell cytotoxicity concentration response curve for the chlorinated 
wastewater after extraction over XAD-8 and XAD-4 resins. The resulting wastewater after XAD 
extraction was reduced in volume by vacuum evaporation and the residual was liquid/liquid 
extracted with MTBE.  
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Figure 4.7. Experiment 2. CHO cell cytotoxicity concentration response curve for the 
chloraminated wastewater EfOM extracted over XAD-8 resin.  
 
 
 
 
 
 
 
 
 
 
EfOM NH2Cl: XAD-8 (2)
(Concentration Factor)
0 2 4 6 8 10 12 14 16
C
H
O
 C
el
l C
hr
on
ic
 C
yt
ot
ox
ic
ity
: C
el
l D
en
si
ty
as
 th
e 
Pe
rc
en
t o
f t
he
 N
eg
at
iv
e 
C
on
tro
l (
±S
E)
0
20
40
60
80
100
	  112	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8. Experiment 2. CHO cell cytotoxicity concentration response curve for the 
chloraminated wastewater EfOM extracted over XAD-4 resin.   
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Figure 4.9. Experiment 2. CHO cell cytotoxicity concentration response curve for the 
chloraminated wastewater after extraction over XAD-8 and XAD-4 resins. The resulting 
wastewater after XAD extraction was reduced in volume by vacuum evaporation and the residual 
was liquid/liquid extracted with MTBE.   
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Table 4.1 Statistical analyses of the cytotoxicity data from the XAD-extracted wastewater samples 
WW EfOM Sample 
LC50 
 Conc. 
Factor a 
r2 b 
Lowest 
Cytotox. 
Conc. 
Factor c 
ANOVA Test Statistic d 
EfOM NH2Cl: XAD-8 (1) 4.51 0.98 2 F11,59  = 103.1; P ≤ 0.001 
EfOM NH2Cl: XAD-4 (1) 34.5 0.99 10 F11,84  = 66.9; P ≤ 0.001 
EfOM HOCl: XAD-8 (2) 5.45 0.99 1 F10,47  = 193.0; P ≤ 0.001 
EfOM HOCl: XAD-4 (2) 44.2 0.99 30 F11,83  = 87.1; P ≤ 0.001 
EfOM HOCl: XAD-8/XAD-4 Spent Water (2) 354 0.99 50 F11,52  = 172.7; P ≤ 0.001 
EfOM NH2Cl: XAD-8 (2) 8.45 0.99 4 F11,52  = 164.1; P ≤ 0.001 
EfOM NH2Cl: XAD-4 (2) 32.3 0.98 10 F10,54  = 115.1; P ≤ 0.001 
EfOM NH2Cl: XAD-8/XAD-4 Spent Water (2) 470 0.99 200 F13,41  = 195.6; P ≤ 0.001 
 
a The LC50 value is the fold concentration factor of the wastewater sample, determined from a regression 
analysis of the data, that induced a cell density of 50% as compared to the concurrent negative controls. b 
r2 is the coefficient of determination for the regression analysis upon which the LC50 value was 
calculated. c Lowest cytotoxic concentration was the lowest concentration factor of the wastewater sample 
in the concentration-response curve that induced a statistically significant reduction in cell density as 
compared to the concurrent negative controls.  d The degrees of freedom for the between-groups and 
residual associated with the calculated F-test result and the resulting probability value.  
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Figure 4.10. A comparison of the CHO cell cytotoxicity index values for each group in 
experiment 1 and experiment 2.   	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Figure 4.11. Experiment 1sample EfOM NH2Cl extracted over XAD-8 illustrating its CHO cell 
SCGE genotoxicity concentration-response curve (bottom panel) and acute cytotoxicity (top 
panel).   
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Figure 4.12. Experiment 1 sample EfOM NH2Cl extracted over XAD-4 illustrating its CHO cell 
SCGE genotoxicity concentration-response curve (bottom panel) and acute cytotoxicity (top 
panel).  
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Figure 4.13. Experiment 2 sample EfOM HOCl extracted over XAD-8 illustrating its CHO cell 
SCGE genotoxicity concentration-response curve (bottom panel) and acute cytotoxicity (top 
panel).  
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Figure 4.14. Experiment 2 sample EfOM HOCl extracted over XAD-4 illustrating its CHO cell 
SCGE genotoxicity concentration-response curve (bottom panel) and acute cytotoxicity (top 
panel).   
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Figure 4.15. Experiment 2 CHO cell genotoxicity concentration response curve for the 
chlorinated wastewater after extraction over XAD-8 and XAD-4 resins (bottom panel). The 
resulting wastewater after XAD extraction was reduced in volume by vacuum evaporation and 
the residual was liquid/liquid extracted with MTBE. The acute cytotoxicity response is illustrated 
in the top panel.  	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Figure 4.16. Experiment 2 sample EfOM NH2Cl extracted over XAD-8 illustrating its CHO cell 
SCGE genotoxicity concentration-response curve (bottom panel) and acute cytotoxicity (top 
panel).  	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Figure 4.17. Experiment 2 sample EfOM NH2Cl extracted over XAD-4 illustrating its CHO cell 
SCGE genotoxicity concentration-response curve (bottom panel) and acute cytotoxicity (top 
panel).  
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Figure 4.18. Experiment 2 CHO cell genotoxicity concentration response curve for the 
chloraminated wastewater after extraction over XAD-8 and XAD-4 resins (bottom panel). The 
resulting wastewater after XAD extraction was reduced in volume by vacuum evaporation and 
the residual was liquid/liquid extracted with MTBE. The acute cytotoxicity response is illustrated 
in the top panel.  
 
 
 
 
 
 
 
 
 
 
	  124	  
 
 
 
Table 4.2 Statistical analyses of the genotoxicity data from the XAD-extracted wastewater 
samples 
WW EfOM Sample 
50% 
TDNA 
Conc. 
Factor a 
r2 b 
Lowest 
Genotox. 
Conc. 
Factor c 
ANOVA Test Statistic d 
EfOM NH2Cl: XAD-8 (1) 76.4 0.99 50 F14,37  = 195.1; P ≤ 0.001 
EfOM NH2Cl: XAD-4 (1) 541 0.99 400 F26,53  = 133.8; P ≤ 0.001 
EfOM HOCl: XAD-8 (2) 112.7 0.98 85 F13,20  = 154.4; P ≤ 0.001 
EfOM HOCl: XAD-4 (2) 522 0.98 300 F11,83  = 89.9; P ≤ 0.001 
EfOM HOCl: XAD-8/XAD-4 Spent Water (2) NA e NA NS f F9,30   =  2.2; P = 0.051 
EfOM NH2Cl: XAD-8 (2) 83.7 0.98 60 F9,30   = 300.1; P ≤ 0.001 
EfOM NH2Cl: XAD-4 (2) 293 0.98 200 F10,54  = 155.7; P ≤ 0.001 
EfOM NH2Cl: XAD-8/XAD-4 Spent Water (2) NA NA NS F13,41  = 0.395; P = 0.928 	  
a The SCGE 50% Tail DNA value is the wastewater sample concentration factor determined from a 
regression analysis of the data that was calculated to induce a 50% SCGE Tail DNA value.  b r2 is the 
coefficient of determination for the regression analysis upon which the SCGE 50%Tail DNA value was 
calculated. c The lowest genotoxic concentration was the lowest concentration factor of the wastewater 
sample in the concentration-response curve that induced a statistically significant amount of genomic 
DNA damage as compared to the negative control. d The degrees of freedom for the between-groups and 
residual associated with the calculated F-test result and the resulting probability value. e NA = not 
applicable, f NS = not significant.   
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Figure 4.19. A comparison of the CHO cell genotoxicity index values for each group in 
experiment 1 and experiment 2. 
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CHAPTER 5 
TOXICITY OF PARTICLE ASSOCIATED POLYCYCLIC AROMATIC 
HYDROCARBONS IN URBAN LAKES 
5.1. INTRODUCTION 
 Increased concentrations of particle associated contaminants (PACs) such as metals and 
highly stable organic compounds are often associated with urbanization (Lopes et al. 1999; Rice 
1999). In New England, samples from sediment cores, streambed sediments, and suspended 
stream sediments showed higher concentrations of polycyclic aromatic hydrocarbons (PAHs), 
polychlorinated biphenyls (PCBs), DDT, and seven trace metals (Cd, Cr, Cu, Hg, Ni, Pb, Zn) 
than the reference concentrations, indicating a strong correlation with urbanization. The strongest 
relationships of PACs were observed to the percentage commercial, industrial and transportation 
land use. The urbanized watershed showed approximately 30 and 6 times higher concentrations 
of PAHs and metals than the reference concentrations, respectively (Chalmers et al. 2007). 
Atmospheric and fluvial pathways are the two main sources of PACs to aquatic system 
(Christensen and Xiaochun 1993). Atmospheric pathways for the Sources of PAHs and trace 
metals include waste incineration, fossil fuel combustion, and industrial emission from plating, 
smelting, and refining. The main sources of PACs with fluvial pathways to aquatic environment 
are, releases of contaminants to land surfaces by different means (such as pesticide use, disposal 
of wastes, and spills), erosion of historically contaminated soils, and wear of infrastructure (e.g. 
asphalt roads, driveways, parking-lot sealants, roofing materials, galvanized metals) (Chalmers et 
al. 2007).   
 In the US, there are different types of paved surfaces. However, most of the driveways 
and parking lots are either made of asphalt or concrete. In order to increase the longevity and 
improve appearance of these pavements, asphalt pavements, driveways, and parking lots are 
coated with a black, shiny material, known as “seal coat” (Dubey). In the US, the most common 
type of sealant is the coal tar; annually, 85 million gallons of coal tar-based sealcoat is used in 
the US (Scoggins et al. 2009). Particles abraded from these coal tar sealants on driveways, 
parking lots, and pavements flow into different water sources such as streams, and urban lakes 
via runoff and can be a primary source of different PACs (e.g. PAHs) in these water-bodies 
(Mahler et al. 2005; Yang et al. 2010).   
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PACs are highly stable; they are not only harmful to flora and fauna in the aquatic system 
but also harmful to humans. They are lipophilic in nature, bioaccumulative and toxic. Studies 
demonstrated that PACs were persistently found in nature even years after their use was 
diminished (Mahler and Van Metre 2003). Studies based on water quality surveys (Van Metre 
and Mahler 2005; Chalmers et al. 2007) showed that some of PACs (e.g. PAHs) concentration 
was correlated with urbanization. Since 1970’s, metal, PCBs, and DDT concentrations decreased 
in water. However, total concentrations of PAHs have increased with increasing urbanization 
(Van Metre and Mahler 2005). 
PAHs are organic compounds with two or more, single or fused benzene rings. They 
share a pair of carbon atoms between the rings in their molecules. PAHs containing less than 
four fused benzene rings have low molecular weight, easily soluble, biodegradable, and more 
volatile than those with four or more than four benzene rings. Compounds with four or less than 
four benzene rings are know as small PAHs and those with four or more benzene rings are know 
as large PAHs (Buha 2011; Mahler et al. 2012). The natural sources of PAHs are coal and 
petroleum products. They are produced due to the incomplete combustion of organic matter e.g. 
vehicle exhaust, cigarette smoke, residential wood burning, and wildfires. PAHs have many 
urban sources; sources of particle-associated PAHs in lake sediments are used motor oil, 
automobile exhaust, industrial emissions, tire particles, coal tar and asphalt based sealcoats on 
parking lots, abraded particles from driveway pavements, and municipal and industrial waste 
incineration (Hoffman et al. 1984; Mahler et al. 2005; Mahler et al. 2012).   
PAHs are present in the environment as a mixture of different PAHs compounds. Out of 
all known PAH sources, coal tar has the highest concentration of PAHs (Mahler et al. 2012). 
Particles abraded from sealcoats, which enter streams and rivers are the major source of PAHs in 
urban lake sediments. Out of all different sealcoats, particles from coal tar sealcoats contribute 
the highest percentage (84%) of the total PAHs in urban lake sediments (Yang et al. 2010). 
Metre et al demonstrated through the contaminant mass-balance receptor modeling that coal tar 
was the main source of PAHs in 40 lakes located throughout the United States for the last 40 
years (Van Metre and Mahler 2010). Due to the lipophilic nature of PAHs, they stay adsorbed on 
particle surfaces in water and can easily bioaccumulate in edible marine organisms. Background 
levels of PAHs in drinking water ranged from 4 to 24 ng per liter. The U.S. EPA selected 17 
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PAHs and profiled them in a single group based on their highest concentrations at national 
Priority List (NPL) sites, their level of harmful effects, exposure and the available information 
for these PAHs (Mumtaz and Julia 1995). Mahler et al demonstrated in a study that PAHs from 
coal tar and asphalt sealcoats are acutely toxic. In this study, Ceriodaphnia dubia and 
Pimephales promelas were exposed to undiluted runoff from unsealed asphalt pavement and 
ultraviolet radiation (UVR) that showed ≤10% mortality. However, when these test organisms 
were exposed to undiluted coal tar runoff after sealcoat applications, results showed 100% 
mortality (Mahler et al. 2015). PAHs were genotoxic and carcinogenic (Farmer 2003) and 
induced lung cancer in workers exposed to coal tar pitch volatiles measured as benzene-soluble 
matter (Armstrong 1994). Several fractions of creosote P1 were found as mutagenic in 
Salmonella typhimurium strain TA98. The mutagenicity of creosote fractions was due to the 
presence of 0.18 and 1.1% of benzo(α)pyrene and benz(α)anthracene, respectively (Bos et al. 
1984).  
The fate of PAHs from coal tar sealcoat in aquatic systems is not well understood. It is 
not clear if PAHs redistribute in water and lose their toxic potential or if they are lost to the water 
column with ageing.  A mechanistic and quantitative approach is needed to understand the 
distribution of PAHs in water and the changes in the toxic potential of PAHs associated with its 
distribution in aquatic systems.   
The objectives of this research were to evaluate the coal tar and soot associated PAHs for 
mutagenicity, and determine if they were direct-acting mutagens or promutagens. By using the 
Salmonella typhimurium his reversion assay for the mutagenicity evaluation we could determine 
if the agents induced base pair substitution mutations and/or frameshift mutations.  
5.2. MATERIALS AND METHODS 
PAHs Extraction and Characterization From Lake Sediments  
   The coal tar extracts (CTE) with PAHs were provided by Dr. Charles Werth laboratory in 
the Department of Civil and Environmental Engineering. For the PAH analysis, subsamples from 
the same depths selected for carbonaceous material (CM) characterization were directly 
subjected to PAH extraction by acetone and dichloromethane using accelerated solvent 
extraction (ASE, EPA method 3545). The extracts were cleaned with silica gel (EPA method 
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3630c), and 16 EPA priority PAHs were analyzed with GC/MS following EPA method 8270c.  
Quality assurance was provided by analyzing triplicate samples, blanks, and spiked reagent 
samples, and recovery of surrogate compounds was monitored. Mean and variance among 
triplicates were reported as described by Yang and his colleagues (Yang et al. 2010).  
Chemicals and Reagents for Mutagenicity Test  
 Coal tar and soot extracts from lake sediments were provided by Dr. Charles Werth 
laboratory in Civil and Environmental Engineering Department. The coal tar and soot 
extracts were rotary evaporated. After rotary evaporation, coal tar and soot extract samples 
were solvent exchanged in 200 µL and 100 µL ethyl acetate, respectively and stored at at –
22°C in sterile glass vials with Teflon seals. General laboratory chemicals and reagents were 
purchased from Sigma Chemical Co. (St. Louis, MO) or Fisher Scientific Co. (Fair Lawn, NJ). 
Aroclor 1254-induced rat hepatic S9 fraction was purchased from Molecular Toxicology, Inc. 
(Annapolis, MD).  
Preparation of the Bacterial Suspensions 
 The experiments for this study involved two strains of S. typhimurium tester strains; 
TA98 (hisD3052, rfa−; ΔuvrB-bio; pKM101, ampr), TA100 (hisG46, rfa; ΔuvrB-bio; pKM101, 
ampr). S. typhimurium strains TA98 and TA100 were originally obtained from Dr. B. N. 
Ames (Berkeley, CA), The bacterial strains were stored as frozen cultures in Luria-Bonner 
broth (LB) plus 10% DMSO at –80°C.  
Plate Incorporation Assay With S. typhimurium Cells (TA100 and TA98) 
    S. typhimurium tester strain TA100 (hisG46, rfa−; ruvrB-bio) + pKM10, ampr) and 
TA98 (hisD3052, rfa−; ΔuvrB-bio; pKM101, ampr), with and without mammalian microsomal 
activation were used. Reverse mutation was measured at hisG46 and hisD3052 (Hartman et al. 
1986). S. typhimurium strain TA100 was sensitive to PAHs (Kevekordes et al. 1998). TA100 and 
TA98 were stored in cryovials at −80°C as a frozen culture in Luria-Bonner (LB) plus 10% 
dimethylsulfoxide (DMSO). The TA98 and TA100 cells from their respective cryovials were 
used to construct master-plates; 100 µL cells from each cryovial were grown in 5 mL LB 
medium plus 10 µL ampicillin solution at 37°C while shaking and log-phase S. typhimurium 
TA100 or TA98 were used to construct master plates. The culture was streaked with a flame 
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sterilized platinum loop across the LB plate and incubated overnight at 37°C. The next day, 
master plate was stored at 4°C (Maron and Ames 1983). For the mutagenicity experiments, the 
single colony isolates of S. typhimurium TA100 and TA98 from there respective master plates 
were grown overnight in 50 mL LB medium 100 µL ampicillin stock solution at 37°C with 
shaking (200 rpm). The following day, the overnight cultures of TA100 or TA98 were utilized to 
check the coal-tar extract with PAHs induced mutagenicity using plate incorporation assay.   
   Most of the PAHs require metabolic activation to exhibit mutagenicity. Metabolic 
activation of PAHs is primarily dependent on cytochrome P-450 monooxygenase that converts 
PAHs into mutagens (Phillipson and Ioannides 1989). Oxidative transformation is an important 
route of metabolism of xenobiotics. The monooxygenase system is formed by the enzyme system 
of cytochrome P-450 and NADPH cytochrome P-450 reductase. The haemoprotein cytochrome 
P-450 functions as the terminal oxidase involved in the hydroxylation of xenobiotics such as 
PAHs.  
S. typhimurium Plate Incorporation Mutagenicity Assay  
 For the plate incorporation assay, overlay tubes were prepared with 2 mL of his-bio 
supplemented top agar, 100 µL of overnight bacterial culture and ± 500 µL S9 mix. The S9 mix 
consisted of 0.2 M sodium phosphate, 0.5 M MgCl2, 1.5 M KCl, 1 M glucose-6-phosphate, 0.5 
M NADP and 40 µL/mL of Aroclor 1254-induced rat hepatic microsomal suspension. The 
required volume of the test agent was added to the overlay tube, mixed and the overlay tube was 
flamed sterilized and immediately poured onto a VB minimal plate. The VB plates were 
incubated at 37°C for 48-72 h. Histidine revertant colonies were counted by hand or with a New 
Brunswick Biotran III automatic colony counter. The data were saved in an Excel spreadsheet. 
The data were analyzed from the Excel spreadsheet using the statistical and graphical functions 
of SigmaPlot 12 (Systat Software, Inc., San Jose, CA). Photographs of specific plates (± 500 µL 
S9 mix) illustrating the induction of his revertants are presented in Figure 5.1-5.2. 
 To confirm the genotype of the TA100 and TA98 cells, 100 µL of the bacterial cell 
suspension was added to an LB plate, and spread with a flamed glass rod. Flamed tweezers were 
used to place a crystal violet disk onto the center of the plate, and the disk was tapped lightly in 
place. Due to the presence of the rfa mutation (Maron and Ames 1983), the large molecules of 
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crystal violet are able to enter and kill the TA100 and TA98 cells. This was indicated by a clear 
zone around the crystal violet disk (Figure 5.1 lower right hand plate). Similar experiments were 
repeated to study the mutagenicity induced by soot extracts in TA100 and TA98 strains.   
5.3. RESULTS AND DISCUSSION 
 In the US, to increase the longevity and improve the appearance of the parking lots and, 
driveways; concrete or asphalt pavements are coated with a black material that is known as seal 
coat (Dubey). In the US, the most common type of seal coat is coal tar (Scoggins et al. 2009). 
The carbonaceous material based sealants (e.g. coal tar) have PAHs adsorbed in them. Usually, 
PAHs are present in the environment as a mixture. In the environment, PAHs have different 
sources but coal tar has the highest concentration of PAHs (Scoggins et al. 2009; Mahler et al. 
2012). In urban lake sediments, particles abraded from coal tar sealcoats, which enter different 
water sources, are the main source of PAHs. These PAHs are highly toxic to biological systems 
and pose human health hazards.  
 To study the PAC based PAHs mutagenicity potential; we used the plate incorporation 
method with and without S9 microsomal activation system. The plate incorporation method was 
used with S. typhimurium TA100 and TA98 bacterial strains to screen for base pair substitution 
and frameshift mutations (Maron and Ames 1983).  
 The concentrations of PAHs were measured in different coal tar and soot extract samples 
using GCMS (Table 5.1-5.2) This study contained two samples for each extract i.e. coal tar 
extract sample 1(CTE-1), coal tar extract sample 2 (CTE-2) and soot extract 1 (SE-1) and soot 
extract 2 (SE-2). GCMS analysis of these samples demonstrated that CTE-2 and SE-1 had higher 
concentrations of PAHs as compared to CTE-1 and SE-1, respectively (Table 5.1-5.2). Out of 
EPA listed 16 priority PAHs (Campro Scientific), coal tar extracts had higher number of PAHs 
as compared to soot extracts.  
 The mutagenicity analysis demonstrated that coal tar and soot extracts were highly 
mutagenic and caused increased base pair substitution mutations by inducing higher frequencies 
of revertants in TA100 as compared to the induction of frameshift mutations in strainTA98. It 
was found that most of these the coal tar and soot samples were promutagens as the mutation 
frequencies were higher with S9 microsomal activation. Results demonstrated that SE-2 had a 
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highest mutagenic potency in TA100 and TA98 with S9 followed by SE-1. CTE-2 produced 
higher number of TA100 revertants as compared to CTE-1. However, CTE-2 had a lower 
mutagenic potency as compared to soot samples, despite the fact that CTE-2 had higher number 
of PAHs as compared to soot samples. Overall, all the soot and coal tar extracts induced base 
pair substitution mutations as compared to frameshift mutations (Table 5.3).    
 Results demonstrated that the average mutagenic potency of CTE-1 was 8 revertants/µg 
for the TA100 revertants with S9 microsomal activation system but without S9 microsomal 
activation system, the TA100 mutagenic potency rate was reduced to 1 revertant/µg. All the 
CTE-1 concentrations used in the experiment induced a significant response compared with their 
negative control after S9 microsomal activation system. CTE-1 without S9 microsomal 
activation system did not produce a significance difference as compared to the negative control. 
Due to the higher rate of random mutations, a large number of revertants were produced even in 
the plate with negative control. Therefore, data were corrected for the negative control (Figure 
5.4.); the raw data are shown in Figure 5.3.   
 Results demonstrated that CTE-1 produced lower number of TA98 revertants as 
compared to the induction of TA100 revertants. The average mutagenic potency induced by 
CTE-1 in TA98 was 4 revertants/µg, with and without S9. Concentrations that induced a 
significance response was in the range of 20.5-205 µg/plate with S9 and 30.75-61.5 µg/plate 
without S9 (Table 5.3). In general, the difference between the number of TA98 revertants 
produced by CTE-1 with and without S9 was smaller than that of the TA100 with and without S9 
(Figures 5.4-5.5, Table 5.3). CTE-2 had relatively higher concentrations of PAHs as compared to 
CTE-1 (Table 5.1). CTE-2 produced higher number of TA100 revertants with S9 with average 
mutagenic potency of 9 revertants/µg as compared to without S9 (3.7 revertants/µg) (Figure 5.6, 
Table 5.3). CTE-2 was a weaker frameshift mutagen (Figure 5.7).  It only produced 3 
revertants/µg in TA98 with S9 and 1 revertants/µg without S9. CTE-2 produced significantly 
higher number of TA100 revertants with S9 as compared to negative control with all the 
concentrations used in the experiment (10.4-166.4 µg/plate). However, only higher 
concentrations of CTE-2 produced significantly higher number of TA98 revertants with and 
without S9 (Table 5.3). This was corroborated by the previous studies where coal tar induced 
TA100 and TA98 revertants in the concentration range of 10-200 µg/plate and produced more 
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revertants with S9 activation as compared to without S9 activation system (Robinson et al. 1984; 
Cosmetic Ingredient Review Expert Panel 2008) 
 SE-1 induced a higher frequency of TA100 revertants with S9 with the average 
mutagenic potency rate of 10 revertants/µg then without S9 (6 revertants/µg). The significant 
concentration range was 11.5-103.5 µg/plate for the revertants produced with S9 and 103.5 
µg/plate without S9 activation. SE-1 produced 9 TA98 revertants/µg with S9 and 5 revertants/µg 
without S9. Concentrations expressing significant mutagenic responses with S9 and without S9 
were 11.5-103.5 µg/plate (Table 5.3). SE-1 produced higher number of TA98 and TA100 
revertants with S9 as compared to without S9 (Figure 5.8-5.9). However, SE-2 had the higher 
PAHs concentrations as compared to SE-1 was highly mutagenic as compared to all other 
samples in the study. SE-2 produced the highest number of TA100 and TA98 revertants with S9 
with the average mutagenic potency rate of 13 revertants/µg and 12 revertants/µg, respectively. 
All the concentrations (10.33-92.97 µg/plate) used for TA100 and TA98 mutagenicity 
experiment induced significantly higher numbers of revertants with S9. SE-2 had a relatively 
lower mutagenic potency rate for TA100 and TA98 without S9 and produced on 5 revertants/µg. 
Only higher concentrations showed a significant increase in the number of TA98 revertants 
(Table 5.3).  Results demonstrated that SE-2 produced the highest number of TA100 and AT98 
revertants with S9 as compared to without S9. However, the effect of S9 on TA98 revertants 
induced by SE-2 was not higher as much as it was on the TA100 revertants (Figure 5.10-5.11). 
(Godefroy et al. 2005)   
 The coal tar and soot extracts with higher concentrations of PAHs were compared for 
their mutagenic potency. Results demonstrated that out of the EPA listed 16 priority PAHs, SE-2 
had relatively lower number of PAHs as compared to CTE-2, despite having lower number of 
PAHs, SE-2 showed a stronger mutagenic potency as compared to CTE-2. SE-2 produced higher 
number of TA100 and TA98 revertants with S9 as compared to CTE-2 (Figure 5.12-5.13).   
5.4. CONCLUSIONS 
 These data demonstrated that coal tar particles adsorbed more PAHs as compared to soot. 
Soot extracts had lower number of PAHs. However, the mutagenic potency of soot extracts was 
greater than the coal tar extracts. Both kinds of PACs were promutagenic and required the S9 
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microsomal activation system. These PACs based PAHs induced more base pair substitution 
mutation as compared to frameshift mutations.  
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5.5. TABLES AND FIGURES  
 
Table 5.1. Concentrations of PAHs extracted from two coal tar samples; sample 1 
with 50 mg of coal tar and sample 2 with 60 mg of coal tar. Coal tar samples were 
extracted with 50:50 acetone: dichloromethane 
  
Concentration in extract (mg/L) 
  
Compound Sample 1 Sample 2 
Naphthalene 2.49 3.20 
Acenaphthalene 0.09 0.09 
Acenaphthylene 0.05 0.04 
Fluorene 2.37 2.38 
Phenanthrene 11.49 14.55 
Anthracene 11.49 14.55 
Fluoranthene 23.23 50.68 
Pyrene 55.10 36.01 
Chrysene 1.44 1.58 
Benz[a]anthracene 8.94 12.41 
Benzo[b]fluoranthene 3.94 4.93 
Benzo[k]fluoranthene 1.66 1.82 
Benz[a]pyrene 2.82 3.40 
Indeno[123-cd]pyrene 2.60 0.16 
Dibenz[ah]anthracene 0.14 0.24 
Benzo[ghi]perylene 0.32 0.35 
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Table 5.2. PAHs extraction from SOOT samples, representing the mass and 
concentrations of PAHs in different soot samples extracts 
     
     Mass PAH in 2 mL 
(µg) 
  
Concentration of PAH 
(mg/L) 
  
  Sample 1 Sample 2 Sample 1 Sample 2 
Naphthalene 
    Acenaphthalene 
    Acenaphthylene 
    Fluorene 
    Phenanthrene 0.584 0.612 0.292 0.306 
Anthracene 
 
0.130 
 
0.065 
Fluoranthene 0.869 0.854 0.434 0.427 
Pyrene 1.379 1.366 0.690 0.683 
Chrysene 0.233 0.232 0.116 0.116 
Benz[a]anthracene 0.238 0.236 0.119 0.118 
Benzo[b]fluoranthene 0.529 0.537 0.264 0.269 
Benzo[k]fluoranthene 
 
0.108 
 
0.054 
Benz[a]pyrene 0.711 0.738 0.355 0.369 
Indeno[123-cd]pyrene 0.756 0.770 0.378 0.385 
Dibenz[ah]anthracene 
    Benzo[ghi]perylene 0.994 1.024 0.497 0.512 
Total conc. (mg/L) 
  
3.146 3.303 
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Table 5.3. Mutagenicity analysis of particle associated polyaromatic hydrocarbons using S. typhimurium  
Carbonaceo
us material 
extract  
Strain S9 
Treatment 
range 
(µg/plate) 
Range with 
significant 
response  
ANOVA test 
Mutagenic 
potency 
(average 
revertants/µg) 
CTE-1 
TA100  +  10.25-61.5 10.25-61.5  F=6.113; P<0.001 8  
TA98 + 10.25-205 20.5-205 F=7.986; P<0.001 4 
TA100  −  10.25-61.5 Not significant  F=2.69;P=0.024  1  
TA98 − 10.25-205 30.75-61.5 F=3.376; P=0.011 4 
CTE-2 
TA100 + 10.4-166.4 10.4-166.4 F=7.96; P<0.001 9 
TA98 + 10.4-166.4 41.6-166.4 F=15.387;P<0.001 3 
TA100 − 10.4-166.4 166.4-104 F=8; P<0.001 3.7 
TA98 − 10.4-166.4 83.2-166.4 F=28.296;P<0.001 1 
SE-1 
TA100 + 11.5-103.5 11.5-103.5 F=253; P<0.001 10 
TA98 + 11.5-103.5 11.5-103.5 F=1079; P<0.001 9 
TA100 − 11.5-103.5 103.5 F=7.85; P=0.002 6 
TA98 − 11.5-103.5 11.5-103.5 F=485; P<0.001 5 
SE-2 
TA100 + 10.33-92.97 10.33-92.97 F=153; P<0.001 13 
TA98 + 10.33-92.97 10.33-92.97 F=293; P<0.001 12 
TA100 − 10.33-92.97 30.99-61.98 F=5.671; P=0.005 5 
TA98 − 10.33-92.97 10.33-92.97 F=445; P<0.001 5 
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Figure 5.1. Diagnostic plates for the S. typhimurium plate incorporation mutagenicity assay. A 
negative control is illustrated by the left top and bottom plates with and without S9, the second 
top and bottom plates are showing vehicle control with and without S9, the top right plate is 
positive control (BaP) and the right bottom plate is the crystal violet rfa− plate showing a clear 
zone of inhibition.  
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Figure 5.2. Mutagenicity of coal tar extract (CTE) from lake sediments with polyaromatic 
hydrocarbons in S. typhimurium, strain TA100, after mammalian hepatic microsomal activation 
showing increasing numbers of histidine revertants as a function of the concentration of the 
CTE.  
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Figure 5.3. Mutagenicity of coal tar extract 1(CTE-1) from lake sediments with polyaromatic 
hydrocarbons (PAHs) in S. typhimurium, strain TA100 with and without microsomal activation. 
CTE-1 is showing increasing number of histidine revertants in the presence of S9 activation 
system as compared to without S9 activation system, as a function of the increasing CTE-1 
concentration.  
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Figure 5.4. Mutagenicity of coal tar extract 1(CTE-1) from lake sediments with polyaromatic 
hydrocarbons (PAHs) in S. typhimurium, strain TA100 with and without microsomal activation, 
corrected for the negative control with higher rate random mutations induced revertants. CTE-1 
is showing increasing number of histidine revertants in the presence of S9 activation system as 
compared to without S9 activation system, as a function of the increasing CTE-1 concentration.  	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Figure 5.5. Mutagenicity of CTE-1 from lake sediments with PAHs in S. typhimurium, strain 
TA98 with and without microsomal activation. CTE-1 is showing increasing number of histidine 
revertants in the presence of S9 activation system as compared to without S9 activation system, 
as a function of the increasing CTE-1 concentration.  	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Figure 5.6. Mutagenicity of CTE-2 from lake sediments with PAHs in S. typhimurium, strain 
TA100 with and without microsomal activation. CTE-2 is showing increasing number of 
histidine revertants in the presence of S9 activation system as compared to without S9 activation 
system, as a function of the increasing CTE-2 concentrations.  	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Figure 5.7. Mutagenicity of CTE-2 from lake sediments with PAHs in S. typhimurium, strain 
TA98 with and without microsomal activation. CTE-2 is showing increasing number of histidine 
revertants in the presence of S9 activation system as compared to without S9 activation system, 
as a function of the increasing CTE-2 concentrations.  
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Figure 5.8. Mutagenicity of SE-1from lake sediments with PAHs in S. typhimurium, strain 
TA100 with and without microsomal activation. SE-1 is showing increasing number of histidine 
revertants in the presence of S9 activation system as compared to without S9 activation system, 
as a function of the increasing SE-1 concentrations.  	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Figure 5.9. Mutagenicity of SE-1from lake sediments with PAHs in S. typhimurium, strain TA98 
with and without microsomal activation. SE-1 is showing increasing number of histidine 
revertants in the presence of S9 activation system as compared to without S9 activation system, 
as a function of the increasing SE-1 concentrations.  
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Figure 5.10. Mutagenicity of SE-2 from lake sediments with PAHs in S. typhimurium, strain 
TA100 with and without microsomal activation. SE-2 is showing increasing number of histidine 
revertants in the presence of S9 activation system as compared to without S9 activation system, 
as a function of the increasing SE-2 concentrations.  
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Figure 5.11. Mutagenicity of SE-2from lake sediments with PAHs in S. typhimurium, strain 
TA98 with and without microsomal activation. SE-2 is showing increasing number of histidine 
revertants in the presence of S9 activation system as compared to without S9 activation system, 
as a function of the increasing SE-2 concentrations.   
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Figure 5.12. Mutagenicity of SE-2 VS CTE-2 from lake sediments with PAHs in S. typhimurium, 
strain TA100 with and without microsomal activation. SE-2 is showing relatively higher TA100 
revertants as compared to CTE-2 with S9 activation system as a function of the increasing SE-2 
concentrations.   
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Figure 5.13. Mutagenicity of SE-2 VS CTE-2 from lake sediments with PAHs in S. typhimurium, 
strain TA98 with and without microsomal activation. SE-2 is showing relatively higher TA98 
revertants as compared to CTE-2 with S9 activation system as a function of the increasing SE-2 
concentrations.   
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CHAPTER 6 
CONCLUSIONS  
 The main focus of this dissertation was to study the toxicity mechanisms of 
anthropogenic water contaminants. The objectives were to i) analyze the toxicity mechanisms of 
haloacetic acids (HAAs) water disinfection by-products (DBPs) and to identify their molecular 
targets, ii) study the cytotoxicity and genotoxicity of chlorinated and chloraminated waste water 
effluents, iii) study the mutagenic effect of particle associated contaminants such as polycyclic 
aromatic hydrocarbons (PAHs) extracted from soot and coal tar particles in lake sediments.  
Following conclusions were derived from these studies.  
 It was concluded from the first study that HAAs were inducing their toxicity by affecting 
glycolytic and mitochondrial metabolism and by disrupting cellular energy homeostasis. 
However, there were differences among mono-, di-, and triHAAs toxicity mechanisms and their 
molecular targets. monoHAAs were the strongest inhibitors of gluceryldehyde-3-phosphate 
dehydrogenase (GAPDH) and greatly reduced the ATP contents of the cells. Di-, and triHAAs 
were weaker inhibitors of GAPDH and increased the ATP contents of the cells. HAAs not only 
affected the GAPDH kinetics but also affected the pyruvate dehydrogenase complex (PDC) 
activity. Most of the HAAs activated PDC. It was concluded that monoHAAs activated PDC 
because of the cellular metabolite ratios (ATP/ADP, NADH/NAD) which was a disruption 
induced by GAPDH inhibition. Reduction in cellular metabolites by the monoHAAs required 
cells to accelerate PDC activity based on the metabolite ratio-dependent pyruvate dehydrogenase 
(PDH) regulation. It was also concluded that the toxicity of monoHAAs was mainly due to the 
GAPDH inhibition as pyruvate supplementation rescued the cells against the monoHAAs 
induced genomic DNA damage and cellular ATP reductions. However, di- and triHAAs were the 
weaker inhibitors of GAPDH, increased celluar ATP levels, and increased the PDC activity. 
From this result I concluded that di-, and triHAAs induced increase in the PDC activity was due 
to the pyruvate dehydrogenase kinase (PDK) dependent regulation of PDH. Some di-, and 
triHAAs inhibited PDK, which blocked the PDK induced PDH inhibition and in turn increased 
the overall PDC activity.   
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 From these results a global conclusion is that monoHAAs affect the mitochondrial 
metabolism by disturbing different metabolite ratios while di-, and triHAAs have a direct effect 
on mitochondrial metabolism by inhibiting PDK. 
 The second study involved a mammalian cell based cytotoxicity and genotoxicity 
analyses of concentrated organics of chlorinated and chloraminated wastewaters effluents. The 
wastewater XAD-8-isolated organic extracts were more cytotoxic and genotoxic than the XAD-4 
extracts of the same wastewaters. It was concluded that halogenated hydrophobic acid fractions, 
aliphatic carboxylic acid fractions, and humic substances, which were eluted from XAD-8 were 
more cytotoxic and genotoxic than the organics eluted from XAD-4 resins. After passage over 
the XAD columns the remaining spent wastewater expressed very little residual toxicity 
indicating that XAD-8/XAD-4 extraction was highly efficient. The method of disinfection also 
affected the overall toxicity of the extracts. The organic extracts eluted from XAD-8 or XAD-4 
for chlorinated water was more cytotoxic and genotoxic than that of the chloraminated 
wastewater extracts.   
 The final study involved the mutagenicity evaluation of PAHs extracted from different 
carbonaceous materials e.g. soot and coal tar from lake sediments. It was concluded from the 
data that coal tar and soot extracts were promutagens and required S9 microsomal activation to 
be converted into active mutagens. The coal tar and soot extracts induced more base pair 
substitution mutations as compared to frameshift mutations. Of the EPA listed 16 PAHs; soot 
samples had a lower number of PAHs as compared to coal tar extracts. However, soot extracts 
induced higher number of TA100 and TA98 revertants as compared to coal tar extracts. 
